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High-quality services and evidence-based care are vital components of a well-
functioning health care system. Currently, the focus on high-quality health care has led to 
the routine measurement of national quality criteria and, in Norway, a national patient 
safety programme. However, parts of the health care system are based more on traditions 
that have developed over the years than on scientific reasoning. For example, the process of 
referral from general practitioners (GPs), i.e., primary care to hospital doctors, i.e., 
secondary care has remained unchanged for many years, although the introduction of 
electronic communication has improved the more administrative aspects. Moreover, the 
clinical content of referral documents continues to be debated, with hospital doctors 
emphasising that the lack of important information makes it difficult for them to deliver 
high-quality care and prioritise those with the highest need. 
The present intervention study looked to facilitate a better transfer from primary to 
secondary care in the Norwegian health care system by implementing referral templates 
(available as laminated paper and electronic documents) which were designed for four 
diagnostic groups (1) patients with dyspepsia, (2) patients with suspected colorectal 
malignancy, (3) patients with chest pain, and (4) patients with chronic obstructive pulmonary 
disease. Using a clustered approach, the fourteen GP surgeries located in the geographical 
area served by the University Hospital of North Norway Harstad were randomised to an 
intervention or control group, with seven surgeries in each.  
In total, 500 patients were included in the analysis, 281 in the intervention and 219 in 
the control group. There were no significant baseline differences between GPs or patients in 
the intervention and control groups, but there were more referrals sent from female GPs 
and GP specialists in the intervention than the control group. The referral template was used 
for about half of the new referrals in the intervention group, which was less than hoped for. 
The main hypothesis in the current project was that the implementation of a referral 
template would lead to a measurable increase in the quality of hospital care. 
Paper I showed that the content of referral documents in the intervention group was 
significantly better than that in the control group, when measured against the referral 
template. After adjustment for whether the GP was board certified or not, centred GP list 
7 
 
size, GP hospital experience (in years), and categorised GP surgery size, the effect of the 
referral intervention was estimated at 18% (95% confidence interval 11, 25 p<0.001). In 
addition, the analysis showed that board certified GPs produced referral documents of 
higher quality, whereas, surprisingly, longer GP hospital experience reduced the quality of 
referral documents. 
To examine the effect of the increase in quality of referral documents on patients’ 
experience of the treatment process, self-administered questionnaires were developed. As 
presented in Paper II, a total of 410 (82.0%) patients returned a completed questionnaire. In 
general, patients were very satisfied with their care, but areas with most dissatisfaction 
concerned patient interaction, involvement, and information. There were no significant 
differences between the responses in the intervention and control groups. Analyses were 
done on a single-question basis, but to further assess the effect of clustering, a multilevel 
model was built after multiple imputation using chained equations with predictive means 
matching to account for missing data in the questionnaires. The effect of clustering was low, 
as assessed when using the imputed data in a multilevel regression model. 
The main outcome measure of the study was the quality of the care process for each 
individual patient, based on quality indicators developed from previous publications and 
guidelines. In addition, each care pathway was given a subjective quality score (scale 1-10) 
by medical specialists who were unaware of the intervention status of the patient. As shown 
in Paper III, we observed no significant effect of the referral template on quality indicator 
score (1.80%; 95% confidence interval -1.46, 5.06, p=0.280) or the subjective quality score. 
The prioritisation of patients in the intervention group was no better than that in the control 
group. 
The current study showed significant improvement in the quality of referral 
documents following the referral intervention, but no significant change in patient 
experience or quality of care. The results may have been influenced by the relatively low 
usage of the referral template (approximately 50% of referrals in the intervention group 
were done using the referral template) and the wide variation in scoring from the specialists. 
Based on this study, broad-scale implementation of referral guidance cannot be 
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Kunnskapsbaserte tiltak og behandling av høy kvalitet er grunnleggende 
komponenter i en velfungerende helsetjeneste. Fokuset på høy behandlingskvalitet har ført 
til at det nå foregår rutinemessige målinger av nasjonale kvalitetskriterier og det er startet et 
nasjonalt pasientsikkerhetsprogram. Selv om dette pågår er det fremdeles deler av 
behandlingskjeden som er mer basert på tradisjoner utviklet over mange år enn 
forskningsbasert kunnskap. Prosessen med henvisning fra allmennlegen til sykehuset har 
ikke endret seg på mange år, selv om introduksjonen av elektronisk kommunikasjon har 
forbedret noen av de mer administrative aspektene av henvisningen. Det kliniske innholdet i 
henvisningene debatteres fremdeles. Sykehuslegene mener ofte at mangelen på viktig 
informasjon gjør det vanskeligere å skape helsetjenester av høy kvalitet og prioritere de som 
trenger tjenesten mest. 
Konseptet til denne intervensjonsstudien var å skape bedre samhandling mellom 
nivåene i helsetjenesten ved å implementere en intervensjon på henvisningene fra fastlege 
til sykehus. I intervensjonsgruppen ble det tatt i bruk henvisningsmaler ved henvisning av 
pasienter tilhørende fire ulike pasientgrupper. Disse fire gruppene var pasienter med (1) 
dyspepsi, (2) mistanke om kreft i tykktarmen, (3) brystsmerter eller (4) kronisk obstruktiv 
lungesykdom (KOLS). De fjorten legekontorene i området som sokner til 
Universitetssykehuset Nord-Norge (UNN) Harstad ble grupperandomisert til en intervensjon 
eller kontroll gruppe, med totalt 7 legekontor i hver.  
500 pasienter deltok i prosjektet frem til analyse og av disse var 281 i 
intervensjonsgruppen og 219 i kontrollgruppen. Det var ingen signifikante demografiske 
forskjeller mellom pasientene eller allmennlegene i de to gruppene. Derimot var flere av 
henvisningene sent fra kvinnelige allmennleger og allmennlegespesialister i 
intervensjonsgruppen enn i kontrollgruppen. Intervensjonen ble tatt i bruk i cirka halvparten 
av de nye henvisningssituasjonene i intervensjonsgruppen, noe som er mindre enn vi 
opprinnelig ønsket. 
Hovedhypotesen i dette prosjektet var at en forbedring i henvisning fra fastlege til 
sykehuset skulle gi en målbar forbedring i kvaliteten på sykehusbehandlingen. 
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Artikkel I viser at henvisningene i intervensjonsgruppen var signifikant bedre enn de i 
kontrollgruppen, når de ble målt opp i mot henvisningsmalene. Korrigert for allmennlegens 
spesialiststatus, sentrert pasientlistestørrelse, allmennlegens sykehuserfaring (i år) og 
kategorisert legekontorstørrelse ble effekten av intervensjonen estimert til 18% (95% CI 11, 
25 p<0.001). I tillegg viste analysen at spesialister i allmennmedisin skrev henvisninger av 
bedre kvalitet og at, overraskende nok, lengre sykehuserfaring hadde sammenheng med 
henvisninger av lavere kvalitet. 
For å undersøke effekten av den økte henvisningskvaliteten på pasienterfaringene 
med behandlingsprosessen utviklet prosjektet spørreskjemaer. Artikkel II viser at etter 
utsendelse av en påminnelse svarte totalt 410 pasienter (82,0%). Generelt var pasientene 
meget fornøyd med sin behandling, men var minst fornøyd med informasjonen fra 
behandlerne og egen involvering i beslutningsprosessene. Det var ingen større forskjeller 
mellom pasienter i intervensjons- og kontrollgruppen. For videre å undersøke effekten av 
grupperandomisering ble dataene analysert med regresjonsteknikk etter at statistisk 
korreksjon for manglende svar i skjemaene var utført. Effekten av grupperandomsering på 
pasienterfaringene var liten.  
Hovedutfallsmålet i studien var effekten av intervensjonen på behandlingskvalitet for 
hver enkelt pasient. For å måle kvaliteten i behandlingskjeden utviklet prosjektet 
kvalitetsindikatorer basert på tidligere publiserte indikatorer og behandlingsretningslinjer. I 
tillegg ble hvert behandlingsforløp scoret på en subjektiv skala (1-10). Scoring ble gjort av 
spesialister uten kjennskap til om pasienten var i intervensjons- eller kontrollgruppen. 
Artikkel III viser at det ikke var noen signifikant forskjell mellom de to gruppene, hverken på 
kvalitetsindikatormålet (1,80 %; 95% CI -1,46, 5,06, p=0,280) eller den subjektive 
kvalitetsscoren. I tillegg ble ikke prioriteringen av pasientene mer presis i 
intervensjonsgruppen enn i kontrollgruppen. 
Denne studien viste dermed ingen forbedring i pasientopplevelse eller 
behandlingskvalitet, til tross for klar forbedring av henvisningskvalitet. Resultatene kan ha 
blitt påvirket av relativt lav aktiv bruk av intervensjonen og stor variasjon i kvalitetsscoring 
gjort av spesialistene. Ut fra denne studien kan en ikke anbefale stor utbredning av 
henvisningsmaler før tydelige effekter er blitt vist i praksisnær forskning. 
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1.0 Introduction  
Health care is commonly organised into levels, with the sharpest divide between out-
of-hospital primary care and hospital-based secondary care. However, individual patients 
often receive care at multiple levels, both physically in the community and in the hospital, 
and across different health care professions. Hence, health care coordination and 
communication are important aspects in any health care system. 
In Norway, general practitioners (GPs) represent primary care and act as gatekeepers 
to hospital doctors at the secondary care level. Health care in Norway is governed by two 
main laws: the act relating to specialised health services[1] and the act relating to municipal 
health services[2], but the act relating to patients’ rights[3] and to health personnel[4] are 
also of interest. All these acts share the common, explicitly stated purpose of safeguarding 
equal access to high-quality health services for all, but they are also meant to ensure the 
appropriate use of resources. At the time of the present study, the act relating to patients’ 
rights gave patients a legal right to health care, provided the patient could be expected to 
benefit from that care and that the costs were in concordance with the effect of the care[3]. 
In practice, the application of this right for secondary care was determined by the hospital 
consultant, based on communication from the GP, usually in the form of a referral 
document.  
Traditionally, the referral document has been the standard form of communication 
and transfer of responsibility from primary to secondary care. Although the content and 
quality of referral documents have been debated for some time[5,6], there has been limited 
research on the clinical benefit of improving this quality[7]. In addition, there has been 
surprisingly little research on the referral process, as indicated in a relatively recent editorial 
from the United States[8]. However, in Norway, research focusing on referral rates[9,10], 
referral interventions[11,12], and cost analyses[13], is starting to emerge. 
The demand for out-patient secondary care in Norway is steadily rising, with a 7% 
increase in out-patient hospital appointments observed between 2008 and 2012[14]. It has 
been estimated that if every single GP referred one additional patient to secondary care 
every day, it would increase the number of referrals by one million per year[15]. Given the 
current number of appointments[14], this would increase the workload by approximately 
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20%, and would, under the current health care structure, be unsustainable. The demand for 
quality care is also increasing, both in Norway and internationally[16,17]. In the everyday 
clinical setting, these increasing demands, coupled with a perceived lack of information in 
the referral documents received, make it difficult to prioritise individuals referred from a GP 
to the hospital according to their needs. 
With this background in mind, the main aim of the present thesis was to investigate 
whether improving the quality of referrals could lead to improved delivery of high-quality 















2.1 Focus on quality and safety in health care 
Internationally, the focus on prevention of medical errors and improving quality of 
medical care is increasing[16-19]. There are journals1 dedicated to the publication of papers 
on quality, quality improvement, and quality measurement, as well as large international 
conferences devoted to the topic. Nationally, the Norwegian Patient Safety Programme: ‘In 
Safe Hands’, was launched in 2014 and aims to reduce preventable patient harm, establish 
lasting structures for patient safety, and improve patient safety culture[20]. This focus has 
taken many forms, from the publication of a multitude of management guidelines [21-23], to 
introducing car production methodology into the efficient management of patient care 
pathways [24-26]. However, much of the work being done focuses on separate and specific 
health care processes, either at the primary or secondary care level, rather than trying to 
assess the entire health care process. In addition, a recent editorial pointed out that care 
must be taken to ensure that quality, and not just quality measurement, remains the 
purpose of any given quality improvement process[27]. 
2.2 The role of the referral in transitions of care 
Transitional care has been defined as “a set of actions designed to ensure 
coordination and continuity of health care as patients transfer between different locations 
or different levels of care within the same location”[28]. Although key roles for both the 
sending and receiving care team have been identified, key information about the patient 
may not be adequately communicated[29]. In Norway, the Health Sector Coordination 
Reform, which started in January 2012, aims to improve health care cooperation to ensure 
effective preventive care and to ensure that health care is delivered at the right level[30].  
When referrals are made from GPs to hospital doctors, the major exchange of 
information is done through the written text of the referral document[31,32]. Problems with 
this communication can lead to difficulties in finding a correct diagnosis or repeat testing 
and initiation of treatment that has already proven ineffective[33]. Thus it is clear that the 
referral document is an important communicative tool between primary and secondary care 
                                                          
1
 E.g., BMJ Quality & Safety, International Journal for Quality in Healthcare, BMC Health Services Research, 
American Journal of Medical Quality 
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providers. However, as a Norwegian study from 2007 amongst elderly patients 
demonstrated, both referral and discharge documents are often missing vital information, 
even “to such an extent that it might represent a health hazard to older patients”[32]. A 
Finnish quality assessment of referral documents for patients with asthma concluded that 
45% of these documents were of poor or unacceptable quality, when evaluated against 
criteria developed by GPs and hospital respiratory specialists[34]. A recent Canadian survey 
showed that the main problem specialists identified in referral documents was that they 
lacked a reason for referral[35]. Others have also reported varying quality and content of 
referral documents in different clinical settings[36-43].  
The quality of the referral document is not always perceived as relevant to the 
referral process. However, there seems to be good agreement between GPs and hospital 
doctors as to what a referral document should contain [5]. In the United States, the National 
Quality Forum has published preferred practices for care coordination, including transitions 
of care[44]. In Norway, there are agreements and guidelines that govern the content of 
electronic referral and discharge documents [45,46], but they are mainly limited to headings 
and content categories, without specifying the precise information needed in each clinical 
scenario. In a recent Norwegian study, it is this lack of information, rather than the structure 
of the referral document itself, the hospital doctors perceived as a barrier to care 
cooperation[47]. 
The present, steadily rising referral rates[48] and demand for out-patient medical 
services[49] are creating a strain on medical departments, with an increasing need to be able 
to prioritise patients. Others have shown high variation in referral rates [10], which may be 
related to a GP’s gender and speciality status[9]. In addition, factors other than the 
perceived risk of serious disease may affect the decision to refer, such as patient 
reassurance, medico-legal risk reduction, handing over of care, or simply to get a second 
opinion[50]. Given this wide variation in referral rates, referral quality, and referral reasons, 
the work that hospital doctors must do to identify referred patients with the highest need 
for health services is becoming more difficult.  
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2.3 Previous interventions applied to the referral process 
In 1964, Kunkle described the communication breakdown in patient referrals as a 
“disorder of medical practice (which) is largely curable”[33]. Since then, many studies have 
aimed to improve the quality of referrals from GPs to hospital doctors, with mixed results. In 
Scotland, a complex intervention combined the dissemination of referral guidelines with 
open access to an investigation service for lower urinary tract symptoms or microscopic 
haematuria, which led to reduced wait times and fewer out-patient appointments[51]. In 
another study amongst patients with dyspepsia, the dissemination of referral guidelines 
alone was compared with the combination of the dissemination of referral guidelines and 
educational outreach. They concluded that the combined approach may be better than the 
dissemination of referral guidelines alone, but the intervention did not change the diagnostic 
yield at gastroscopy[52]. For patients with lower bowel symptoms, Jiwa et al compared 
interactive electronic referral alone to a combination of interactive electronic referral and 
educational outreach or no intervention. The interventions did increase the amount of 
information in referral documents, but it did not increase the proportion of organic 
pathology amongst those referred[53]. However, the uptake of the intervention was poor. In 
a systematic review by Faulkner et al on interventions in primary care and their effect on 
referral quality, the authors concluded that such assessment is difficult[54], as end-points 
and targets are not clearly defined in the literature. Does improving quality mean a simple 
reduction in referral numbers, more appropriate referral content, or more relevant care of 
higher quality? 
Drawing on some of the studies discussed above, a Cochrane review on interventions 
to improve referrals from primary to secondary care concluded that few interventions on the 
referral system have been rigorously evaluated[7]. The review further concluded that 
structured referral sheets and local educational interventions have an impact on referral 
rates. However, few studies have been able to present findings on several aspects of the 
referral process simultaneously. The review recommended further studies, both to validate 
current findings and highlight others factors of the referral process, such as referral 
numbers, referral quality, secondary care management, flow of patients through the referral 
process, patient outcome and satisfaction, and resource use. 
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2.4 Quality of care 
In the evaluation of any health care intervention, the assessment of the effect on the 
quality of care delivered to patients is paramount. Quality of health care is defined by the 
American Institute of Medicine as: “the degree to which health services for individuals and 
populations increase the likelihood of desired health outcomes and are consistent with 
current professional knowledge”[55]. On a more operative level, it has been suggested to 
define quality of care as “the degree to which health services achieve a level of care deemed 
adequate by evidence-based quality measures of the structure, process and outcomes of 
care”[56]. 
Health services evaluation and the measurement of quality of care is a complex field. 
Much of the perceived global quality measurements are done to measure adherence to 
specific actions and for accreditation or reimbursement purposes[57,58]. However, this 
measurement is thought to be useful in documenting quality of care, making comparisons, 
prioritising, and improving quality of care and accountability[59,60]. The area of quality 
measurement is still under development, and new areas, including patient feedback, are 
continually evaluated, even via Facebook[61]. 
Quality measures are usually classified into structural, process, or outcome measures, 
as suggested by Donabedian[62]. Structural measures are often easy to evaluate, such as 
equipment, facilities, and staffing numbers. However, structural measures are often only 
weakly associated with outcomes[63]. Process measures consider components of the 
encounter between the patient and the health care professional, such as tests ordered or 
treatment initiated[60]. Outcome measures use specific health outcomes as quality 
measures and directly measure survival, complications, and quality of life [63]. However, the 
assessment of outcome measures is often hampered by the infrequency of events (e.g., 
mortality) and the length of time between an intervention and the possible outcome[64]. If a 
structural or process measure is used, it should already be shown to be associated with 
better outcomes[64]. Today the use of quality criteria range from system- or national-level 
measurements for reimbursement and quality efforts[65,66] via disease-specific 




However, quality indicators are only tools to support quality improvement; they are 
not necessarily direct measures of quality[71].  Others have raised the issue of whether the 
measurement of smaller aspects of care may shift the focus from other unmeasured, but 
equally important, aspects of care[57,72]. A review of performance indicators in the 
speciality referral process identified multiple indicators[73], but most of these focused on 
the structural components of the referral process, and as such, may not holistically depict 
the quality of the entire treatment process. As we recognise the difficulties of quality 
measurement, the current thesis aimed to holistically depict the quality of the entire patient 
care pathway across several of the domains of quality indicated by the Institute of Medicine 
in the landmark 2001 report Crossing the Quality Chasm; safety, effectiveness, patient-
centeredness, timeliness, efficiency, and equity[55]. 
2.5 The four diagnostic groups 
In this PhD project, the intervention and subsequent quality measurement focused 
on four diagnostic groups, i.e., patients referred within four common diagnostic scenarios in 
the hospital ambulatory care setting. The scenarios were chosen to represent several 
specialties across the medical spectrum. In addition, they represent clinical situations with 
some diagnostic difficulty in primary care, encompass symptoms with which patients 
commonly present in GP practice, and are adept for relatively simple referral guidelines. 
They are also scenarios in which differential diagnoses are potentially very serious, but 
where many patients have more mundane explanations for their symptoms.  
2.5.1 Dyspepsia 
Dyspepsia usually refers to recurrent pain or discomfort in the upper abdomen[74]. 
In the Roma III classification of functional gastrointestinal disorders, functional dyspepsia 
includes one or more of the following symptoms: (a) bothersome postprandial fullness, (b) 
early satiation, (c) epigastric pain, and (d) epigastric burning. For the Roma III criteria to be 
fulfilled there also has to be no evidence of structural disease (including at upper endoscopy) 
that is likely to explain the symptoms[75]. However, dyspepsia is a term which has had many 
interpretations by different physicians[75], and the diagnosis of functional dyspepsia can 
only be applied after investigation. In the primary care setting, the term ‘uninvestigated 
dyspepsia’ is often used[74], as it is difficult to clinically differentiate between dyspepsia 
20 
 
and, for instance, gastroesophageal reflux disease[76]. The current PhD project considered 
referrals from primary care, and as such a wider definition of dyspepsia was used: all 
patients referred with uninvestigated upper gastrointestinal symptoms were included. This 
included patients with upper abdominal pain/discomfort, upper abdominal burning, reflux 
symptoms, early satiety and so forth.  
Approximately 20-30% of people in Western societies report dyspeptic 
symptoms[77,78]. Dyspepsia represents about 2-5% of all medical consultations, in 
European populations[79]. Of these, approximately 25% have an underlying organic cause at 
gastroscopy[80]. In the United Kingdom, the cost of dyspepsia from a health services 
perspective was estimated at £500 million in 2002[81]. This figure is probably lower today, in 
light of cheaper medication, but dyspepsia still represents major financial burden, in addition 
to the burden of symptoms borne by patients.   
Others have tried to use symptoms to differentiate significant from more mundane 
underlying disease[82], and to prioritise between patients with upper gastrointestinal 
symptoms[83]. There is an internationally accepted set of ‘alarm features’ (Table 1) 
specifically aimed at identifying underlying malignancy[84]. In this PhD project, these 
features were included in the construction of the referral template, although not all of them 
were prioritised in the final version. 
Table 1 – Alarm features in a patient with dyspepsia 
Age >55 years with new-onset dyspepsia 
Family history of upper gastrointestinal cancer 




Unexplained iron deficiency anaemia 
Persistent vomiting 





2.5.2 Suspected colorectal malignancy 
Colorectal cancer is a major malignancy. In 2012, the age-standardised incidence rate 
of colon cancer in Norway was 24.1/100,000 for women and 26.7/100,000 for men, making 
it the second most common cancer amongst women and third most common amongst 
men[85]. Colon cancer ranked third in terms of cancer mortality in Norway 2012 for both 
men and women[85].  Cancers of the rectum and anus are also potentially serious 
conditions.  
Common symptoms of colorectal cancer include occult blood in stool, rectal bleeding, 
change in bowel habits, abdominal pain, weight loss, fatigue, and diarrhoea[86]. However, 
no single, clear symptom can currently identify patients with colorectal cancer in primary 
care, although a combination of symptoms can alert a GP as to the possible diagnosis[87-89]. 
Referral prioritisation systems, like the 2-week wait in the United Kingdom, have struggled to 
improve diagnostic certainty[90]. Some countries have screening programmes in place for 
colorectal cancer, but the Norwegian programme is still in a pilot phase[91]. Hence, the early 
identification of patients with this potentially serious disease remains difficult. 
2.5.3 Chest pain 
Coronary artery disease remains an important, albeit decreasing, cause of mortality; 
ischaemic heart disease was responsible for 11.6% of deaths in Norway in 2012[92]. Chest 
pain is the symptom most classically associated with coronary artery disease, but non-life-
threatening aetiologies are much more common explanations for chest pain in general 
practice[93]. Causes of chest pain other than coronary artery disease include acute diseases 
such as pulmonary embolus, aortic dissection, and perforated gastric ulcer, together with 
more benign, less acute diseases, such as musculoskeletal chest pain, gastroesophageal 
reflux disease, pneumonia, pleuritis, stress, panic disorder, and other psychogenic 
diseases[94]. 
Earlier epidemiological work in the United Kingdom suggests that 14% of men report 
chest pain suggestive of coronary artery disease and a further 24% report atypical chest 
pain[95]. Patients with chest pain represent approximately 1% of the GP caseload[96,97]. 
However, only about 10% of patients end up with a diagnosis of stable coronary artery 
disease, and about 1-4% with acute coronary syndrome[97,98]. Much of the diagnostic 
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work-up and consideration is focused on the identification of those 10% of patients with 
coronary artery disease. The patients referred by the GP to the hospital for chest pain 
evaluation represent an important, and sometimes challenging, proportion of medical out-
patients. Hence, the current project included patients referred for chest pain evaluation or 
evaluation of suspected coronary artery disease. 
2.5.4 Chronic obstructive pulmonary disease  
Chronic obstructive pulmonary disease (COPD) is an airway disease with persistent, 
and usually progressive, airflow limitation, coupled with an enhanced chronic inflammatory 
response[99]. It is often associated with acute exacerbations and comorbidities[99]. In many 
countries, the prevalence of COPD is directly related to tobacco smoking; however indoor 
and outdoor pollution may also be contributing factors, especially in developing 
countries[100].  
It has been estimated that between 250,000 and 300,000 suffer from COPD in 
Norway[101], with a yearly incidence of about 1% of the population[102]. For approximately 
1% of the population, the disease is serious enough to warrant regular review by primary 
and/or secondary care[101]. In 2009, almost 1% of the Norwegian health expenditure was 
estimated to be attributable to COPD[103]. More than 2000 people die from COPD every 
year in Norway, which is almost equal to the number of people who die from lung 
cancer[92]. It is also clear that many of those affected are unaware that they have the 
disease, as only 43% of incident cases in a Norwegian population study had a prior diagnosis 
of asthma, bronchitis, emphysema, and/or COPD[102], suggesting a clear phenomenon of 
underdiagnosis.  
2.6 The Norwegian health care system 
The Norwegian health care system is relatively uniform throughout the country. In 
2013, 98.8% of the population had a regular GP, and at the end of 2013 there were 4387 GPs 
with an average list size of 1150 patients[104]. Specialist health care is delivered through 
government-owned regional health authorities, mainly via public hospitals. However, the 
regional health authorities do outsource some out-patient care to privately operating 
specialists. GP services are organised through the 426 municipalities. GPs either work 
privately, with capitation payment and fee-for-service reimbursement, or as municipal 
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employees. There are no financial incentives related to the referral process. GPs represent 
primary care and act as gatekeepers to secondary care, including hospital doctors and 
private specialists. In the study area, access to specialist care is practically impossible 
without referral from a GP, whereas in more urban areas, some access may be possible.  
In Norway, the use of electronic health records (EHR) and electronic referrals is 
almost ubiquitous. In 2008, 98% of the GP surgeries surveyed reported using EHR[105], and 
in 2010, 96% of the GPs surveyed reported that they always used EHR for their daily clinical 
work[106].  
2.7 Current referral practice 
Referrals to the University Hospital of North Norway (UNN) Harstad are nearly all 
electronic, but some paper referrals are still in use, mainly from smaller GP surgeries and 
temporary GPs. Paper referrals are scanned by hospital support staff and included in the 
hospital EHR. The demographic data in referrals are automatically extracted from the GP’s 
EHR, whereas the clinical content is based on free text and may be very short or very long, 














3.0 Aims of the thesis 
The increasing focus on quality in health care, together with the obvious 
shortcomings in the transition of care and the rising need for services within confined 
financial boundaries, inspired this PhD project. 
The main aim of the thesis was to document the need for good communication 
between providers when referring patients from primary to secondary care. Indeed, the 
referral is the “key” which unlocks access to the large and expensive secondary care system. 
In the trial that constituted this PhD project, we postulated that improvement of the referral 
document would lead to a measurable increase in the quality of health care delivered. 
Primary hypothesis: 
 The use of a referral template in the communication between GPs and secondary 
care will lead to a measurable increase in the quality of health care delivered (Paper 
III) 
Secondary hypotheses: 
 The use of a referral template in the communication between GPs and secondary 
care will lead to a measurable improvement in referral quality (Paper I) 
 The use of a referral template in the communication between GPs and secondary 
care will lead to improved patient experience (Paper II) 
 The use of a referral template in the communication between GPs and secondary 
care will lead to more appropriate prioritisation of patients, as measured by final 
diagnosis (Paper III) 
 The use of a referral template in the communication between GPs and secondary 
care will lead to an increase in the ‘appropriateness’ of referrals (Paper III) 
Hence, we hope to enlighten the debate regarding health care cooperation in the 




4.0 Material and methods 
4.1 Study design 
This PhD project is based upon a cluster randomised study, in which GP surgery was 
used as the clustering unit. Local GP surgeries were randomised to use either referral 
templates (intervention group) or standard referral practice (control group). 
4.2 Study population 
The GP surgeries in the area served by the Medical Department at the UNN Harstad 
were randomised, and study participants were recruited from out-patient clinics at the UNN 
Harstad. The UNN Harstad is a general medical hospital located in Northern Norway. It 
serves an area with a small town and the surrounding, less densely populated countryside 
(Figure 1). At the time of the study, the UNN Harstad had general medical admissions and 
out-patient clinics with specialists in cardiology, gastroenterology, haematology, nephrology, 
rheumatology, neurology, and pulmonary medicine. Except for one private cardiology 
specialist, no other specialist medical services were available locally. At the time of the 
study, the UNN Harstad handled approximately 3000 admissions each year, and 
approximately 5500 patients were seen in the out-patient clinics for a total of about 9000 
consultations (own data). The nearest tertiary referral centre is located in Tromsø, 




Figure 1 - Map of area served by the UNN Harstad. Source: Kartverket (The Norwegian Mapping Authority) 
4.2.1 GP surgeries 
14 community GP surgeries were included in the randomization process. These 14 GP 
surgeries had an average of 4.2 doctors. On average each GP had a list size of 848 patients. 
Of these GP surgeries five were larger, town-based centres whereas nine were smaller, more 
rural centres. 
4.2.2 Study participants 
The study population consists of patients referred from a GP for elective 
appointments at the Medical Department UNN Harstad. Only patients initiating a new period 
of contact were asked to participate. Patients referred from a hospital doctor or who 
attended for a scheduled follow up appointment were not included. Children (<18 years of 
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age) and patients with reduced capacity to consent were excluded from participation in the 
study.  
4.3 Randomisation  
To ensure that intervention and control groups were comparable in terms of number 
and socio-demographic characteristics, GP surgeries were randomised after stratification by 
location (town-based vs. rural surgery). This was done because, as previously mentioned, the 
area served by the UNN Harstad has one town and several surrounding municipalities of 
much smaller size. As an example, as of 1 January 2011, Harstad had 23,423 inhabitants and 
Ibestad had 1419, with an average age of 39.91 and 48.54 years, respectively[107]. The 
location of the GP surgery was not expected to influence the outcome variables in the study. 
Others have shown variation in referral rates based on hospital proximity[108], but the 
outcomes in this PhD project were designed to assess the individual patient/doctor contact 
episode for each patient, not referral rates. When approached, two GP surgeries declined 
the invitation to be part of the intervention group; therefore they were used as part of the 
control group, and two additional GP surgeries were randomly selected to the intervention 




Figure 2 - Flow chart of the randomisation process. ‡ From the four rural GP surgeries initially randomised to the 
intervention group, two refused. Therefore, they were used as part of the control group, and two additional GP surgeries 
initially randomised to the control group were randomised to, and consented to take part in, the intervention group. 
4.4 Recruitment 
The study population consists of patients within the four diagnostic groups described 
in Chapter 2.5 (patients referred with dyspepsia, suspected colorectal malignancy, chest 
pain, and COPD or suspected COPD), who were referred by a GP to the Medical Department 
of the UNN Harstad for elective appointments. In total, these diagnostic groups represented 
a substantial number of the new referrals to the Medical Department of the UNN Harstad 
(own data, 2008) and, as such, enabled our clinical research to be conducted in a small 
hospital. Only patients initiating a new period of contact were considered eligible for 
inclusion in the study.  
Eligible patients received written information about the present study, a consent 
form, and a prepaid return envelope along with their hospital appointment letter. These 
were sent out by a hospital nurse unaware of the intervention status of the GP surgery that 
referred the patient. At the hospital appointment, doctors asked eligible patients to 
participate in the study and, if needed, gave them a new consent form and prepaid return 
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envelope. The study organisers regularly reminded hospital doctors to recruit eligible 
patients. If hospital doctors forgot to ask patients to participate at their appointment, but 
subsequently remembered, a new information letter and consent form was sent to the 
patient. This procedure was followed in the intervention and control groups. 
The referral documents sent by GP surgeries in the intervention group were sent 
electronically to a separate inbox at the UNN Harstad, as described below. This enabled 
study organisers to send information letters and consent forms to intervention patients who 
were not recruited at their hospital visit. A similar procedure could not be followed for the 
control group, as it would have required reviewing all referrals and appointments, which was 
outside the ethical approval of the project.  
4.5 Intervention 
The intervention consisted of the implementation of referral templates for the four 
diagnostic groups to be used at the initiation of a referral to the UNN Harstad. The PhD 
candidate was unable to locate existing referral guidelines in the literature that were 
appropriate for the current study. Therefore the referral templates for the four diagnostic 
groups were developed by the PhD candidate in collaboration with local specialists, based on 
national prioritisation guidelines and international literature[109-116]. No formal theory of 
development was employed. Specific informational bullet points were collected by the 
candidate and local specialists based on the literature and subject knowledge. These 
informational bullet points were then ranked by other specialists across Northern Norway on 
a scale of 1-5, and the specialists were given the option to add further bullet points. Earlier 
studies have had problems with the uptake of referral interventions[7,53]. To reduce this 
problem, only informational bullet points considered imperative (i.e., with a ranking of 5) by 
the consulted specialists were kept in the final referral template, to keep the number of 
items as low as possible. Local GPs were invited to the take part in the development of the 
referral templates at a meeting, but no formal feedback was elicited. The intervention was 
piloted by GPs at two GP surgeries before implementation. The items in the referral 
template for suspected colorectal malignancy are presented in Table 2, with the all four 




Table 2 – Items in the referral template for suspected colorectal malignancy 
Item no Item text 
  
1 Change in bowel habits 
2 Blood in stool 
3 Weight loss 
4 Family history of colorectal cancer 
5 Previous medical history of bowel disease or results from previous bowel 
investigations 
6 Results of digital rectal examination 
7 Iron deficiency anaemia 
8 Clinical findings at abdominal examination 
9 Results of faecal occult blood test 
10 GP’s clinical suspicion 
 
Referral templates were provided to GP surgeries in the intervention group as laminated 
paper copies and as electronic templates in the EHR. The electronic referral templates did 
not function as a required electronic check list, but as bullet points that could be used in the 
referral text if the GP so wished. Referrals from GP surgeries in the intervention group were 
sent electronically to a separate inbox at the UNN Harstad, which could only be accessed by 
two secretaries and the PhD candidate. These referrals were then immediately sent to the 
inbox of the appropriate clinical speciality for assessment, thereby entering the normal 
electronic referral pathway. This setup was chosen to enable the estimation of referral 
template uptake, as discussed later in this thesis. The study team did not consider this setup 
to be part of the intervention, as it did not change GP behaviour when referring, but the fact 
that referrals from GP surgeries in the intervention group were sent to a separate inbox did 
serve as a reminder to GPs. No evaluation and care processes after referral receipt in the 
separate inbox were altered, compared with standard referral practice. No referral 
templates were provided to the GP surgeries in the control group. The referral pathway is 
represented in Figure 3.  
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During the study period, each GP surgery in the intervention group received regular 
lunch time visits, mail reminders, and updates regarding the progress of the project. No such 
visits or reminders were provided to the GP surgeries in the control group, nor was 
information about the project easily publically available. 
 




4.6 Expected change process 
In this project, the development of the referral intervention was empiric, with no 
formal evaluation of the expected change process. The intervention consisted of two 
separate parts: (1) the four referral templates and (2) visits and follow-up by study 
personnel. The expected change process for the individual participants at each level in the 
health care chain is presented in Figure 4. It is worth noting that the intervention did not 
change hospital out-patient scheduling, the sending or content of hospital appointment 
letters, or any other aspect of health care logistics surrounding the intervention. The 
intervention was developed with feedback from local stakeholders (GPs, hospital 
consultants, and information technology staff), but no formal, in-depth interviews were 
carried out regarding the expected change process outlined in Figure 4. 
 




4.7 Primary outcomes 
4.7.1 Quality of care 
This study aimed to assess the impact of increased referral quality on quality of care. 
To assess quality of care, quality indicators were developed for each of the diagnostic 
groups. The indicators were generated from previous, international quality assessment tools, 
in addition to national and international guidelines. Where necessary, adaptations were 
made to correspond to locally accepted practice. The necessity of such adaptations has been 
previously demonstrated when quality indicators are to be used in a new context[117]. As an 
example, the quality indicators for dyspepsia were developed using guidelines from the 
American Gastroenterological Association, the National Institute of Clinical Excellence 
(United Kingdom), the Swedish Gastroenterological Association, international articles, and 
UpToDate[23,83,118-126]. The full set of quality indicators and references are available in 
the Appendix. 
Each patient care pathway was scored by medical specialists (scoring panel), blinded 
to the intervention status of the patient. The total quality score used in the final analysis was 
calculated as adherence scores, that is, the number of criteria met divided by number of 
applicable criteria, expressed in percentages, as illustrated by Ashton[127]. If a criterion was 
deemed applicable, but no information was found in the clinical notes, it was recorded as 
‘not met’ (applicable, but not answerable); in essence a conservative approach[128]. It was 
decided not to apply weighting based on clinical importance. Although it would seem 
tempting to give items specific criteria weights according to their importance, this practice 
also adds complexity without adding much to the clinical findings, as discussed by Lyons and 
Payne in 1975[129]. 
4.8 Secondary outcomes 
4.8.1 Referral quality 
The aim of the implementation of the referral template was to increase the quality of 
referrals and then to assess whether this translated into improved care. Hence, a measure of 
referral quality was paramount to the completion of this study. The scoring system was 
based on the referral template used, with one point awarded for each clinical detail 
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requested in the referral template that was present in the received referral. This is similar to 
scoring systems used in other referral evaluations[34,38]. No weighting was applied.  
Referrals were scored by three raters, blinded to the intervention status of the 
patient. However, when the electronic template was used the intervention status was 
sometimes obvious. Twenty percent of the referrals were scored independently by two 
raters, no referral was scored by all three raters, and the three rater-pairs shared at least 25 
referrals each. 
4.8.2 Patient experience 
Patient experience is an ever more important aspect in the evaluation of health care 
interventions, and the evaluation of patient experience can help drive improvements in 
quality of care[130]. Better patient experiences are associated with safety and clinical 
effectiveness[131]. Multiple tools exist to measure various aspects of care coordination[132] 
and patient experience. However, after a thorough search, no relevant questionnaire was 
found in Norwegian. Therefore, a patient experience questionnaire was developed for the 
current project; it aimed to measure patient experience with the care coordination and 
treatment process. The questionnaire included all questions from the full version of the 
Generic Short Patient Experience Questionnaire[133,134] and the two questions about 
health interaction from the Commonwealth Fund Survey 2010[135]. Further questions were 
added to assess (1) who referred the patient, (2) if the referral was seen as appropriate, and 
(3) an overall assessment of the hospital (Table 3). The full questionnaire is included in the 
Appendix. The questionnaire was piloted with local health professionals and patients to 
evaluate the content, face validity, and acceptability[136,137]; however, no further formal 
evaluation of the questionnaire was done. 





1 Did the cliniciansa talk to you in a way that was easy to understand? 
2 Do you have confidence in the clinicians’ professional skills? 
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3 Did you get sufficient information about how examinations and tests were to be 
performed?   
4 Did you get sufficient information about your diagnosis/conditions? 
5 Did you perceive the treatment to be adapted to you situation? 
6 Were you involved in decisions regarding your treatment? 
7 Did you perceive the institution work practices as well organised? 
8 Did you perceive the equipment at the institution to be in good working order? 
9 Overall, was the help and treatment you received at the institution satisfactory? 
10 Do you believe that you were in any way given incorrect treatment (according to 
your own judgement)? 
11 Did you have to wait before you were given an appointment at the institution? 
12 Overall, what benefit have you had from the care at the institution? 
13 Did the hospital specialist lack basic medical information from your GP about the 
reason for your visit or test results? 
14 After your saw the hospital specialist, did your GP lack important information about 
the care you got from the specialist? 
15 Was the referral to the out-patient department necessary (according to your own 
judgement)? 
16a Were you referred by your GP for the out-patient appointment? 
16b If no in question 16a; who referred you? 
17 If you take an overview of your entire treatment process, how would you evaluate 
the institution? 
a
 ‘Clinicians’ refers to those who had the main treatment responsibility. This is linguistically clearer in the 
Norwegian wording. 
The questionnaire was mailed to study participants after their hospital appointment. 
To increase the response rate, pre-paid envelopes were provided, addresses were hand-
written, the questionnaire was kept as short as possible, and association with the research 
body was clearly indicated[138]. For initial non-responders, a mail reminder was sent 
approximately 1 month after the first questionnaire was sent out.  
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4.8.3 Health process outcomes 
To further assess the effect of the referral template on the care pathway, information 
on other health process outcomes was retrieved through a manual review of EHR: 
 wait time from date of referral to date of first hospital appointment in days 
 time from referral to initiation of treatment in days 
 number of hospital appointments before a diagnosis was made 
 outcome of referral – hospital appointment/return information/referral rejected 
 application of ‘right to health care’  
‘Right to health care’ is a legal term in Norwegian health care[3]. Every referral 
received is evaluated by a hospital doctor, who determines whether that individual patient, 
in that care pathway, has the right to prioritised health care. The ‘right to health care’ is 
applied only if the patient can be expected to benefit from the health care process and if the 
cost is in accordance with the expected benefit. Patients to whom this legal right is applied 
are then assigned a maximum wait time in accordance with prioritisation 
guidelines[110,139,140]. 
In addition, the positive predictive value was calculated as it was for glue ear referrals 
in otolaryngology by Bennett et al[141]. When adapting this concept to a hospital medical 
out-patient department, we defined positive predictive value as the proportion of referrals 
that led to a histological diagnosis, diagnostic clarification, or change in medical 
management. This was scored by the scoring panel on the same scoring sheets as the quality 
of care criteria, though under a separate heading. 
The scoring panel also applied a subjective assessment of the care pathway. This was 
done in two ways. Firstly, a quality rating of the treatment process was given on an ordinal 
scale of 1-10. Secondly, the scorers assessed whether the treatment process was 
appropriate with a binary yes/no response. 
To evaluate the correlation between seriousness of diagnosis and initial prioritisation, 
the variable ‘wait time’ was correlated with severity of final diagnosis. Wait time was defined 
as the time from the referral was received at the hospital until the first out-patient 
appointment, measured in days. To differentiate between the seriousness of the various 
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illnesses, the possible outcome diagnoses were grouped into two, three, or four severity 
levels. The four-level structure was used for the analysis in Paper III. The categorisation was 
done by the PhD candidate based on the International Classification of Diseases tenth 
revision (ICD-10) diagnostic codes, and it was reviewed by specialists in the relevant field. If 
more than one diagnosis was located for an individual patient, the ICD-10 code associated 
with the highest severity grouping was used in further analyses. 
4.9 Blinding 
As per protocol, the referring GP could not be blinded in the trial, since the 
intervention was to be actively used by the GP. The patient was not aware of the 
intervention, but no active effort was made to keep the patients blinded. Hospital doctors 
who recruited the patients were not aware of the intervention status of the referring GP 
surgery. Further down the care pathway in the hospital, intervention and control patients 
were mixed into the general caseload for each hospital doctor. However, complete blinding 
was not always possible, as a small number of GPs used the referral template electronically; 
thus the use of the referral template was graphically visible in the hospital EHR. However, 
the majority of the time, the hospital doctor was blinded to the intervention status of the 
patient. In addition, the hospital doctors were not informed of which outcomes were 
recorded to assess the treatment process. The quality scorers were blinded to the 
intervention status of the patient. 
4.10 Statistical methods 
Detailed descriptions of statistical methods are provided within each paper. In 
general terms, all baseline characteristics and outcome data were compared between the 
intervention and control groups using appropriate statistical tests. P-value of <0.05 was set 
as the significance level, although in regression modelling a p-value of 0.10 was used for 
interactions in Paper I. The rational for this is discussed in the paper. 
The PhD project was designed with a two-level data structure, with the intervention 
aimed at the level of the GP surgery and the outcomes measured at the level of the 
individual patient. A further division into three levels, as detailed in Figure 5, could be argued 
for, but no statistical benefit was found for introducing a third level in the analysis. 
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Moreover, adding a third level to an analysis also increases the complexity of modelling. 
Multilevel analyses were employed throughout the project, when appropriate. 
In addition, a significant number of returned questionnaires in Paper II had missing 
data. The primary analysis was done on a single-question basis, but to further examine and 
verify the findings, imputation was performed. There was deemed to no clear pattern of 
missingness, and multiple imputations using chained equations with predictive means 
matching was employed.  
 
Figure 5 - Multilevel structure of data represented - on the left a three-level structure and on the right a two-level 
structure, as employed in this thesis. 
4.11 Sample size 
Sample size calculation is presented in the methods paper, which was published prior 
to the start of this PhD project [142], with additional discussion in Paper III and Chapter 6.1.1 
of the current thesis. The calculations were based on the primary outcome; a change of 10% 
in the quality score was determined to be clinically interesting. Setting a significance level of 
0.05 and using PASS 2008 (NCSS, LLC, Kaysville, Utah, USA), a sample size of 855 patients in 
the intervention and 855 patients in the control group was needed for an 80% power to 
detect a 10% difference between the groups. Using intra-cluster correlation coefficient (ICC) 
values from different primary care-based interventions[143-145], the design effect (Deff) 
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would increase the sample size by between 1.15 and 12.9, depending on the ICC. This 
sample size was used for planning, but later analysis showed that this included a 
mathematical error. For further discussion please refer to Chapter 6.1.1. 
4.12 Study registration and accordance with the CONSORT statement 
Before inclusion began, the study was registered at www.clinicaltrials.gov with the 
registration number NCT01470963. During statistical analysis and article writing, every effort 
was made to follow the CONSORT statement for the reporting of cluster randomised 
trials[146]. 
4.13 Ethics 
The study followed the directions of the Helsinki Declaration. Before inclusion 
started, the project was presented to the Regional Ethical Committee for Medical Research 
in North-Norway, who determined that it was not within the scope of the Health Research 
Act (REK NORD 2010/2259). As such, it did not require further evaluation in the ethical 
committee. The project has been approved by the Data Protection Official for Research. All 













5.0 Summary of results in Papers I-III 
5.1 Paper I: Impact of referral templates on the quality of referrals from primary to 
secondary care: a cluster randomised trial 
Paper I presents the results of the referral intervention on the quality of referral 
documents received. Referrals were scored by three raters, blinded to the intervention 
status of the patient. The scoring system was devised from the referral templates, hence it 
measured how much of the information deemed important by the specialists was actually 
available. 
A total of 500 patients (281 patients in the intervention group and 219 patients in the 
control group) were included in Paper I, after the exclusion of 38 patients who did not fulfil 
the inclusion criteria. There were no significant baseline differences between the patients or 
GPs in the intervention and control group. There were more referrals sent from female GPs 
and GP specialists in the intervention than the control group. About 50% of referrals in the 
intervention group were sent to the designated electronic address. The interrater reliability 
was very good with Kappa = 0.90 (p<0.0001). 
Average referral quality, not corrected for clustering, was significantly higher in the 
intervention group for all diagnostic groups, except COPD. Using a multilevel regression 
model with the GP surgery as the clustering unit, a 20% difference was seen between the 
intervention and control groups. The ICC was calculated to be 0.14 (95% confidence interval 
[CI] 0.02, 0.25). The final model was adjusted for whether the GP was board certified, 
centred GP list size, GP hospital experience (in years), and categorised GP surgery size. 
Taking these variables into account, the effect estimate was reduced to 18% (95% CI 11, 25; 
p<0.001). The model also suggested that board certified GPs produced referrals more in line 
with the referral template (9%; 95% CI 4, 14; p<0.001), whereas longer hospital experience 
predicted slightly less complete referrals, with a point estimate of -2% per year of hospital 
experience (95% CI -1, -3; p<0.001). 
Paper I showed a clear effect of the referral intervention on referral quality. This 
effect was of a large enough magnitude to seem clinically interesting. The increase observed 
was in line with effects noted in other studies. However, several limitations must be noted. 
Firstly, as the scoring system measured the completeness of information, it is likely that 
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some of the effect size noted was due to conscientious GPs who took a special interest in the 
study. In addition, the inclusion rate of patients from the Medical Department at the UNN 
Harstad is not known, nor is the proportion of GPs who actively used the intervention. 
However, a non-protocol analysis (data not shown) showed that, when considering only 
referrals sent from GP surgeries in the intervention group, a difference in referral quality as 
large as the intervention effect was seen the comparison was made between GPs in the 
intervention group who sent their referrals to the designated electronic address and those 
who did not.  
This paper also highlights the difficulties of implementing change in ongoing medical 
practice. Future studies should aim to use simple referral guidance, collaboratively 
developed by primary and secondary care providers, and preferably embedded in the EHR. 
5.2 Paper II: Impact of referral templates on patient experience of the referral and 
care process: a cluster randomised trial 
This paper presents patient experience of the referral intervention. Evaluation of 
patient experience is widespread in the health care field. Such evaluations can help drive 
quality improvement and are associated with safety and effectiveness.  
A patient questionnaire was developed, based on previously validated 
questionnaires, to assess patient experience with the care coordination and treatment 
process. The resulting questionnaire was piloted with health professionals and patients, but 
no further validation took place. Questionnaires were sent to all patients who consented to 
take part in the referral project, with a new questionnaire sent to non-responders after 
approximately 1 month. 
The response rate after the mailing of the first questionnaire was 69.4%, but after 
reminders were sent to non-responders, this increased to 82.0%. Non-responders were 
younger than responders, but there were no significant differences between the non-
responders in the intervention and control groups. Results are presented on a single-
question basis, but to further assess the effect of clustering, a multilevel model was built 
after multiple imputation using chained equations with predictive means matching was 
employed to account for missing data in the questionnaires. Due to a high level of ‘not 
applicable’ answers, one question was left out of the imputed analysis. 
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Four hundred ten questionnaires were returned; 236 (57.6%) from the intervention 
group and 174 (42.4%) from the control group, which reflected the difference between 
these groups in the whole study population. When looking at individual questions, overall 
satisfaction was very high, with only minor differences between the intervention and control 
groups. Interestingly, the most negative responses in both groups concerned questions on 
patient interaction and information. When looking at a multilevel regression model using 
imputed data, the effect of clustering was low.  
In total, this indicates no clear effect of the implementation of referral templates on 
the patient experience, in a setting of generally high patient satisfaction. The negative 
feedback concerning patient interaction, involvement, and information could be of use to 
the UNN Harstad for improvement of the patient experience. 
5.3 Paper III: The effect of referral templates on out-patient quality of care in a 
hospital setting: a cluster randomized controlled trial 
This paper presents the main outcome of the study, the quality of the hospital-based 
care and health care process following the referral intervention. The measurement of quality 
is becoming increasingly important in modern medicine, partly for quality improvement, but 
also for prioritisation, accountability and comparison purposes. The measurement of quality 
of care is challenging as it is mainly a subjective and intangible concept. 
To measure quality of care, the current study developed process quality indicators 
based on previously published indicators, treatment guidelines, and international literature 
for each of the four diagnostic groups. The criteria were adapted to fit locally acceptable 
practices. Scoring was done by external specialists from other Norwegian hospitals, blinded 
to the intervention status of the patient. The scoring panel also provided a subjective quality 
assessment (scale 1-10) and assessed the positive predictive value of a referral. The 
adequacy of prioritisation in the intervention and control groups was also assessed by 
comparing the seriousness of the final diagnosis against the wait time from referral to 
hospital appointment. There was wide variation in the scoring across members of the 
scoring panel, but there was no indication of bias in the scoring between the intervention 
and control groups. 
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The study sample consisted of the same 500 patients presented in Paper I (281 in the 
intervention and 219 in the control group). In addition to the baseline characteristics 
described in Paper I, there was no difference between the patients in the intervention and 
control groups with regard to who they saw at the hospital (specialists vs junior doctor in 
training) or whether ‘right to health care’ was applied in their case. 
The results showed no significant effect of the intervention on the measured quality 
indicator score, the subjective quality score, or the positive predictive value of referral. The 
prioritisation in the intervention group was not significantly different from that in the control 
group. A reworking of the sample size calculation showed that, given the ICC and the study 
estimates for average score and standard deviation, the study was adequately powered to 
detect the 10% difference deemed clinically relevant in the methods paper. 
Hence, Paper III showed no clear impact of the referral intervention on quality of 
care. However, these results are hampered by low intervention uptake and wide scoring 
variation. Although the current assessment proved negative, it still seems reasonable to 
assume that more referral information will improve patient management, but more 















6.1 Methodological considerations 
6.1.1 Cluster randomised trial – rational and statistical considerations 
The study was planned as a cluster randomised trial. In essence this means 
randomising groups of individuals rather than individuals themselves[147]. However, the 
unit of observation remains the individual within these groups. Hence, randomisation is 
carried out at an overarching level, whereas measurement happens at the individual level 
(Figure 6). 
 
Figure 6 – Graphical representation of the two levels in the current cluster randomised study 
The cluster randomised design was chosen due to its suitability for interventions 
implemented at the level of the health care organisational unit[148]. The present project 
could not be carried out at the level of the individual patient, or even at the level the 
individual GP, due to the risk of contamination between either subsequent referral 
situations for each individual GP or contamination between different GPs at the same 
surgery[149]. Such contamination would likely reduce the point estimate of the intervention 
effect and introduce more uncertainty in the final results. In addition, as future interventions 
are likely to be EHR-based, the relevance of the study would be reduced if individual GPs 
were randomised, as the EHR is usually the same for all GPs in a single surgery. 
However, the choice of cluster randomisation carries several concerns, mainly in the 
areas of power and analytical techniques. Firstly, the power of a cluster randomised study is 
not as high as that of an individually randomised study, given a fixed number of potential 
participants[150]. Standard statistical techniques, such as the t-test, assume independence 
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of observations[151]. However, as the name suggests, in cluster randomised trials, members 
of the same cluster are more likely to have similar outcomes than randomly selected 
individuals from the general population[147]. This similarity will also depend on the outcome 
measured. Therefore, in the current study, a higher clustering effect was expected on the 
measurement of referral quality (mainly GP surgery-dependent) than on the measurement 
of quality of care (mainly hospital-dependent). Clustering increases the variance, as less 
information is gained from each observation, and hence it also increases CIs, compared to 
individual randomisation[152]. This non-independence of outcomes must be accounted for 
in the sample size calculation to give appropriate power to any study[152].  Some previous 
publications have used only one cluster in the intervention and control groups, which, in 
essence, is the same as having one patient in each group. This comes about as there is no 
way to mathematically correct for the variation between clusters, and therefore any 
difference observed can be a between-cluster difference instead of a true intervention 
effect[153]. 
The Deff is often used to correct sample size for the clustered design, by multiplying 
the sample size needed in an individually randomised trial with an otherwise identical design 
with the Deff[154]. This is given as Deff = 1 + ρ(m-1), where ρ is the ICC and m is the size of 
each cluster. Increases in both ICC and cluster size lead to more statistically inefficient 
designs. Hence, any cluster randomised study benefits more, in terms of power, by 
increasing the number of clusters[155]. Calculation using the Deff requires equal cluster sizes 
and an identical ICC in the intervention and control groups[147]. 
For the current PhD project, the number of clusters could not be increased above the 
14 GP surgeries in the area served by the UNN Harstad. In addition, no precise ICC for similar 
interventions at the referral interface could be found in the literature. After reviewing other 
primary care interventions, it was determined that an ICC ranging from 0.001 to 0.08 was 
plausible[143-145]. This gave a design effect of 1.15 to 12.9. For a power of 80%, and setting 
the limit for a clinically interesting difference between the intervention and control group of 
10%, a sample size requirement of between 1964 and 22,093 was estimated in the methods 
paper[142]. This sample size was used as the basis for study planning, but in addition to 
assuming equal cluster size and varying amount of clusters, it also included a mathematical 
error in the basic calculation. Using the correct baseline data (with Power and Precision V4), 
46 
 
a sample size range from 84 to 180 was revealed to be more correct. In a relatively recent 
publication, Hemming et al showed[156] how to calculate sample size when the cluster 
number is fixed. Using this formula, the study was feasible under the given conditions, but it 
quickly became unfeasible if the ICC increased above the given range. The uncertainty of ICC 
from the literature and its impact on sample size calculations is further discussed by Donner, 
who recommends sensitivity analyses using a range of ICC in the planning of any study[157].  
In reality, the ICC for the main outcome was 0.02 (95% CI 0.00, 0.06) and the sample 
size range of 84 to 124 presented in Paper III seems appropriate. Therefore, in retrospect, 
the effort to achieve adequate sample size to avoid a type II error was unnecessary. Indeed, 
with the sample size of 500, the study was, in fact, powered to detect much smaller 
differences than the arbitrarily set, clinically important difference of 10% for the main 
outcome. 
The choice of analytical method in cluster randomised trials is paramount. As noted 
above, the correlation between individuals within the same cluster leads to estimation of CIs 
that are too narrow, and hence an increase in type 1 error, if standard analytical techniques 
are applied[147]. Although it is paramount to use correct analytical techniques when 
performing and reporting on cluster randomised trials[146], it is also important to note that 
the effect of clustering is usually small where the outcomes relate to individual participants’ 
health or behaviour[147,158], as opposed to more cluster-specific outcomes. This is clearly 
identified in the current study, as the estimated ICC for referral quality was 0.14 (95% CI 
0.02, 0.25), whereas the estimated ICC for the main outcome was 0.02 (95% CI 0.00, 0.06). 
Hence the clustering of data was stronger with regard to referral quality and almost 
negligent with regard to the main outcome. This is illustrated in Figure 7, in which data 
generated for the purpose of example only was used, with three GP surgeries, 30 patients, 
and two outcomes. In Figure 7, the outcome ‘Referral quality score’ is more influenced by 
the GP surgery level, and the ‘Quality of care score’ is measured purely at the patient level. 
Regardless of the actual level of correlation in the data, it remains good practice to analyse 
data in a manner that is appropriate to the study design. The current study applied 




Figure 7 – Graphical representation of clustering with the Referral quality score data showing more clustering on the 
level of the GP surgery than the Quality of care score data. 
In general, appropriate analysis of cluster randomised trials can be done either at the 
cluster level or at the patient level[149]. In the cluster-level analysis, data are aggregated for 
each cluster (using cluster mean, cluster proportion, or other summary data), and one data 
point is provided from each cluster. This enables the use of standard analytical techniques, 
as the data points are now considered independent. However, this does not allow for the 
correction of covariates at the individual level[149]. In addition, this analytical technique is 
less efficient when there is substantial variation in cluster size[152]. At the patient level, 
more advanced techniques, such as multilevel modelling, must be employed, which allows 
for the inclusion of covariates measured at the patient level. In this thesis, the inclusion of 
covariates was paramount to understanding the relationship between the intervention and 
its outcome; consequently, patient-level analysis was employed throughout, with the 
exception of the questionnaire data. The design of the questionnaire necessitated analysis 
based on the summarised data from each question. For further assessment of the results, 
regression models were also employed, but this was only done to further investigate the 
data and assess the effect of clustering. 
Individual-level analysis provides more precise estimates than cluster-based analysis, 
especially when clusters vary in size[147], as in the current study. However, the number of 
clusters in this PhD project was small (seven both in the intervention and control groups), 
and in these settings, the use of advanced analytical techniques may be inappropriate[152]. 
Textbooks suggest that at least 10 clusters are necessary for a multilevel/mixed-model 
approach, which was applied in this study[147]. With few clusters there is a higher need for 
model assumptions to be met, and few clusters allows for fewer covariates at the cluster 
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level[147]. In this PhD project, the covariates used were almost exclusively at the level of the 
individual GP or individual patient, but care was taken to include only appropriate 
covariates, while explaining the relationship between the intervention and outcomes as 
precisely as possible. 
In essence, the clustered nature of the study design put constrains on the statistical 
strength and analytical possibilities of this study. However, it also allowed the results to be 
more applicable to a standard health care setting. This applicability was a clear goal from the 
outset of the project, and as such necessitated the more complex, clustered design. 
6.1.2 Randomisation 
This trial has been presented as a cluster randomised trial. The clusters in the study 
were contacted and consented to participate after the initial randomisation had taken place. 
This is not recommended practice[147]; pre-randomisation consent for all available clusters 
(in this case, GP surgeries) is preferred. In addition, two GP surgeries declined to participate 
as part of the intervention group and were subsequently placed in the control group, 
meaning that a further two surgeries had to be randomised to the intervention group (see 
Chapter 4.3).  
At the time of the study, the area served by the UNN Harstad had 14 GP surgeries 
(see Chapter 4.2.1). To achieve an adequate sample size, the study needed to recruit 
individual patients from all these GP surgeries. As discussed in Chapter 6.1.1 increasing 
cluster numbers is preferred over increasing cluster size. Extending the study area to include 
other hospitals was also considered at length, but was abandoned due to the complexities of 
running a multisite study. In addition, it was postulated that using relatively stable GP 
surgeries that were closely related to a small hospital would make the intervention more 
acceptable and uptake more complete. During the design phase, the PhD candidate and the 
study team envisaged an objective and quantifiable measurement, akin to a classical 
randomised drug trial. However, during the trial, the PhD candidate gradually came to 
understand that, in reality, the implementation was more like a pragmatic trial: it aimed to 
include all clusters and relevant patients with a significant degree of intervention flexibility, 
usual-care comparators, and clinically significant outcomes measured under normal 
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conditions[159]. This intention of clinically relevant, patient-oriented research probably led 
the drive to use all available data and a suboptimal randomised procedure. 
In a sense, this form of inclusion of clusters increased the external validity of the trial, 
in that all potential individual participants were included. On the other hand, this reversal of 
randomisation could have led to selection bias at the cluster level, as more interested GPs 
consented to join the study. Given the lack of consent from some of the GP surgeries, it is 
possible that the entire design of the study should have been changed. 
The research project in this thesis is presented as a randomised trial, with the 
limitations discussed above. Papers I-III would have benefitted from a deeper discussion of 
the randomisation process, and support and advice from experienced research institutions 
could have been sought earlier in the PhD project. However, the conclusions presented and 
the implications for further research remain, in the view of the PhD candidate, valid. 
6.1.3 Complex interventions in a real life clinical setting 
In a recent Norwegian study, only 38% of newly diagnosed lung cancer patients were 
referred to a specialised service for assessment of whether their lung cancer could have 
been caused by occupational exposure, even when frequent reminders were sent[160]. In a 
study by Jiwa et al, colorectal referrals were sent using a newly developed, interactive, 
electronic pro forma, but the uptake of the intervention was only 18%[53]. Both of these 
studies were performed with educational outreach and follow-up, yet the intervention 
uptake was very limited. This highlights the difficulties of research in a ‘real life’ clinical 
setting. Not only can interventions be complex, but complexity already exists at the level of 
the health care system[161]. In a health care setting, a complex intervention is defined as 
being “built up from a number of components, which may act independently and inter-
dependently”[162]. A complex system, on the other hand, is one that “is adaptive to changes 
in its local environment, is composed of other complex systems, and behaves in a non-linear 
fashion”[161], with examples such as primary care, hospitals, and schools. Hence, the effect 
of any given intervention must be interpreted not only in the context of its own complexity, 
but also in light of its effects on the entire system. It is therefore not surprising that uptake 
may be low and performance difficult when applying interventions at the GP/hospital 
interface, where many other factors than the ongoing study impact clinical decisions. 
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A classic example of a complex intervention in the medical field is the stroke unit. In 
any trial assessing the impact of stroke units on morbidity and mortality after a stroke, it is 
hard to define the specific active component (e.g., various health professionals, drugs, 
guidelines, discharge routines), and hence replicating the results is more challenging[162]. 
The current project introduced a referral template at the GP/hospital interface coupled with 
educational follow-up, a seemingly straightforward and simple intervention. However, given 
the complexities of the health care system and the interaction between the system and the 
intervention, it would be unwise to assume that all of the observed effect was purely based 
on the referral template itself, and that the study had envisaged all the potential effects of 
the intervention.  
Although the complexities of the intervention and systems make the interpretation of 
intervention effects difficult, it more than likely improves generalisability. The 
implementation of an acceptable and feasible intervention using a clustered study technique 
in normal clinical practice likely mirrors the effect in other settings, and follows guidelines 
set out for the evaluation of complex interventions[162]. However, further evaluation, 
especially quantitatively, would probably cast further light on the factors that affected the 
referral process.  
6.1.4 Expected change process 
The current project was not designed or prepared as a complex intervention. The 
basic research concept was primarily to design a simple intervention, implementable in 
everyday clinical practice with limited unintended consequences. Much effort was expended 
to identify measurable, relevant outcome measures to evaluate the intervention. In the 
design of the project, the PhD candidate somewhat underestimated the complexity of what 
was intended as a simple intervention. A good theoretical understanding of how the 
intervention causes change has been said to be paramount in designing and evaluating 
complex interventions[163]. This was not formally outlined prior to the implementation of 
referral templates, but in hindsight, many of the aspects regarding a more formal process 
were discussed. In this Chapter, a short description of the thought processes and expected 
effects of the intervention during the planning phase is provided along the framework 
provided by the Medical Research Council[164]. 
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6.1.4.1 Development of the intervention and evaluation process 
 As presented in Chapter 2.3, two systematic reviews were found on the topic of 
referral improvement[7,54]. These reviews suggested that structured referral guidance and 
local educational outreach can achieve the intended effects on referral rates. No further 
major studies were found, and no further formal review paper was produced. Therefore, the 
research group concluded that referral improvement was possible. Underpinning the aim of 
referral improvement in the literature is the belief that improved referrals would lead to 
improvements in both service delivery and care. The cost of change in the current project 
would mainly be incurred at the level of the GP, with a potential increase in the time spent 
on each referral. Therefore, this PhD project was not designed to evaluate if referrals could 
be improved, but if improved referrals could lead to a measurable change in the care 
delivered to each patient, and hence justify the increased workload for GPs.  
 GP uptake and use of the intervention was recognised early as an important potential 
limitation (see Chapter 6.2). The use of obligatory electronic pop-up solutions were 
considered, but rejected based on the time necessary to develop this application, the cost, 
and the lack of flexibility it would provide to the referring GP.  
Considering the intervention as a whole, the research team expected a measurable 
change in the outcome measures described in Chapters 4.7 and 4.8, but no large effect on 
referral numbers or other organisational factors. No appropriate prior assessment tools 
could be identified, and considerable time was spent researching and discussing different 
evaluation options. Given the expected change highlighted above, outcome evaluation was 
envisaged at several levels (Figure 4), as described in Chapters 4.7 and 4.8. With the aim of 
taking patient assessment into account, self-administered questionnaires were used. 
Although the intervention itself was not aimed directly at patients, the questionnaire was 
intended to measure the expected positive change in the experience of a more appropriate 
care pathway of higher quality.  
6.1.4.2 Piloting of the intervention 
 The literature on both cluster randomised trials[147] and complex interventions[164] 
recommends piloting an intervention for feasibility, usage, and recruitment. No formal 
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feasibility or pilot study took place in the current PhD project. Instead, the intervention was 
piloted at local GP surgeries, and the patient questionnaire was piloted with health care 
personnel and patients. A formal feasibility study may have provided clues on how to 
improve the uptake of the intervention and improve sample size estimation. A pilot study 
could have highlighted the potential effect of the intervention on the outcome measures. 
This is especially interesting in a trial were the outcome measures have not been previously 
documented, as was the case in this trial.  
6.1.4.3 Evaluation 
 A good theoretical understanding of the intervention has been described as the key 
to suitable outcome measures[164]. As shown in the current project, the assessment of 
health care interventions can be less straightforward than expected, and the effects difficult 
to assess accurately. In addition to the potential benefits of a pilot study, the discussion 
regarding a continuous, qualitative process of evaluation in Chapter 6.5.3 is pertinent in 
helping plan the evaluation of an intervention. 
6.1.5 Blinding 
Blinding is an important concept in modern medical research; ideally treatment 
allocation should not be known to the patient, investigators, or assessors[165]. It has been 
shown that intervention effects can be overrated if randomisation concealment is not 
carried out in a satisfactory manner[166]. Non-blinding of participants, organisers, or 
evaluators in any given study may give rise to bias in the form of differential treatment 
during the study process, differential drop out, or differential outcome assessment 
(information bias). However, as with the current study, full blinding may be unattainable 
with complex interventions[146,162,167]. In the design of the present study, efforts were 
made to ensure that patients and outcomes assessors remained blinded to the intervention 
status of all patients. It was especially important to also keep patients blinded, as patient 
experience was included as an outcome. However, because the referral template was 
included in an electronic form in the GPs EHR, it was sometimes evident when it had been 
used for referral. This was noted beforehand as a possible breach of both carer and assessor 
blinding, but very few of the GPs used the electronic referral template, instead referring to 
the laminated paper template.  
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As noted above, the lack of blinding in a study generally tends to increase the effect 
of the intervention. In the current project the intervention showed no clear effect on the 
main outcome, and no clear indication that bias has affected the patient treatment or 
outcome assessment. 
6.1.6 Development of referral criteria 
Transition of care and referrals have been part of the health care system for a long 
time, and the frustration amongst doctors with regard to these aspects is probably just as 
long-standing[168]. Therefore, it may come as a surprise that these processes seem 
excessively varied and idiosyncratic[9,169-171]. Guidelines and content advice exists from 
several sources across several specialities[5,12,44,109,172], but locating relevant content 
information for the referrals was more difficult than expected. Most of the symptoms 
included in the referral templates for each diagnostic group[110,173,174] were present in 
national guidelines for prioritisation. A clear scientific basis existed for the inclusion of some 
of the symptoms[83], and for others there seemed to be some consensus[109], but some 
research has shown that symptoms which are considered important may actually be of little 
value in predicting serious disease[175]. Therefore, priority was given to validated symptoms 
and previously published consensus documentation, but also to local adaptation and support 
for the final versions of the referral template. Ideally, there would have been more input 
from patients and GPs, as this could have strengthened both the content and acceptability of 
the intervention[44,162]. 
6.1.7 Development of quality indicators  
In his book The Definition of Quality and Approaches to its Assessment Avedis 
Donabedian presented some of the first clear ideas of the assessment of quality in health 
care. In his framework, he identified three areas from which information on quality can be 
obtained: structure, process, and outcome[176]. As presented in the methods paper[142] 
and Paper III, the current PhD project mainly employed process quality indicators. This 
entails assessing whether certain actions have taken place during a care pathway[60]. 
However, it is not necessarily easy to develop quality indicators. Baker and Fraser presented 
four criteria that characterise a good quality indicator (Table 4)[177]. Several methods for 
the development of scientifically valid quality criteria also exist, for instance the RAND/UCLA 
appropriateness method[178], which utilises panels of experts to combine 
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recommendations from clinical guidelines with health care providers’ opinions. However 
other methods have also been described[179,180]. 
Table 4 – Characteristics of an ideal quality criterion 
Based on research evidence 
Prioritised according to strength of research and influence on outcome 
Measurable – clear and precise 
Appropriate to the clinical setting 
 
Initially, the current PhD project aimed to utilise existing quality indicators in the 
measurement of the intervention effect. However, early in the planning phase it became 
clear that few relevant clinical process indicators existed. Much of the indicators have been 
developed for use in national programmes, and to measure things like, ‘how many stroke 
patients at a given hospital receive thrombolytic treatment’[181]. In the current PhD project, 
the aim was to compare the effect of an intervention at the GP/hospital interface by 
measuring the quality of care delivered to each individual patient, and not at an over-arching 
hospital or county level. Notable differences from these holistic quality criteria were found 
in, for instance, performance measures in the speciality referral process[73] and COPD care 
measures[182]. However, it is the view of the PhD candidate that the available published 
measures were not sufficient to capture the subtle effects of the intervention in the current 
project, and it was therefore decided to develop a new set of criteria to assess the outcome. 
Although a formal RAND/UCLA approach would have been preferable, it was not achievable 
within the time frame. In addition, the quality criteria score was only one of several 
outcomes that were recorded. Using advice from several sources[59,179], quality criteria 
were developed from available national and international literature. Although no formal 
panel process took place, the feedback from specialists within each diagnostic group was 
invaluable to the shaping of the indicator sets; it ensured that the criteria were indeed 
prioritised, measurable, and appropriate.  
The current indicator set was created to depict the entire treatment process, and not 
focus solely on small aspects of care. In addition, a multilevel analysis with single-unit 
indicators would have been challenging. Therefore, the decision was made to generate a 
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total score from the indicators themselves. Some have argued that it is important to state 
the relative importance of different quality indicators, based on the available evidence[177]. 
In the current PhD project, this could have been achieved by weighting the indicators before 
calculating the final score. However, after consideration, and as shown by Lyons and Payne 
in 1975[129], it was decided that the considerable extra effort needed to weight the 
indicators was unlikely to provide better estimates for the intervention effect. 
6.1.8 Statistical considerations 
The main statistical aspects are discussed in each paper, with important aspects 
regarding statistical strength in cluster randomised trials discussed in-depth in Chapter 6.1.1.  
The analysis plan for the study and papers was outlined in the methods paper. The 
only major deviation from this plan was the non-protocol analyses reported in Paper I, which 
used only referrals sent directly to the study-specific electronic address. This was done to 
highlight the importance of participating GPs actually utilising the intervention, and care was 
taken to ensure that this deviation from strict “intention-to-treat” analyses was highlighted 
in the paper.  In addition, the nature of the questionnaire necessitated an analysis based on 
single questions rather than a combined, total score.  
To assess the adequacy of prioritisation, possible outcome diagnoses were grouped 
into two, three, or four severity levels (see Chapter 4.8.3). In the final analysis, the four-level 
structure was used, as it most closely resembled normal clinical thinking, and the numbers in 
each group were large enough to allow for such analyses. 
6.2 Uptake of the intervention 
Uptake of the intervention in this PhD project is discussed in both Papers I and III, but 
deserves further mention and discussion, as it is imperative to the assessment of the 
intervention effect and future research. Internationally, interventions at the referral level 
have always had difficulties with uptake. Examples include a study by Jiwa et al, which had 
an uptake as low as 18%[53]. A Cochrane review of referral interventions indicated that, at 
best, only half of structured referral sheets were complete at referral[7]. However, a recent 
Norwegian study utilising electronic optional guidelines in the referral process reported that 
88% of the intervention GPs used the intervention “all the time”[12].  
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With the referral intervention presented in this PhD thesis, the research team hoped 
that the implementation of a complex intervention at the GP/hospital interface would be 
more achievable in a small group of GPs who are geographically and traditionally closely 
linked to hospital staff. As noted above, this PhD project cannot, due to privacy and ethical 
concerns, provide a completely accurate figure for intervention uptake, as this would have 
required reviewing the records of all patients with a new hospital appointment during the 
study period. However, as presented in Paper I, 49.5% of the referrals in the intervention 
group were sent to the project-specific electronic address (Figure 8). This number represents 
the absolute minimum use of the intervention, and it is reasonable to assume that it was 
used also for some of the referrals sent by intervention GP surgeries to the standard 
electronic address.  
 
Figure 8 – Graphical representation of the use of the specific referral address created for the project 
Given the relatively low intervention uptake observed in the present PhD project 
compared to the study by Rokstad et al, it seems prudent to advise that further research on 
referral interventions should be implemented in the EHR, and these interventions should be 
in a format that allows their use in normal clinical workflow. 
6.3 Assessment of bias 
6.3.1 General assessment of bias in the study 
The assessment of bias in any given study is important to ensure there is no major 
threat to the validity of the results. In the first section aspects of bias relevant to the general 
design of the study are presented. Following this is a brief assessment of specific issues 
related to bias in the each of the papers that form the basis of this thesis.  
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Selection bias is present when individuals have different probabilities of being 
included in the study sample according to relevant study characteristics[183]. In clinical 
research today, the main reason for choosing a randomised design is to reduce selection 
bias[184] by ensuring the study groups are as similar as possible. Although randomisation 
can often reduce selection bias, the lack of concealment of randomisation may lead to 
exaggerated effect estimates[166].  Lack of concealment is of particular interest in cluster 
randomised trials, which usually involve randomisation at one level and recruitment at 
another level. Ideally all patients and clusters (in this study the GP surgeries) should be 
included before randomisation[147]. In the current study this was not feasible, as 
consecutive patients who presented to their GP for referral to secondary care were to be 
subsequently recruited at their hospital appointment. Hence the identity of eligible patients 
was not known prior to the randomisation process.  In addition, the suboptimal 
randomisation procedure discussed in Chapter 6.1.2 may have contributed to bias. The study 
therefore contained a risk of selective recruitment in the two study groups, and as such 
there was a clear risk of selection bias.  
To reduce this risk, GP surgeries were randomised by a person not connected to the 
study. We also intended to recruit all potential patients and kept the list of exclusion criteria 
as short as possible to avoid further selection bias at the patient level. In addition, patients 
were recruited by hospital doctors who were unaware of the intervention status of the 
referring GP, thus preserving allocation concealment at the patient level. In a small subset of 
cases, however, the intervention status was obvious to the recruiting hospital doctor, as the 
electronic form of the referral template had been used. The available data shows no clear 
indication of selection bias in the study; the baseline characteristics of the two patient 
groups and the two GP surgery groups were similar. In addition, there was similar patient 
distribution across the four diagnostic groups in both the control and intervention groups. 
However, more patients were recruited into the intervention than the control group. As 
discussed in Paper I, we have no clear explanation for this. It is possible that increased focus 
on the four diagnostic groups in the intervention GP surgeries led to increased referral rates, 
a finding that has been shown in other studies[54]. We were unable to calculate the referral 
rates to assess this possibility within the material collected. As suggested by authors of a 
different study with recruitment imbalance, we employed recruitment at the hospital, not at 
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the GP surgery[185]. This form of recruitment has also been suggested in situations where 
individual recruitment occurs after cluster randomisation[186]. We have no reason to 
believe that there was differential recruitment between the intervention and the control 
groups at the out-patient department. However, study personnel did follow up on referrals 
sent to the dedicated electronic address (see Figure 8) and sent new consent forms to 
patients who had been referred within the project but had not been asked to participate 
during their hospital appointment. This practice may also account for the somewhat higher 
inclusion in the intervention group, but the actual secondary patient recruitment through 
this system was no larger than 20 patients. 
Selection bias can also exist on levels other that the patient level. Recruitment 
strategies in large studies often preclude participation of many of patients seen in everyday 
clinical practice, and as such renders them less applicable. In cluster randomised trials, a 
more diverse group of patients is often recruited than in pure randomised trials, and more 
complex interventions are often employed[147]. The diversity of the included patients often 
more closely resembles normal clinical practice, and as such, it can alleviate some of the 
criticisms of randomised trials, e.g., not being directly comparable or relevant to standard 
care pathways[187]. In the current study, we aimed to recruit all patients referred within the 
four diagnostic groups to most closely resemble normal clinical practice. 
Performance bias refers to systematic differences between the care provided, or 
exposure to factors other than the intervention of interest[188]. Avoidance of performance 
bias is best achieved by blinding of the participants, study personnel, and outcome 
assessors[184]. Blinding may be more challenging in cluster randomised trials than in 
standard trials[147]. Blinding in the current trial is described in the methods paper[142] and 
in Chapters 4.9 and 6.1.5 of the current thesis. We have no reason to believe that the lack of 
blinding that did occur significantly affected the care provided. 
Attrition bias is related to systematic differences in withdrawals/exclusions. For the 
current study, the number of exclusions was relatively low and did not differ between the 
intervention and control groups (9, 3.1% and 8, 3.5%, respectively). Only one patient 
withdrew from the study. For cluster randomised trials, attrition may also occur at the 
cluster level. In this study, all clusters randomised were included in the final analysis. In 
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addition, an intention-to-treat analysis was performed, both at the cluster and the patient 
level, further reducing the chance of attrition bias[189]. Therefore, it is unlikely that attrition 
bias affected our results.  
Contamination bias can exist when intervention-like activities find their way into the 
control group[190]. Several authors, including the authors of the methods paper for the 
current thesis, claim that the clustered design can reduce the risk of 
contamination[147,152]. Others have argued that contamination may not be much of a 
statistical problem and can be corrected in ordinary randomised trials with a smaller 
increase in sample size than would be required by the clustered design[191]. It is not 
impossible that our intervention GPs communicated with control GPs about the 
intervention, but it is unlikely that large-scale contamination took place. This is also 
supported by the actual increase in measured referral quality seen in the intervention group. 
This result would have been biased towards the null if large-scale contamination had 
occurred.  
6.3.2 Assessment of bias in Paper I 
Paper I presented the effect of the intervention on referral quality. The unknown, but 
likely high variation in the use of the intervention at intervention GP surgeries represents a 
potential bias. It is likely that the referral guideline was used in at least 49.7% of referrals 
(Figure 8), which may indicate a potential non-use of about 50%. This non-uptake would 
have biased the intervention effect towards the null, and carries importance for future 
interventions, in which the uptake of any intervention will be paramount.  
The Hawthorne effect is well known, and relates to changes in behaviour because an 
individual is under study, not because of the intervention itself[192]. In most trials, this 
effect increases response in both the control and intervention groups, as it is the application 
of research interest, follow-up, and so forth that causes the effect[192]. However, the 
Hawthorne effect likely had very little impact on referral quality in the control group, as no 
intervention was carried out in the control group, and little general information about the 
study was disseminated in the local community. In the intervention group, however, it is not 
improbable that some of the intervention effect was due to a Hawthorne-type effect. The 
non-protocol analysis discussed in Paper I and Chapter 6.5.2 shows that the intervention 
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effect was mainly seen in those who used the dedicated electronic address for this study and 
therefore could be assumed to have used the referral template. This suggests that most of 
the effect seen was due to the intervention itself, and not a Hawthorn effect.  
6.3.3 Assessment of bias in Paper II 
In addition to the issues raised above, any study that employs questionnaires will 
always have to consider non-response bias. This occurs when there are important 
differences in patient-reported outcomes between responders and non-responders. As 
presented in Paper II, non-responders were younger than responders, but no significant 
differences in the variables measured were found between the intervention and control 
groups. As discussed in Paper II, several authors have shown that non-response bias is 
relatively small in health research[193,194]. This, coupled with the high response rate in our 
study, suggests that the risk of non-response bias is probably low. 
On the other hand, questionnaire replies can be affected by a range of psychosocial 
determinants, previously dubbed “social-psychological artefacts”[195].  In essence, this 
contains cognitive biases that influence patient responses based on, for instance, self-
interest bias, ingratiating response bias, and gratitude. These lead to responses that may be 
skewed positively due to a patient perception of his/her interest in gaining good standing 
with health providers[195]. As a net result, patient satisfaction surveys often show high 
levels of satisfaction; some have argued that dissatisfaction rates may be more useful[196]. 
The study questionnaire aimed to measure patient satisfaction with the entire referral 
process. The intervention occurred at GP level and probably went unnoticed by most 
patients. It is therefore unlikely that these biases had a differential effect on the intervention 
and control groups, but they may have contributed to the high patient experience ratings 
seen in Paper II.  
6.3.4 Assessment of bias in Paper III 
Paper III presents the assessment of the patient care pathway. The main outcome, 
the quality criteria, measured mainly the quality of treatment at the hospital. As such, a 
Hawthorne effect is potentially present as the hospital doctors knew that a research project 
was taking place. Frequent oral and written reminders of the project were used to ensure 
that as many patients as possible from both groups were recruited by hospital doctors. 
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These reminders were done to reduce potential selection bias, but they may also have 
improved the care at the hospital. However, hospital doctors did not have access to the final 
quality criteria and thus did not know how the care they provided would be assessed. In 
addition, hospital doctors generally did not know whether a patient was referred from an 
intervention or control GP surgery, although with the limitations discussed above. It is 
therefore unlikely that any Hawthorne effect had a selective effect in the intervention or 
control group, but we cannot rule out that the general quality of care increased during the 
intervention period. 
Scoring was done by a panel of independent scorers based on anonymised EHR 
documentation. This process carries a definite possibility of lack of information, and even a 
form of information bias in the final results. We used EHR documentation as the primary 
source of quality information. Quality criteria could therefore only be assessed if they were 
adequately documented, and the quality of medical documentation and of the EHR has been 
debated[197-199]. There is no reason to believe that the documentation at the UNN Harstad 
is better or worse than that in Norwegian health care in general, although we did not 
measure this in the current study. Additionally, there is no indication that the quality of 
documentation differed between the intervention and control groups, though this was not 
formally evaluated in the study. It is plausible to assume that the potential Hawthorne effect 
discussed above led to more detailed documentation during the study period. It is hence 
unlikely that there was significant information bias in the current study, but it is possible that 
quality criteria were fulfilled, but not documented, in the care process.  
6.4 Harms and unintended effects 
No harmful event for any one patient was noted during the trial, but several potential 
harms were considered in the planning phase of the trial. Increased focus on the four 
diagnostic groups could have led to an increased number of referrals and longer wait times 
for patients in general, but there is no clear indication that this took place (see Chapter 
6.5.1). In addition, the increased focus on referral content could have caused prolonged wait 
times for intervention patients who were categorised by the hospital specialist as probably 
less seriously ill, based on the referral. Although this could have increased the wait time for 
some patients, the correct prioritisation of patients is a clearly stated goal of the Norwegian 
health care system[200]. In the final study, no clear effect on prioritisation was found.  
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6.5 Other methodological considerations 
6.5.1 Wait time 
During the design of the intervention and outcome measures, the research team 
debated how best to measure the effect of the intervention on the quality of care and 
hospital management of the patients. In addition to the main outcome, secondary outcomes 
were defined, including wait time (see Chapter 4.8).  In Paper III, wait time was analysed 
against the severity of the outcome diagnoses in order to see if prioritisation was more 
appropriate in the intervention than the control group. Apart from the statistical issues 
regarding the ordinal analysis discussed in that paper, the issue of wait time deserves some 
discussion. 
 The UNN Harstad is, in international and national terms, a small hospital. About 5500 
patients a year attend medical out-patient consultations, whereas national out-patient 
numbers in Norway were approximately 1,650,000 in 2013[49]. This relatively small hospital 
size is also reflected in number of staff at the UNN Harstad. During much of the PhD project, 
staffing at the gastroenterological division was very good, with short wait times (median 
wait for dyspepsia patients in the project was 33 days and for suspected colorectal cancer it 
was 32 days). At other times, the staffing situation was less adequate; according to data 
from the Free Hospital Choice Norway the wait time in December 2014 was 8 weeks for both 
gastroscopy and colonoscopy[201].  
As presented in Paper III, patients with very serious diseases were given higher 
priority than other patients, but no significant difference existed between the intervention 
and control groups. It is quite possible that the relatively short wait time during the PhD 
project meant that any difference would have been difficult to measure, although the 
evidence given for this is, at best, circumstantial. On the other hand, it would be unethical to 
argue for longer wait times for potential seriously ill patients just to ease the evaluation of a 
referral intervention. It is possible that further implementation of similar interventions at 
larger units may have a greater impact on referral prioritisation. 
6.5.2 Non-protocol analysis and related retrospective thoughts on outcome measures 
Throughout the project analyses, the comparison of the intervention and control 
groups was done based on the originally assigned groups (intention-to-treat), as 
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recommended in the CONSORT statement for parallel group randomised trials[202]. These 
results formed the basis for the conclusions presented in this thesis and in the papers. 
However, for completeness, Paper I also presents an unplanned non-protocol analysis, which 
shows a difference in referral quality between intervention GPs who used the dedicated 
electronic address and intervention GPs who did not that was just as large as the difference 
observed between the intervention and control groups. During the preparation of Paper III, a 
similar analysis was carried out for the main outcome (quality score), with results which 
were not significantly different from those presented in the intention-to-treat analysis in 
Paper III.  
These analyses serve to highlight an important point in the design of the PhD project, 
which has been touched upon earlier, but deserves more specific mention. The project 
aimed to assess whether more relevant clinical information in the referral at the GP/hospital 
interface would lead to better prioritisation and quality of care at the hospital[142]. The 
analysis from Paper I confirms that the referrals contained more relevant information, 
especially in the situations where the referral templates were actively utilised (as illustrated 
by the non-protocol analysis). The analysis in Paper III showed no effect of the intervention 
on quality of care, and the non-protocol analysis also indicated no effect, even when the 
analysis was restricted to cases in which the referral template had been utilised. This 
highlights the difficulties mentioned in Chapter 6.1.3 about the implementation of complex 
interventions in real clinical life. The quality assessment presented in Paper III mainly 
measured how the performance at the hospital related to internationally accepted standards 
of care. In retrospect, it seems unlikely that hospital doctors would provide inferior quality of 
care only because the patient was unlucky enough to be referred by a GP who wrote 
referrals of lesser quality. Therefore, maybe not surprisingly, there was no clear effect of the 
main intervention, even when it was very likely that the intervention had been used. Future 
research would need to broaden the assessment of the referral intervention in clinical 
practice.  
6.5.3 Quantitative versus qualitative research 
Traditionally, medical research has been based on empirical verification via 
biomedical methods[203], but qualitative methods have gained popularity and are now an 
integral part of medical research[204]. This is not surprising, as the complexities and 
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subjectivity of clinical practice are often not reflected in the scientific logic of 
refutation[203], as exemplified by the specialist’s evaluation in the current trial. Qualitative 
research involves various ways of systematically collecting, organising, and interpreting 
information gained from talking to, or observing people[205]. In a further development, 
mixed methods research has emerged to combine quantitative and qualitative methods, 
hoping to draw on the strengths of both schools of thought to better understand complex 
research objectives[206]. 
This PhD project aimed to examine if a referral intervention would lead to a 
measurable increase in the quality of care delivered at the hospital, using a traditional 
biomedical model with a randomised design and statistical analysis[142]. As shown in Papers 
II and III, no measurable effect was noted. In a project assessing the effect of interactive 
referral guidance at Akershus University Hospital[207], no effect was seen on referral 
quality, but a qualitative assessment[208] showed that GPs had a largely positive attitude 
toward the intervention and wanted it to be expanded. In the early phase of planning, we 
hoped to have the current intervention assessed by qualitative as well as quantitative 
methods, but this was cancelled due to funding and practical constraints. In retrospect, it 
would have been very useful to more formally assess the impact of the intervention on the 
GPs, patients, and hospital doctors from a qualitative perspective. A mixed methods 
approach to such a complex intervention can be especially useful in health services 
research[206] and would be recommended for future referral intervention assessments.  
6.6 Generalisability  
Assessment of generalisability, or external validity, is important in any study to help 
clinicians decide whether the findings are applicable to a wider range of patients[187,202]. 
Lack of consideration of external validity is a frequent criticism of trials, reviews, and 
guidelines[187]. Although generalisability has been highlighted in the various papers 
constituting this PhD, its importance warrants a more concise debate about the applicability 
of the results.  
The setting of the trial includes the health care system, country, and selection of 
participating centres and clinicians (see Chapter 2.6). The current results are likely relevant 
for patient care pathways in Norway, but also in other health care settings in which GPs have 
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a gatekeeper role. In the selection of participating GP surgeries, all potential participants 
were included, which should increase the generalisability of the final results. The hospital 
was a local secondary hospital, university affiliated, but not a tertiary referral centre. It is 
therefore likely that similar interventions at facilities with a different case-mix may lead to 
different results. 
The selection of patients is an important determinant of external validity (see Chapter 
4.2.2). The current study utilised few exclusion criteria and included a variety of patients 
from ordinary clinical practice. However, as discussed in Papers I and III, we have no 
conclusive indication of the percentage of the eligible patients that actually participated. The 
clear intent of the study to include all patients would ensure generalisability, at least within 
similar health care systems, but the unknown inclusion rate hampers the analysis to some 
extent. 
Characteristics of the randomised patients also contribute to external validity. The 
baseline characteristics of patients in the current study did not differ significantly. However, 
this does not necessarily mean that they are representative of the general population 
referred to this, or any other hospital. The underlying pathology, severity of disease, and 
comorbidities may differ between the study population and the general population referred 
to a hospital for care within the four diagnostic groups[187]. The project scored patient care 
pathways, but did not register specific final diagnoses in detail. We did, however, record 
presence or absence of a diagnosis of incident cancer. In the group referred for suspected 
colorectal cancer, the overall cancer rate was 8.4%, and in the dyspepsia group it was 0.8%. 
This corresponds well with findings from colonoscopies in a screening programme in the 
United Kingdom[209] and with findings at gastroscopies of dyspeptic patients[80]. Of course, 
the population in a screening programme will not be entirely the same as ours, but those 
who underwent colonoscopy in the screening programme already had a positive faecal 
occult blood test, and hence were not that dissimilar from patients with suspected colorectal 
malignancy in the current study. There is no clear indication that our study population 
deviates significantly from the general population under care for similar conditions 
elsewhere in Norway or Western Europe. 
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Often in clinical trials there are differences between the trial protocol and routine 
practice, which may hamper the generalisability of results[187]. The current cluster 
randomised trial was designed to be as close to ordinary clinical practice as possible. 
Although a Hawthorn effect may have affected the results, a direct transfer of the methods 
applied would be possible within any health care system that utilises referrals sent from a 
gatekeeping GP to a hospital. 
In relation to outcome measures, the current trial employed novel quality criteria, 
together with patient experience and health care process outcomes. It is evident that the 
variation in quality assessment highlights some of the difficulties in assessing quality of care 
at a practical, patient-centred level. This variation may very well be seen as a limitation to 
the generalisability of the outcome measures. However, the options do not provide an easy 
alternative (Paper III). Many common quality metrics are developed to measure specific 
actions at the hospital/GP surgery level, and do not necessarily highlight the care pathway of 
the individual patient[210], as envisaged in this project. The outcome measures related to 
prioritisation, subjective quality score, and positive predictive value of referral are likely 
more generalisable. 
Overall, the current study design and implementation means the generalisability of 
the results is quite high, at least to other areas where access to specialist services is via a 
gatekeeping GP. The transfer of the results to other health care settings may be hampered, 
as the baseline quality of referral and hospital/GP communication in a small Northern 




7.0 Implications for future research  
The implementation of simple tools in the health care system can, as this thesis 
shows, be much more difficult to perform and evaluate than face value suggests. Our 
referral intervention intended to improve health care cooperation between independent 
organisations, but it did not manage to create the change expected in the health care 
delivered to each patient. Given the increased focus on quality and prioritisation[16,211], it 
is important and relevant to further examine the effect of the referral on the patient care 
pathway. Based on the current thesis, multiple areas are essential for future research. 
7.1 Intervention improvement 
 Future interventions on the referral in a gate-keeper based system with two 
separate, independent levels of care should be based around the principles of complex 
interventions. Lack of effect is often due to shortcomings of the intervention itself[147]. The 
current PhD project shows that both the intervention itself and its implementation need to 
be strengthened. The development of the intervention should be performed according to 
internationally recognised frameworks[163]. Because GPs have different working styles, a 
higher degree of GP participation is needed to ensure the intervention is acceptable and 
applicable across variations in clinical practice. Once updated, the Norwegian National 
prioritisation guidelines could serve as a basis for referral guidance. As shown by Rokstad, 
embedding these solutions in the GPs EHR seems necessary to ensure uptake and 
usability[12]. 
7.2 Outcome assessment improvement 
 The current outcome measurement tools did not show an effect of the intervention. 
In the future, it will be important to produce a sound pre-trial concept of how referral 
intervention produces change at the hospital and to assess the change across varying GP 
settings[212]. The concept of attempted quality measurement using the quality indicators 
from this trial is unlikely to show an effect of any referral intervention. Instead, assessment 
of prioritisation, doctor/patient satisfaction, and cost are more likely to quantify these 
effects. In addition, continuous qualitative assessment of the process and outcome 




 As shown by Rokstad[12], embedding of referral guidance is possible and acceptable, 
but their study was limited to a single symptom area. The research into the relevant content 
of referral documentation is also progressing[213]. Future piloting of solutions should focus 
on outcome assessment and qualitative assessment of the referral process to clarify complex 
pathways, in addition to acceptability and relevance in GP practice.  
7.4 Wider implementation 
Following further evaluation, it would also be pertinent to implement referral 
guidance in several different hospital areas and clinical cultures. Norway, with its well-
developed primary care sector and almost ubiquitous EHR coverage, is very well suited for 
wide-scale assessment of the impact of such guidance. The relative simplicity of the 
Norwegian health care system (mainly governmentally provided and well-funded) could 




8.0 Implications for health services design 
Given the increasing use of health resources and the focus on prioritisation of scarce 
resources, the introduction of changes to improve the health care process seems tempting. 
In a prioritisation report from a governmental committee lead by Norheim, the issue of 
referral guidelines and their implementation in the EHR is discussed[211]. In light of the 
evidence from this PhD project, it is not certain that widespread implementation of 
mandatory referral guidelines will provide an immediate effect on health care services 
delivered, although the referral quality is likely to increase. It would seem unwise to widely 
implement obligatory referral guidance at every GP surgery without prior rigorous 
assessment, given the time constraints and the wide variations in clinical practice across GP 
surgeries. Before implementation, more rigorous evaluation of barriers to change should 






The current thesis presents a cluster randomised intervention on the interface 
between GPs and hospital doctors. In Paper I, a clear increase in referral quality (18%; 95% CI 
11, 25; p<0.001) was noted when measured by criteria that specialists saw as important in 
their field. This did not translate to the expected improvement in patient experience (Paper 
II) or quality of hospital care (Paper III). A finding of no result or limited effect is not 
uncommon in health services interventions[147]. Retrospectively, it does seem unlikely that 
hospital doctors would provide an inferior level of care to individual patients just because 
their referral was substandard. More disappointing was the lack of effect on secondary 
outcomes, such as appropriate prioritisation and the subjective quality score for the patient 
care pathway. 
The study performance itself was based on a pragmatic approach to real-life clinical 
work. It is hampered by questions regarding the randomisation procedure, lack of uptake, 
and a wide variation in scoring.  
It is very unlikely that the lack of results we observed is due to conceptual error. It 
seems counterintuitive that more appropriate information does not allow easier 
identification of sicker patients and hence more adequate care. However, this study 
underestimated the complexities of research into health service delivery and failed to 
identify appropriate outcome measures. Further research with scientifically sound referral 
guidance embedded in the GP’s EHR seems pertinent before widespread changes are made 






Erratum I: In Paper I page 5 it is stated that “patients ranged from 17 to 90 years of 
age”. Re-examination of baseline data shows that one patient was indeed aged 17 years at 
the time of inclusion and should not have been included. At the time, children >16 were 
treated at the adult facility, so no undue harm was done to the individual. Rerunning of the 
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Abstract
Background: The referral letter is an important document facilitating the transfer of care from a general
practitioner (GP) to secondary care. Hospital doctors have often criticised the quality and content of referral letters,
and the effectiveness of improvement efforts remains uncertain.
Methods: A cluster randomised trial was conducted using referral templates for patients in four diagnostic groups:
dyspepsia, suspected colorectal cancer, chest pain and chronic obstructive pulmonary disease. The GP surgery was
the unit of randomisation. Of the 14 surgeries served by the University Hospital of North Norway Harstad, seven
were randomised to the intervention group. Intervention GPs used referral templates soliciting core clinical
information when initiating a new referral in one of the four clinical areas. Intermittent surgery visits by study
personnel were also carried out. A total of 500 patients were included, with 281 in the intervention and 219 in the
control arm. Referral quality scoring was performed by three blinded raters. Data were analysed using multi-level
regression modelling. All analyses were conducted on intention-to-treat basis.
Results: In the final multilevel model, referrals in the intervention group scored 18 % higher (95 % CI (11 %, 25 %),
p < 0.001) on the referral quality score than the control group. The model also showed that board certified GPs and
GPs in larger surgeries produced referrals of significantly higher quality.
Conclusion: In this study, the dissemination of referral templates coupled with intermittent surgery visits produced
higher quality referrals.
Trial registration: This trial has been registered at ClinicalTrials.gov. The trial registration number is NCT01470963.
Background
A referral facilitates the transition of care from a general
practitioner (GP) to secondary care to establish a diag-
nosis, to provide treatment including surgery, and to
offer advice or reassurance. Hospital specialists fre-
quently have complained about the perceived quality of
referral letters. Several studies have highlighted the
varying quality and content of referrals across a range of
clinical specialities [1–12]. A recent Canadian survey of
more than 3000 GPs and specialists found that, among
the main problems specialists identified, 51 % of referral
letters had an unclear reason for referral [13]. This vari-
ation in quality makes the evaluation and prioritisation
of incoming referrals difficult, with one author stating
that prioritisation cannot be performed based on referral
letters alone [14].
A high quality referral process will generally involve
referral letters containing all necessary information in a
context of shared understanding between GPs, patients
and hospital staff [15]. There have been previous defini-
tions of what referral letters should contain [16]. In
Norway, the Norwegian Centre for Informatics in Health
and Social Care (KITH) has developed guidelines gov-
erning the content of electronic referral and discharge
letters [17, 18]. However, these guidelines present head-
ings and content categories, but do not specify the pre-
cise clinical information required for different clinical
* Correspondence: henrik.wahlberg@uit.no
1Department of Community Medicine, UiT The Arctic University of Norway,
9037 Tromsø, Norway
2University Hospital of North Norway Harstad, St. Olavsgate 70, 9480 Harstad,
Norway
Full list of author information is available at the end of the article
© 2015 Wåhlberg et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Wåhlberg et al. BMC Health Services Research  (2015) 15:353 
DOI 10.1186/s12913-015-1017-7
areas. A recent Norwegian study has highlighted that it
is the lack of information in the referrals, rather than the
structure and categories of the referral, that hospital
doctors perceive as a barrier to high quality cooperative
care [19]. To measure referral quality, it therefore seems
necessary to focus more on measuring the informational
quality of referrals than on measuring their structure.
This conclusion is echoed by other publications in the
field [8, 12, 20]. Several of these studies developed scor-
ing systems collaboratively between hospital doctors and
GPs [12, 20].
The introduction of electronic health records and com-
munication has, to some extent, eliminated some of the
structural problems with referral letters, but further work
is needed to elucidate the relationship between the quality
of clinical information in referrals and high quality health
care processes. This is important as healthcare costs are
rising globally [21] and services are being delivered within
a framework of increasingly limited resources. In this con-
text, it is imperative to improve patient prioritisation
based on referrals in order to aid swift diagnosis in those
with more serious disease and to provide evidence based
high quality care to each individual patient. Tools to im-
prove referral quality are paramount.
This paper reports the effects of a referral intervention
on the quality of referrals in a cluster randomised trial.
We hypothesized that the referral intervention would
improve informational quality in the referrals. We assess
whether other GP-related factors, including patient list
size and years of experience, affect the quality of refer-
rals written. This paper is part of a larger study assessing
the effect of a referral intervention on the quality of
health care delivered to individual patients. Information
about further assessments within the referral project is
available in the published methods paper [22].
Methods
Study setting
The Norwegian health care system is relatively uniform
throughout the country. Each person has a regular GP
who acts as a gatekeeper to secondary care [23]. GPs
work either privately, with capitation payment and fee-
for-service reimbursement, or as municipality em-
ployees. Specialist health care is delivered through
governmentally owned regional health authorities,
mainly in public hospitals. Some specialist outpatient
care is purchased by the regional health authorities
from private specialists, but access to this is very lim-
ited in the geographical area of the current study. Elec-
tronic health records are almost ubiquitous and
referrals are sent according to a national standard that
automatically includes demographic information in-
cluding address, contact details and GP details [17].
Study design
This study was designed as a cluster randomised trial with
the general practitioner surgery as the clustering unit. All
14 community GP surgeries in the area served by the
University Hospital of North Norway (UNN) Harstad
were randomised to the intervention or control group.
The cluster design was chosen to avoid contamination be-
tween GPs, which could have occurred if individual GPs
at the same surgery were randomised to different groups.
The referring GP could not be blinded because the
intervention was actively used by the GP. Patients, hos-
pital doctors and outcome evaluators were blinded to
the patient’s intervention status. However, in some cases
the referral letter revealed the intervention status. Fur-
ther information about study methods are available in
detail in the methods paper [22].
Intervention
The intervention consisted of the distribution of referral
templates to the intervention surgeries. The templates
were provided in paper and electronic forms. The tem-
plates were to be used when initiating a new referral to
the medical outpatient clinic for patients within the four
diagnostic areas specified below. These referral tem-
plates were developed based upon national and inter-
national literature [12, 24–31] and in collaboration with
local specialists within each medical field. A clinical as-
sessment process using specialists from other Northern
Norwegian hospitals provided further insight into tem-
plate contents. To ensure intervention implementation
by keeping it as simple as possible, we reduced the num-
ber of items in the referral template to include only
those that the specialists felt were imperative in a refer-
ral for that clinical area. The templates contained a
heading soliciting further information in the referral
about each item listed in the subsequent list of items.
For example, the items in the referral template for pa-
tients with suspected colorectal cancer are shown in
Table 1 (translated into English). The other templates
are available in Additional file 1. The intervention offices
were also provided with a separate electronic referral ad-
dress at the hospital to enable study organisers to track
the use of the intervention.
The templates were distributed by the corresponding au-
thor (HW) during educational and/or lunch meetings at
the intervention surgeries. Prior to the distribution of tem-
plates, the project had been presented to the GPs at similar
meetings. The intervention was in use for approximately
2 years, from September 2011 to November 2013.
Additional follow-up was provided in the form of
lunchtime visits to the intervention surgeries approxi-
mately twice yearly and intermittent mail leaflets and re-
minders. The lunchtime visits were performed by HW
and provided information about the progress of the
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study, reminders to use the intervention templates and
answers to questions about the project. In addition,
personal letters to participating doctors were sent when
it was evident that the intervention had not been used in
a received referral.
In the control group, normal referral practice contin-
ued. No information about the study was provided to
the control surgeries.
Four separate diagnostic groups were selected; these
represent both important clinical areas and a substantial
amount of outpatient appointments.
 patients referred with dyspepsia
 patients referred with suspected colorectal cancer
(CRC)
 patients referred with chest pain
 patients referred with confirmed or suspected
chronic obstructive pulmonary disease (COPD)
At UNN Harstad in 2008 these diagnostic areas
accounted for approximately 26 % of all patients in the
medical outpatient clinics (own data), although separating
new referrals from control patients in this material was
not possible. In addition, patients in these clinical areas
often represent a diagnostic challenge in primary care [32]
and are well suited for simple referral templates.
Participants
The 14 GP surgeries in the area primarily served by
UNN Harstad were included in the randomisation
process. In 2013, these surgeries had a total list size of
39,253 patients. Five surgeries were town-based and nine
were rural. To ensure equal sociodemographic back-
grounds between groups, the surgeries were randomised
stratified by town or countryside location, although the
location of the surgery itself was not expected to influ-
ence the main outcome variables. Two centres initially
randomised to the intervention group declined to partici-
pate, one because of lack of interest and one because the
GP was about to retire. Two further centres were there-
fore randomly selected. The final intervention group con-
sisted of three urban and four rural surgeries, with two
urban and five rural surgeries in the control group.
New patients referred to the UNN Harstad medical
outpatient clinics in any of the four diagnostic groups
received written information about the study and a par-
ticipant consent form along with their appointment let-
ter. Patients were orally reminded of the study by the
hospital doctor at their hospital outpatient appointment
and were given a new consent form if appropriate.
Children (<18 years of age) and patients with reduced
capacity to consent were excluded from the project. Fur-
ther details about the GP surgeries and the recruitment
process are published in the methods paper [22].
Recruitment
Recruitment ran for about 2.5 years, from September
2011 to February 2014, to ensure that patients referred
during the project (the template was used until November
2014) had an outpatient appointment before inclusion
closed. This timeframe was chosen because few patients at
the hospital experience waiting times of >4 months from
the time of their referral to the time of their hospital ap-
pointment. A total of 538 patients were included in the
project. Thirty-eight patients were excluded because they
did not fulfil the inclusion criteria, as depicted in Fig. 1. In
total, 290 patients were included in the intervention arm
and 227 patients in the control arm.
Ethics
The study followed the directions in the Helsinki Declar-
ation. Before recruitment started, the study was pre-
sented to the Regional Ethical Committee for Medical
Research in North-Norway, who determined it not to be
within the scope of the Health Research Act (REK
NORD 2010/2259). The study was approved by the Data
Protection Official for Research. The study is registered
at ClinicalTrials.gov. The trial registration number is
NCT01470963. All patients provided written informed
consent.
Sample size
For the overall study, sample size calculation was per-
formed for the main outcome variable (a health care
quality score), as shown in the methods paper [22]. No
specific sample size calculation was performed for the
referral quality outcome reported in this paper.
Referral scoring
The referrals were rated according to a scoring system
derived directly from the referral templates used. These
Table 1 Referral template for patients with suspected colorectal
cancer
Item # Item text
1 Change in bowel habit
2 Blood in stool
3 Weight loss
4 Family history of colorectal cancer
5 Previous medical history of bowel disease or
results of previous bowel investigations
6 Results of digital rectal examination (DRE)
7 Iron deficiency anaemia
8 Clinical findings at abdominal examination
9 Result of faecal occult blood test (FOBT)
10 The general practitioners clinical suspicion
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templates specified the clinical information that specialists
deemed most important in the referral, based on literature
documented above. One point was awarded for the pres-
ence in the referral of each of the clinical details requested
in the referral template. The maximum score possible for
referrals for dyspepsia, suspected CRC, COPD and chest
pain were 17, 10, 15 and 13 respectively. Other studies
have also awarded points for the presence of core infor-
mation including full contact details and legibility of refer-
rals [33]. Because all but six referrals in this project were
electronic, and such information is automatically included
in the electronic referral, this information was not in-
cluded in the scoring. The final referral score therefore
represents how many of the information points in the
template were actually articulated in the referral. Each
score was then transformed to a percentage value.
Three raters scored the referrals. A sample of 100 out of
the 500 referrals was scored independently by two raters.
No referral was scored by all three raters, and all three
rater pairs shared at least 25 referrals. The raters were
blinded to the intervention status of the referring GP.
For further analysis, a small amount of data was im-
puted. For referrals initiated by interns, the list size was
missing by default. Interns in Norway spend six months
attached to a GP surgery where they do not have their
own list of patients. Instead, they take part in the general
workload of the surgery. For each referral initiated by an
intern, the list size value in the dataset was set to the
average list size value for the surgery the intern was at-
tached to. This was believed to best represent the antici-
pated workload of each intern.
Speciality status was available for all referring GPs. Years
of experience as a GP and in hospitals was available for
499 of 500 referrals, while data for the last case were im-
puted as mean values.
Statistical analysis
Analyses were stratified by intervention group and control
group. To ensure rater consistency an interrater reliability
analysis using the weighted Kappa statistic was performed,
as developed by Cohen [34]. Referral scores were divided
into centiles, and a weighted Kappa analysis was per-
formed using quadratic weights. Additional analysis was
carried out for each rater pair separately and with the data
divided into quintiles to ensure consistency of analysis.
We chose to use standard weights (quadratic) to im-
prove interpretability, in concordance with discussion on
the appropriate use of Kappa analysis [35]. In this way,
the weighted Kappa coefficient approximates the intra-
class correlation coefficient [36]. The weighted Kappa
coefficient increases with increasing numbers of categor-
ies, especially when using quadratic weights [37]. How-
ever, this increase seems more pronounced in the range
of two to five categories.
The cluster randomised design necessitates an analysis
that is suitable for clustering. In this project, multi-level
regression modelling was used. A stepwise approach was
used to build the multi-level model. Likelihood ratio
tests were used to evaluate whether random regression
coefficients should be considered. Continuous variables
were centred to facilitate interpretation. Because the
intervention was randomised at the level of the GP sur-
gery, no slope could be added for the intervention effect.
To assess the addition of confounders to level one of the
model, a change in the magnitude of the regression coef-
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Fig. 1 Inclusion process. Flow chart of the inclusion process
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considered indicative of a confound. In addition, the fol-
lowing variables were included based on prior subject
knowledge: whether the referring GP was a specialist, the
length of GP experience and GP list size. Effect modifica-
tion was checked for relevant variables using p < 0.10 as
the significance level. This level was chosen because the
power to detect relevant interactions is often low, espe-
cially concerning cross-level interactions in multilevel
studies [38]. Although increasing the type 1 error rate has
been shown to be ineffective [39], it was judged to be bet-
ter than missing important interactions. Analysis was
done on an intention-to-treat basis, as recommended [40].
All referrals from intervention surgeries were therefore
analysed as if they had used the referral intervention, even
though it may have been evident that the intervention was
not used. Stata version 13 (StataCorp. 2013. Stata Statis-
tical Software: Release 13. College Station, TX: StataCorp
LP) was used for all analysis.
Results
Baseline characteristics
Table 2 presents baseline characteristics of the study
population. Patients ranged from 17 to 90 years of age.
In both the intervention and control groups there were
more women (59 and 58 %) than men (41 and 42 %).
The majority of the referrals were in the dyspepsia
group. Baseline characteristics for GP surgeries and
referrals are available in Table 3. The groups appear
similar, except that more referrals were initiated by male
GPs in the control group than in the intervention group,
which is probably caused by the slightly higher number
of male GPs in the control group. Further, significantly
more of the referrals in the intervention group than in
the control group were made by GP specialists, thereby
necessitating this as a covariate in the regression model.
There were 37 referrals from interns, accounting for
7.4 % of the total number of referrals. A total of 139 of
the 281 (49.5 %) intervention group referrals were sent
to the designated electronic referral address created for
the project; the rest were sent to the standard hospital
electronic address.
Interrater reliability
The interrater reliability was found to be Kappa = 0.93
(p < 0.0001), 95 % CI (0.73, 1). Additional analysis
with the data divided into quintiles showed Kappa = 0.90
(p < 0.0001), 95 % CI (0.71, 1). Analysis for each rater pair
separately yielded Kappa values ranging from 0.85 to 0.93
(further details available upon request).
Primary outcome
The average referral quality in each of the four diagnostic
groups, not corrected for clustering, was higher in the
intervention than the control group (Fig. 2). Large varia-
tions in quality were seen across all four diagnostic areas,
both in the intervention and control groups. Table 4 pre-
sents these findings, not corrected for clustering, showing
highly significant improvements in referral quality scores
in all clinical areas except COPD. However, the absolute
number of COPD referrals was very low.
Baseline evaluation of the main outcome variable (re-
ferral quality) demonstrated that it was nearly normally
distributed. Naïve analysis of data—that is, using a
mixed models approach without adding the level of GP
surgery into the analysis—was compared with a model
including the GP surgery as clustering unit. Adding the
random intercept to the model decreased the −2 log
likelihood by 4529.25–4493.50 = 35.75. This is highly sig-
nificant according to the Chi squared distribution with
one degree of freedom. From the above analysis, the
intraclass correlation coefficient (ICC) was calculated to
be 0.14 (95 % CI (0.02, 0.25)). The final model corrected
for whether the GP was a board certified specialist,
centred mean GP patient list size, GP hospital experi-
ence (in years), and categorised GP surgery size. GP ex-
perience (in years) was removed from the model because
Table 2 Selected patient baseline characteristics by intervention status
Intervention group Control group p-value
Patient demographics1
Female/male, n (%) 166 (59.07)/115 (40.93) 127 (57.99)/92 (42.01) p = 0.807
Age, years 59.21 ± 13.64 57.08 ± 15.26 p = 0.101
Urban/rural, n (%) 169 (60.14)/112 (39.86) 121 (55.25)/98 (44.75) p = 0.272
Clinical group, n (%)
- dyspepsia 144 (51.25) 120 (54.79)
- suspected colonic malignancy 87 (30.96) 68 (31.05)
- chest pain 46 (16.37) 27 (12.33)
- chronic obstructive pulmonary disease 4 (1.42) 4 (1.83)
Hospital appointment with senior house officer/specialist, n (%) 130 (46.26)/151 (53.74) 96 (43.84)/123 (56.16) p = 0.588
1Data are presented as mean ± SD or number (%)
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it had no impact on the outcome of interest and had no
clear association with referral quality. In addition, GP
experience was clearly correlated with being a GP spe-
cialist, and its inclusion would thus reduce the power of
the analysis without adding further insight.
Allowing the result to vary randomly at the level of
the referring GP further decreased the −2 log likelihood
of the baseline model to 4419.70 and reduced residual
variance. The addition of a third level added complexity
to the model and only changed the estimation of the
intervention effect by 2 percentage points. It was there-
fore decided to keep the two level model proposed in
the methods paper [22].
With this model, the multi-level regression analysis sug-
gested a significant intervention effect with an approxi-
mately 20 % higher referral score in the intervention
group. In the final model, adjustment reduced the effect
estimate to 18 % (95 % CI (11, 25), p < 0.001) (Table 5).
The model suggests that board certified GPs produced re-
ferrals that were closer to the referral template (9 %, 95 %
CI (4, 14), p < 0.001), whereas longer hospital experience
during a GP’s career predicted slightly less complete refer-
rals (−2 %, 95 % CI (−3, −1) p < 0.001). Larger GP surger-
ies also tended to produce higher quality referrals, but this
association was not statistically significant. A Q-Q nor-
mality plot of residuals from the model showed no viola-
tion of normality assumptions.
Because only roughly 50 % of the intervention group
referrals were sent to the intervention hospital electronic
address, we performed a non-protocol multilevel model
analysis comparing the quality of referrals between the
intervention GPs who used the referral address and
those intervention GPs who did not. We found a referral
quality difference that was approximately as large as be-
tween the intervention and control group in the main
analysis (21.9 %, 95 % CI (16.5, 26.2), p < 0.001).
Discussion
The current paper presents the impact of the dissemin-
ation of a referral template on referral quality. The inter-
vention improved referral quality by 18 %, which is
presumably clinically relevant. Our finding is consistent
with reported increases in referral quality in similar
intervention studies [41, 42], whereas another study re-
ported a smaller effect size [43]. However, as discussed
in a Cochrane review on the subject, there have been
few studies aimed at improving the quality of referrals,
and several have had methodological weaknesses [44].
The current study suggests that dissemination of refer-
ral templates combined with local follow-up measures
can indeed improve referral quality in the communica-
tion between primary and specialist health care, which is
consistent with the conclusions in the Cochrane report
[44]. The data also suggest that being a board certified
Table 3 Selected general practitioner (GP) baseline characteristics by intervention status1
Intervention group Control group p-value
GP surgery variables2
List size 830.79 ± 208.78 865.48 ± 100.69 p = 0.475
Female/male GP, n (%) 14 (58.33)/10 (41.67) 10 (43.48)/13 (56.52) p = 0.308
Specialist yes/no, n (%) 18 (75)/6 (25) 11 (47.83)/12 (52.17) p = 0.055
Years experience 16.02 ± 10.40 15.15 ± 11.15 p = 0.784
Years experience in hospital 2.81 ± 5.94 1.89 ± 3.06 p = 0.510
Number of GPs in surgery 4.33 ± 1.61 4.04 ± 1.58 p =0.536
- median 5 5
- mode 5 5
GP referral variables per referral in dataset2
Female/male referring GP, n (%) 182 (64.77)/99 (35.23) 93 (42.47)/126 (57.53) p < 0.000014
Number of GPs in surgery 4.43 ± 1.46 4.01 ± 1.62 p =0.0033
Specialist yes/no n (%) 189 (67.26)/92 (32.74) 114 (52.05)/105(47.95) p = 0.0005564
Years experience 16.21 ± 11.96 15.41 ± 11.70 p = 0.456
Years experience in hospital 1.54 ± 1.88 1.54 ± 2.46 p = 0.994
Other variables per referral in dataset2
Electronic/paper referral n (%) 281 (100)/0 (0) 213 (97.26)/ 6 (2.74) p = 0.0053
1Two GPs shared two lists at two separate surgeries, both in the intervention group. Weighted analysis taking this into account did not lead to significant change
in the baseline characteristics
2Data are presented as mean ± SD or number (%)
3Significant at p < 0.01
4Significant at p < 0.001
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GP improves the quality of written communication to
specialist health services as measured by the referral
scoring system. Surprisingly, a GP’s experience as a hos-
pital doctor does not appear to predict referrals that in-
clude more of the content requested by hospital
consultants. Years of experience as a GP showed no as-
sociation with the outcome of interest and was left out
of the model entirely. This may suggest that it is the
communication and collaboration between hospital-
based specialists and dedicated GPs that can produce
better referral quality, and not the experience of the GP
or the presence of a referral template per se.
However, it is important to recognise that while a hos-
pital physician will try to prioritise received referrals
based on the risk of serious illness, many referrals are
sent for reasons other than ruling out or diagnosing dis-
ease. These can include patient reassurance, reduction of
medico-legal risk, handing over of care, or to obtain a
second opinion [45]. Others have shown that factors in-
cluding GP gender and GP speciality can affect referral
rates and have discussed whether higher professional in-
security and/or higher responsiveness to patient demand
may explain some of this variation [46]. It is conceivable
that some of these factors also affect referral content,
and that referrals are not purely based on the GP’s per-
ception of the patient’s individual risk of serious disease.
As shown above, in this study the quality of the refer-
rals varied between the four clinical areas, with referrals
for suspected colonic malignancy scoring highest (aver-
age 70.1 % in the intervention group and 53.4 % in the
control group) and referrals for patients with COPD
scoring lowest (43.3 vs. 40.0 %). We have found no com-
parable studies in which referrals for different clinical
areas have been scored using the same scoring tech-
nique, and it is therefore hard to assess whether this
quality difference is a general phenomenon. However,
the referral template for colonic malignancy contained
the fewest requested clinical data points, and the scien-
tific basis for these points was better documented than
those for the COPD or dyspepsia referrals. This may
Table 4 Average referral quality by diagnostic group,
uncorrected for clustering1
Intervention Control p-value
Dyspepsia 57.3 (53.0, 61.7) 31.4 (28.7, 34.1) <0.001
Suspected colonic
malignancy
70.1 (65.6, 74.6) 53.4 (48.5, 58.3) <0.001
COPD 43.4 (7.1, 79.6) 40.0 (0, 83.3) 0.857
Chest pain 61.9 (56.2, 67.5) 45.3 (38.3, 52.3) <0.001




























Fig. 2 Referral quality. Referral quality by diagnostic group, uncorrected for clustering, presented as percentages
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suggest that for referral templates to be effective, simpler
templates based on solid scientific research may be more
acceptable and user-friendly in clinical practice than
complicated templates.
The referral scores varied widely for each diagnostic
area (Fig. 2). This confirms the pre-trial clinical suspi-
cion of variation, which was one of the motivations for
this study. Especially within the area of dyspepsia, wide
variation was seen in both the intervention and control
groups, with several outliers. This suggests that some
GPs produce referrals of high quality, regardless of the
referral intervention, and that some general practitioners
in the intervention group took no interest in the interven-
tion at all. This wide range in performance has also been
noted when the referral rate has been assessed [46, 47].
Although uniformity does not necessarily equate to qual-
ity, it is intuitive that some degree of increased uniformity
in referral quality would improve equity in the health care
delivered to patients.
Adding interactions to the model showed a significant
interaction between intervention status and being a
board certified GP. This suggested a stronger interven-
tion effect amongst those who were board certified. This
was felt to be adequately represented in the model by
the combination of the terms ‘board certified GP’ and
‘hospital experience’.
The weighted Kappa analysis equates to ‘almost perfect’
agreement among raters (Kappa 0.81–1.00) according to
Landis and Koch [48]. Even considering the increasing
Kappa values with increasing categories discussed above,
this shows not only excellent overall reliability, but also
excellent agreement between all three rater pairs.
This study has several limitations. The referral tem-
plates used in the project were developed according to
international literature and local practices. Referrals
were scored based on how closely they followed this re-
ferral template. Conscientious GPs were therefore likely
to score very high on the referral score, and this could
bias the results in favour of the intervention. Nonethe-
less, the scoring system does equate with referral quality
measurement scores used in other referral evaluation
studies [2, 5]. In addition, further work in this project
aimes to assess whether the presence of a greater quan-
tity of relevant clinical information improves the quality
of the health care process, and consequently this scoring
system seemed appropriate. It is possible that some of
the effect size noted above was caused by GPs who took
a special interest in the study.
A further weakness is that the current project does
not provide a clear indication of the proportion of the
referring GPs who actively used the referral intervention.
The referral templates were distributed and follow-up
visits were arranged to ensure adherence to the study
protocol. As presented above, only about 50 % of the re-
ferrals from intervention GPs were sent to the newly
formed intervention electronic address. This suggests a
fairly modest uptake of the intervention, and the non-
protocol analysis showed a higher intervention effect
amongst those GPs who actively utilised the electronic
address. Because intention-to-treat analysis was used,
this has probably attenuated the intervention effect.
Similar difficulties have been seen in other projects, with
an uptake as low as 18 % in a referral intervention study
for patients with lower bowel symptoms [49]. However,
a recent Norwegian project using referral guidance as an
electronic pop-up reported that the 88 % of the inter-
vention GPs used the intervention ‘all the time’ [20].
Many known barriers to changes of behaviour and ap-
plication of clinical knowledge exist, including lack of
knowledge/awareness, lack of applicability to the individ-
ual patient and organisational factors [50]. Feedback
from the GPs in this project suggests that the interven-
tion was used and appreciated, but also easily forgotten
in hectic everyday clinical work. If wider application of
referral guidelines is to be considered, careful assessment
should be undertaken to identify barriers to their use
and to indicate tailored interventions to overcome these
barriers, as this has been shown to be more likely to im-
prove professional practice [51].
Another limiting factor is that the rate of inclusion of
relevant patients is unknown. During the inclusion
phase, regular reviews took place to assess the rate of
Table 5 Intervention effect estimates
Regression coefficient 95 % CI p-value
Crude1 20.25 10.23, 30.27 p < 0.001
Adjusted2 18.00 11.03, 24.98 p < 0.001
- GP specialist yes/no 9.19 4.39, 13.99 p < 0.001
- GP list size (centred) 0.02 −0.01, 0.05 p = 0.196
- GP experience in hospital (in years) −2.06 −3.08, −1.05 p < 0.001
- GP surgery size3 4.81 −2.73, 12.35 p = 0.211
1Baseline model with intervention effect with random intercept
2Adjusted for the variables listed below
3Categorised into binary variable 0–3 GPs and 3–6 GPs
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inclusion at the hospital, which was estimated to be ap-
proximately 60 % of possible outpatient candidates. A
completely accurate figure is not available, as this would
require a manual search of the charts of every patient
with an outpatient appointment, which is beyond the
ethical approval of this project.
It is also clear that more patients were recruited from
intervention GP surgeries than control GP surgeries.
The total number of listed patients in the intervention
and control group GP surgeries was very similar (19,347
vs. 19,906). The study did not have access to referral
rates, and it is not clear whether these varied between
the practices. There is no clear indication of major base-
line differences between the GP surgeries and the study
patients that can explain the difference in inclusion. One
possible explanation is that the focus on the four diag-
nostic areas in the intervention offices caused more pa-
tients to be referred, but this cannot be demonstrated
from the current data.
It is important to note that making referral informa-
tion more in line with the hospital physicians’ wishes
does not automatically predict improved outcomes. It is
conceivable that referrals that are more pleasing to the
hospital consultant may give a false sense of precision in
the evaluation and prioritisation of referrals. For colorec-
tal cancer, a review of symptoms and diagnostic tests in
primary care suggests that few symptoms and signs are
sensitive and specific enough to be used to identify pa-
tients at higher risk. However, it does indicate that refer-
ral guidelines and symptom combinations may aid in
this process [52]. Further research is necessary to iden-
tify the clinical symptoms, signs or tests that will allow a
clear prediction of risk in order to guide the information
included in referrals. As we wait for this guidance, we
must use the tools currently available, including good
communication and clear and informative referrals.
Healthcare costs are rising [21]. For healthcare man-
agers and policymakers, it would be helpful if the imple-
mentation of referral guidelines can improve patient
prioritisation, as suggested in a recent Norwegian report
supporting the use of referral guidelines and their imple-
mentation in the electronic health record [53]. As dis-
cussed, caution must be exercised, because a more
precise referral may not predict better quality of care.
Further analysis within this project is currently under-
way to determine whether improved referral quality re-
sults in a meaningful change in patient prioritisation and
quality of care.
Conclusion
This cluster randomised study assessing the impact of
the dissemination of referral templates coupled with
intermittent surgery visits by study personnel demon-
strates a significant and substantial improvement in the
measured quality of referrals in the intervention group.
Further analysis is underway to determine whether this
improvement in observed referral quality will predict an
increase in the quality of care delivered to individual pa-
tients. For future studies, it appears prudent to utilise
simple referral guidance, developed in collaboration be-
tween primary and secondary care. The referral guidance
will need to be embedded in the patient record system
to ensure its implementation.
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Objectives: To evaluate if a referral intervention
improves the patient experience of the referral and
treatment process.
Setting: Interface between 14 primary care surgeries
and a district general hospital.
Participants: The 14 general practitioner (GP)
surgeries (7 intervention, 7 control) in the area around
the University Hospital of North Norway Harstad were
randomised and all completed the study. Consecutive
individual patients were recruited at their hospital
appointment. A total of 500 patients were recruited
with 281 in the intervention and 219 in the control
arm.
Interventions: Dissemination of referral templates for
4 diagnostic groups (dyspepsia, suspected colorectal
cancer, chest pain and chronic obstructive pulmonary
disease) coupled with intermittent surgery visits by
study personnel. The control arm continued standard
referral practice. The intervention was in use for
2.5 years.
Outcome: The main outcome was a quality indicator
score. This paper reports a secondary outcome, the
patient experience, as measured by self-report
questionnaires. GPs in the intervention group could not
be blinded. Patients were blinded to intervention status.
Analysis was based on single-question comparison
with a questionnaire subscore used to assess the effect
of clustering.
Results: On the individual questions, overall
satisfaction was very high with minor differences
between the intervention and control group.
Interestingly, the most negative responses, in both
groups concerned questions relating to patient
interaction and information. Very little evidence of
clustering was found with an estimated intracluster
correlations coefficient at 1.21e−11.
Conclusions: In total, this indicates no clear effect of
the implementation of referral templates on the patient
experience, in a setting of generally high patient
satisfaction.
Trial registration number: NCT01470963; Results.
INTRODUCTION
Evaluation of patient experience and satisfac-
tion is widespread with a wealth of literature
concerning the development and use of
questionnaires.1–5 The evaluation of patient
experience can help drive quality improve-
ment,6 and improved patient experience is
associated with safety and clinical effectiveness.7
Care coordination is an important aspect
of a well-functioning high-quality health
service. It has been defined as ‘the deliberate
integration of patient care activities between
two or more participants involved in a
patient’s care to facilitate the appropriate
delivery of health care services’.8 In the USA,
the National Quality Forum (NQF) has pub-
lished preferred practices for care coordin-
ation, including transitions of care.9 This
report includes clear recommendations for
participation of the patient, or his/her
designee, in the decision, planning and exe-
cution of a care transition. This is important,
as exemplified by a recent Australian article,
where patients with colorectal cancer per-
ceived that poor information exchange led
to suboptimal care.10 Hence assessing patient
experience of the referral process may be
beneficial in assessing the effect of a referral
intervention.
This article presents the patient experience
aspect of a cluster randomised study evaluat-
ing the effect of the implementation of refer-
ral templates for four diagnostic groups—
dyspepsia, suspected colorectal cancer, chest
pain and chronic obstructive pulmonary
disease (COPD)—in the patient referral
pathway.11 Previously, we have shown that the
referral templates led to increased referral
quality,12 and the effect on the main
outcome, quality of care at the hospital, is in
Strengths and limitations of this study
▪ Clinically relevant research in a regular district
hospital setting.
▪ High response rate.
▪ Newly developed questionnaire hampers wider
generalisation.
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publication. This publication aims to assess whether the
implementation of a referral template in the transition
of care from the general practitioner (GP) to the hos-




In Norway, the healthcare system is quite uniformly orga-
nised throughout the country. GPs act as gatekeepers to
secondary care,13 with specialist health services delivered
by governmentally owned regional health authorities,
mainly through public hospitals. Some specialist out-
patient care is delivered by private specialists, but this is
mainly purchased by the regional health authorities.
The access to private specialists in the geographical area
of the current study is very limited.
Study design
The study was designed as a cluster randomised study
with the GP surgery as the clustering unit. A total of 14
surgeries were randomised, 7 to the intervention and 7
to the control group. The clustered design was chosen
to avoid possible spill-over effect from the intervention
to control GPs. Randomisation was performed by simple
drawing by a person not connected to the research
team, stratified by town versus countryside location of
surgery.
As the intervention was to be actively used by the GPs,
the referring GP could not be blinded. Patients, hospital
doctors and outcome evaluators were blinded to the
intervention status of the patients. Owing to the design
of the intervention, the referral letter would sometimes
reveal the intervention status, if the electronic template
was used. No separate sample size calculation was per-
formed for the patient experience outcome. The full
study details are published in the methods paper.11
Intervention
The intervention consisted of the distribution of four
separate referral templates to the intervention surgeries.
These templates covered four clinical areas (dyspepsia,
suspected colorectal malignancy, chest pain and COPD).
The templates were to be used when initiating a new
referral to the medical outpatient clinic at the University
Hospital of North Norway, Harstad (UNN Harstad). The
templates were distributed by the corresponding author
(HW) during educational and/or lunch meetings and
were provided as laminated reference sheets or in elec-
tronic form. In addition, follow-up visits were conducted
regularly during the study period and intermittent mail
leaflets and reminders were distributed to the interven-
tion surgeries. Control offices continued standard refer-
ral practice.
Outcomes
The main outcome in the project was the quality of care
delivered to each individual patient. In addition, health
process indicators such as correct prioritisation were
recorded and referral quality was also compared
between the intervention and control group. The
current paper presents the patient experience aspect of
the study, as measured by self-report questionnaires.
Participants
The 14 GP surgeries primarily served by UNN Harstad
were included in the randomisation process. In 2013,
these surgeries had a total list size of 39 523 patients.
The individual patients were recruited from consecutive
new patients within one of the four clinical areas
referred to, at the medical outpatient clinics at UNN
Harstad. Study information and a consent form were
sent to each individual patient together with their
appointment letter. Further information, including a
new consent form if appropriate, was provided at their
hospital appointment. The individual patients were ana-
lysed as part of the intervention or control group
depending on the intervention status of the GP surgery
they were referred from. Children (<18 years of age)
and patients with reduced capacity to consent were
excluded from the study.
Recruitment
The study recruited patients for ∼2.5 years and a total of
538 patients were included with 290 in the intervention
arm and 227 in the control arm. The remaining 21
patients were referred from GP surgeries outside the
regular area of UNN Harstad, and as such neither in the
intervention nor the control group. These 21 were
excluded, together with 17 patients who did not fill the
inclusion criteria. In total, this left 281 patients in the
intervention arm and 219 patients in the control arm
(figure 1).
Questionnaire development
Multiple tools exist for measuring different aspects of
care coordination14 and patient experience; however, no
complete questionnaire was located that covered the
area in the current study completely. Therefore, a ques-
tionnaire was developed by combining validated ques-
tionnaires regarding patient experiences and care
coordination. The questions used were the full version
of the Generic Short Patient Experiences Questionnaire
(GS-PEQ),15 together with two further questions used in
patient experience questionnaires in the Norwegian
healthcare system (questions 11 and 12)16 and the
two questions about health interaction from the
Commonwealth Fund Survey 2010.17 Three further ques-
tions were added to assess (1) who referred the patient,
(2) if the referral was seen as appropriate and (3) an
overall evaluation of the institution. Table 1 presents the
questions in the questionnaire. GS-PEQ and questions
11–12 use Likert-style response categories. The health
2 Wåhlberg H, et al. BMJ Open 2016;6:e011651. doi:10.1136/bmjopen-2016-011651
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interaction questions had a yes/no response. The full
questionnaire, including the demographic questions, is
available on request.
The questionnaire was piloted for content validity with
four local health professionals; these felt that it covered
the important aspects of patient experience and care
coordination. It was then piloted with five outpatients
with a median age of 72 years (average 68.8 years) to
ensure face validity and acceptability. Two patients
needed clarification on one of the questions before they
felt they could answer, and the wording of this question
was adjusted accordingly. The patients felt the question-
naire was acceptable, with logical response categories
and that the questions covered their clinical path during
the referral process well. These patients did not take
part when the project was later initiated. No further
formal evaluation of the questionnaire was carried out.
Questionnaire distribution
The questionnaire was mailed to patients who had con-
sented to take part in the referral project presented
above. To increase response rates, a prepaid response
envelope was included, addresses were handwritten, the
questionnaire was kept short and association with
research bodies was indicated.3 For non-responders, one
reminder was sent ∼1 month after the first question-
naire, with a new questionnaire and prepaid response
envelope.
Ethics
The study followed the principles of the Helsinki
Declaration. Before recruitment started, it was presented
to the Regional Committee for Medical and Health
Research Ethics Northern Norway, who determined it
not to be within the scope of the Health Research Act
(REK NORD 2010/2259). The project has been
approved by the Data Protection Officer for Research.
The study is registered at http://www.clinicaltrials.gov,
with trial registration number NCT01470963. All patients
provided written informed consent.
Imputation
To further aid the assessment of clustering, missing data
were imputed. For the imputation, answers set as ‘not
applicable’ were counted as missing. Missing data were
seen to be random and multiple imputation using
chained equations was employed. This has been shown
to perform well for a variety of variable scaling types.18
Every variable used in further statistical analysis was
entered into the imputation model, as failure to do so
may bias estimates towards the null.19 The ordinal
response scales for each single question were to be com-
bined into a continuous score, and as such, it was deter-
mined that imputation with predictive mean matching
was appropriate. As shown by van Buuren,19 the number
of iterations can usually be quite low, between 5 and 20.
In this study, the Stata standard of 10 iterations as
burn-in period was used.
Statistical analysis
Results are presented on single question basis with com-
parison between the two groups using the
Mann-Whitney U test for ordinal data and χ2 test for
nominal data. No correction for clustering was made as
the estimated ICC was very low (shown below).
Aggregation of scores was postulated in the methods
paper,11 but discarded as a main outcome as properties
of the questionnaire, with a ‘not applicable’ answering
Figure 1 Patient inclusion and
questionnaire response.
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category, are not easily suitable for such an approach.
However, to assess the effect of clustering, a sum of
scores from the GS-PEQ part of the questionnaire was
calculated and a multilevel regression model was built
with the GS-PEQ score from the questionnaire as the
dependent variable. Intervention status was included in
the model as this is the main point of interest. Gender,
age, education level and self-perceived health were
included in the model, as these tend to influence
patient experience.20–22 Age was centred to ease inter-
pretation in a mixed model analysis.23 Self-perceived
health was reported on a five-level Likert-style scale and
education level in four categories. Both were included as
dummy variables in the analysis. Other confounding
variables were assessed in the model and included if
their inclusion led to a >10% change in the main
outcome when added to the base model (main outcome
+intervention status). Relevant interactions were
checked for relevant variables, where p<0.10 was set as
the significance level. As imputation was used, Monte
Carlo error estimates were employed to assess the level
of simulation error, as suggested by White et al.24
Normal evaluation of multilevel models with loglikeli-
hood ratio tests were not carried out, as this is not well
defined for multilevel models with imputed data. The
analysis employed restricted maximum likelihood tech-
niques throughout, as suggested when the number of
clusters is small.25 As described, multiple imputation
was used to account for missing data in the multilevel
regression model assessing the effect of clustering.




The response rate was 69.4% before reminders were
sent out, rising to 82.0% after reminders (figure 1). The
mean age for responders was 61 years and for non-
responders 47 years (t-test <0.0001). There was no sig-
nificant gender difference between the responders and
non-responders, and the response rate did not differ sig-
nificantly between the intervention and control group
(χ2 test).
Missing data
Missing data for most questions were low, ranging from 0
to 11 out of 410 answered questionnaires. Statistically,
these were considered missing completely at random
(MCAR) with no clear relation to either age, gender,
self-perceived health, disease severity or other vari-
ables.26 However, questions 6, 10 and 12 in the general
part of the questionnaire had higher amounts of not
applicable ranging from 14 to 34 representing 3.4–8.3%
of returned questionnaires. In these questions, the word
‘treatment’ was used. This was intended to cover the
medical examination and interventions during the out-
patient visit. However, it seems that this has been misun-
derstood by several patients. It seems reasonable to
assume that patients who underwent ‘only’ diagnostic
evaluation felt that they had received no ‘treatment’,
and hence felt unable to answer the question. This was
also highlighted by one patient in a free-text response in
the questionnaire. ‘Not applicable’ to questions 6, 10
and 12 did not vary significantly with age (t-test), in-
tervention group status (χ2 test), gender (χ2 test) or
Table 1 Questionnaire details
Question no. Wording of question
1 Did the clinicians* talk to you in a way that was easy to understand?
2 Do you have confidence in the clinicians’ professional skills?
3 Did you get sufficient information about how examinations and tests were to be performed?
4 Did you get sufficient information about your diagnosis/conditions?
5 Did you perceive the treatment to be adapted to your situation?
6 Were you involved in decisions regarding your treatment?
7 Did you perceive the institution work practices to be well organised?
8 Did you perceive the equipment at the institution to be in good working order?
9 Overall, was the help and treatment you received at the institution satisfactory?
10 Do you believe that you were in any way given incorrect treatment (according to your own judgement)?
11 Did you have to wait before you were given an appointment at the institution?
12 Overall, what benefit have you had from the care at the institution?
13 Did the hospital specialist lack basic medical information from your GP about the reason for your
visit or test results?
14 After you saw the hospital specialist, did your GP lack important information about the care you
got from the specialist?
15 Was the referral to the outpatient department necessary (according to your own judgement)?
16a Were you referred by your GP for the outpatient appointment?
16b If no in question 16a; who referred you?
17 If you take an overview of your entire treatment process, how would you evaluate the institution?
*With ‘clinicians’, we mean those who had the main treatment responsibility. This is linguistically clearer in the Norwegian wording.
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self-reported health (χ2 test). This was treated as missing
at random for imputation purposes (MAR).26 Question
14 had a missing rate of 15.9% but also yielded a high level
of not applicable responses, at 46.0% of returned question-
naires. This was expected, as many people will not have
had a new appointment with their GP following the hos-
pital outpatient evaluation. It is also reasonable to assume
that the high amount of missing was related to the same
concept. The response ‘not applicable’ did not significantly
vary with age (t-test p=0.868), intervention group status
(χ2 test p=0.064) or self-reported health (χ2 test p=0.459).
A histogram of responses to questions with five cat-
egories showed all response sets to be skewed to the left.
However, earlier work has indicated that multiple im-
putation can perform well, even when the categorical
variable is non-normally distributed, as long as MAR
does not exceed 10%.27 In a 2010 article, Finch26 argues
that multiple imputation performs well for imputation
of missing categorical questionnaire data. There was
no association between levels of missing data and the
multilevel structure of the data.
Baseline characteristics
Baseline characteristics are presented in table 2. There
was no major difference between the intervention and
control group with regard to gender, age, urban or rural
residency or questionnaire response. The effect of the
referral intervention on referral quality has previously
been shown to be clinically significant with an effect of
18% (95% CI 11 to 25, p<0.001).12 However, this was for
the full data set of 500 patients. To ensure that this was
also representative of the subpopulation who answered
the questionnaire, the multilevel regression model was
employed using data from only the 410 patients who
answered it. This showed an intervention effect of 19%
(95% CI 12 to 27, p<0.001) on referral quality, well
within the 95% CI of the full analysis.
Questionnaire results
Overall satisfaction with services was high and as pre-
sented in table 3, there was little difference between the
intervention and control group for the individual ques-
tions. Using the Mann-Whitney U test, χ2 test and Fisher
exact test, only two questions had significant p values
(Q14 and Q17); however, in these questions, the abso-
lute difference in numbers was very small. All response
sets were skewed to the left, that is, towards more posi-
tive responses.
Interestingly, the highest numbers of scores indicating
dissatisfaction were for questions 4 and 6, for the inter-
vention and control group patients. These questions
concern patient interaction and information on the
treatment process.
The Cronbach α for questions 1–15 was 0.83 and for
questions 1–10 0.88.
Assessment of clustering effect
In the regression model, no significant difference was
seen in the GSPEQ score between the intervention and
control group with the regression coefficient 0.55 (95%
CI −0.37 to 1.47, p=0.24) when taking clustering into
account and adjusted for confounding variables 0.57
(95% CI −0.31 to 1.46, p=0.20). No significant inter-
action was found, and the result was not confounded by
GP specialist status, GP gender, specialist status of hos-
pital doctor or seriousness of final diagnosis. The Monte
Carlo error estimates were within the limits recom-
mended.24 Initial multilevel analysis of the data revealed
virtually no variance of the intercepts. The ICC was esti-
mated at 1.21e−11. Hence, very little of the variation in
the data was related to the clustered design.
DISCUSSION
In the presentation of the data from each question in
table 3, it is quite clear that, for the most part, patients
in this project report positive experiences, with no differ-
ences between the intervention and control group. It
hence seems that although the intervention has
increased the referral quality significantly,12 this has not
translated into a more positive patient experience with
the referral process and treatment, as measured by self-
report questionnaires. In the current study, indepth data
analysis with imputation and multilevel regression mod-
elling was employed to further explore the effect of clus-
tering. No clear effect of clustering was found.
Table 2 Selected patient baseline characteristics by intervention status
Intervention group Control group p Value
Female/male, N (%) 140 (59.3)/96 (40.7) 102 (58.6)/72 (41.4) 0.89
Age (year), mean (±SD) 60.9±12.5 60.3±13.5 0.63
Urban/rural, N (%) 145 (61.4)/91 (38.6) 95 (54.6)/79 (45.4) 0.17
Clinical group, N (%)
Dyspepsia 117 (49.6) 96 (55.2) 0.29
Suspected colorectal malignancy 75 (31.8) 57 (32.8)
Chest pain 40 (17.0) 18 (10.3)
Chronic obstructive pulmonary disease 4 (1.7) 3 (1.7)
Hospital appointment with senior house officer/specialist, N (%) 107 (45.3)/129 (54.7) 78 (44.8)/96 (55.2) 0.92
Questionnaire returned promptly/after mailed reminder, N (%) 202 (85.6)/34 (14.4) 145 (83.3)/29 (16.7) 0.53
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A strength of the current study is the fairly high
response rate (82.0%) compared with other mail
response studies.28 However, the potential for non-
response bias is always present. Others have previously
shown the effect of this to be small.29 30 Earlier
Norwegian studies have suggested only minor differ-
ences between answers provided by responders and
non-responders, when the latter have been obtained
through telephone follow-up interviews.31–33 A clear
limitation is the use of short-form questionnaires with
single items, which may be less valid than longer
forms.34 However, shorter forms will increase the
response rate.4 35 The current project aimed to assess
the effect of a health system intervention and the
patient experiences with care after this intervention.
We hence decided to keep the questionnaire short to
enable a high response rate and keep the patient and
staff workload manageable.
The current project used a newly developed ques-
tionnaire to assess patient experience by combining
previously validated questions. The general nature of
the final questionnaire may be seen as a weakness, as
small changes in the patient experience induced by
the intervention may have been missed. Further pilot-
ing might have revealed more clearly if the question-
naire did indeed assess the patient experience with the
referral and care process in an adequate way. However,
in this clinically oriented project, the authors hoped
that a more general questionnaire would highlight
whether the intervention would cause a more overall
positive, or even a negative, change. It is probable
that for each individual patient, it is the experience
with the entire process that matters, as opposed to the
experience of a subpart of the process. If large-scale
implementation of referral guidance is contemplated,
a more specific questionnaire may need to be
validated.
An additional weakness was the lack of a sound analyt-
ical plan proposed in the methods paper.11 To ensure
transparency, the analysis presented in this paper is there-
fore simple and based on single-question assessment.
Given the clustered nature of the study, an assessment of
clustering is given for a subsection of the questionnaire,
but very little effect was seen.
Table 3 Questionnaire results
Question Answering categories* Intervention Control p Value
Question 1† 5 (4, 5) 5 (4, 5) 0.92
Question 2† 5 (4, 5) 4 (4, 5) 0.39
Question 3† 5 (4, 5) 4 (4, 5) 0.23
Question 4† 4 (3, 5) 4 (4, 4) 0.12
Question 5† 4 (4, 5) 4 (4, 5) 0.88
Question 6† 4 (3, 5) 4 (3, 4) 0.19
Question 7† 4 (4, 5) 4 (4, 5) 0.22
Question 8† 4 (4, 5) 4 (4, 5) 0.81
Question 9† 5 (4, 5) 4 (4, 5) 0.15
Question 10† 5 (5, 5) 5 (5, 5) 0.60
Question 11‡ No 33 (14.0) 21 (12.1) 0.33
Yes, but not too long 155 (66.0) 111 (64.2)
Yes, quite long 34 (14.5) 29 (16.8)
Yes, too long 13 (5.5) 12 (6.9)
Question 12‡ No benefit 3 (1.4) 5 (3.1) 0.56
Little benefit 12 (5.5) 7 (4.3)
Some benefit 59 (27.2) 44 (27.0)
Large benefit 106 (48.9) 86 (52.8)
Very large benefit 37 (17.1) 21 (12.9)
Question 13‡ Yes 4 (1.7) 6 (3.5) 0.25
No 229 (98.3) 165 (96.5)
Question 14‡ Yes 4 (4.2) 8 (13.1) 0.04
No 92 (95.8) 53 (86.9)
Question 15‡ Yes 232 (99.2) 170 (99.4) 0.75
No 2 (0.8) 1 (0.6)
Question 17‡ Much poorer than expected 0 (0) 1 (0.6) 0.03
Somewhat poorer than expected 0 (0) 5 (3.1)
As expected 119 (54.1) 94 (58.4)
Somewhat better than expected 50 (22.7) 32 (19.9)
Much better than expected 51 (23.2) 29 (18.0)
*For questions 1–10, the following scoring was used: 1, not at all; 2, to a small extent; 3, to some extent; 4, to a large extent and 5, to a very
large extent.
†Data presented as median (25th centile, 75th centile).
‡Data presented as number (%).
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Comparison with other studies was difficult as no
clearly comparable analysis was found, except for the
two health interaction questions. In the current study,
1.7% in the intervention group and 3.5% in the control
group felt the hospital specialist lacked information
from the GP. About 4.2% in the intervention and 13.1%
in the control group felt the GP lacked information
from the specialist. In the Norwegian part of the 2010
Commonwealth Fund Survey, the same questions gave
much higher negative ratings, with 12.1% indicating
that the specialist lacked information from the GP and
38.3% indicating that the GP lacked information from
the hospital.17 Data from the 2013 Commonwealth Fund
Survey suggest similar ratings as in 2010, although the
wording of the questions is slightly different.36 A
Norwegian report concerning patient experience as
inpatients also suggests higher dissatisfaction with
co-operation between the hospital and the GP37 than in
the current study. In total, this clearly suggests that the
patient experience of the GP/specialist communication
is better in a small district hospital than the country
average suggests. It is therefore possible that the effect
of the intervention on patient experience could have
been higher if the level of dissatisfaction with the health-
care cooperation had been higher in the local popula-
tion. However, this also may suggest that although the
hospital consultants often feel information is lacking in
the referrals,38 39 this is not necessarily experienced as a
problem by patients.
In the current study, two questions were answered
more negatively than others. These questions therefore
probably provide the most interesting points for further
quality improvement at the local facility. These two ques-
tions represent areas where communication is the main
concept, namely patient involvement in the treatment
process and information from doctors to patients.
Others have previously shown communication and infor-
mation errors as a cause for dissatisfaction,40 and in
other jurisdictions even malpractice claims.41 42
CONCLUSION
In this project, patient satisfaction, as measured by
patient experience questionnaires, was generally high,
with no major differences between the intervention and
control group. No clear effect of the implementation of
referral templates on patient satisfaction was evident.
Interestingly, the most negative feedback, from the
intervention and control group, was concerning patient
interaction, involvement and information. Effective
communication and involving patients in decision-
making may help to increase patient satisfaction to an
even higher level.
Contributors The administration and daily running of the study was
performed by HW, who was also the grant holder. ARB and HW developed
the questionnaire. All authors participated in the analysis and interpretation of
the data. All authors revised drafts of the manuscript and approved the final
version.
Funding This work was funded by a research grant from the Northern
Norway Regional Health Authority (Helse Nord RHF) with grant number
HST1026-11.
Competing interests None declared.
Ethics approval The project has been approved by the Data Protection Officer
for Research.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement No additional data are available.
Open Access This is an Open Access article distributed in accordance with
the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license,
which permits others to distribute, remix, adapt, build upon this work non-
commercially, and license their derivative works on different terms, provided
the original work is properly cited and the use is non-commercial. See: http://
creativecommons.org/licenses/by-nc/4.0/
REFERENCES
1. Crow R, Gage H, Hampson S, et al. The measurement of satisfaction
with healthcare: implications for practice from a systematic review of
the literature. Health Technol Assess 2002;6:1–244.
2. Garrat A, Solheim E, Danielsen K. National and cross-national
surveys of patient experiences: a structured review. July 2008. Oslo:
Norwegian Knowledge Centre for the Health Services, 2008.
3. Edwards PJ, Roberts I, Clarke MJ, et al. Methods to increase
response to postal and electronic questionnaires. Cochrane
Database Syst Rev 2009:MR000008.
4. Edwards P. Questionnaires in clinical trials: guidelines for optimal
design and administration. Trials 2010;11:2.
5. Fitzpatrick R, Davey C, Buxton M, et al. Evaluating patient-based
outcome measures for use in clinical trials: a review. Health Technol
Assess 1998;2:74.
6. Ellins J. Great expectations? Reflections on the future of patient and
public involvement in the NHS. Clin Med 2011;11:544–7.
7. Doyle C, Lennox L, Bell D. A systematic review of evidence on the
links between patient experience and clinical safety and
effectiveness. BMJ Open 2013;3:pii: e001570.
8. McDonald K, Sundaram V, Bravata D, et al. Closing the quality gap:
a critical analysis of quality improvement strategies (Vol. 7: Care
Coordination). Rockville, MD: Agency for Healthcare Research and
Quality (US), 2007.
9. National Quality Forum. Preferred practices and performance
measures for measuring and reporting care coordination: a
consensus report. Washington, DC: National Quality Forum, 2010.
10. Pascoe SW, Veitch C, Crossland LJ, et al. Patients’ experiences of
referral for colorectal cancer. BMC Fam Pract 2013;14:124.
11. Wåhlberg H, Valle PC, Malm S, et al. Practical health co-operation—
the impact of a referral template on quality of care and health care
co-operation: study protocol for a cluster randomized controlled trial.
Trials 2013;14:7.
12. Wåhlberg H, Valle PC, Malm S, et al. Impact of referral templates on
the quality of referrals from primary to secondary care: a cluster
randomised trial. BMC Health Serv Res 2015;15:353.
13. Carlsen B, Norheim OF. Introduction of the patient-list system in
general practice. Changes in Norwegian physicians’ perception of
their gatekeeper role. Scand J Prim Health Care 2003;21:209–13.
14. Schultz EM, Pineda N, Lonhart J, et al. A systematic review of the
care coordination measurement landscape. BMC Health Serv Res
2013;13:119.
15. Sjetne IS, Bjertnaes OA, Olsen RV, et al. The Generic Short Patient
Experiences Questionnaire (GS-PEQ): identification of core items
from a survey in Norway. BMC Health Serv Res 2011;11:88.
16. Sjetne IS, Bjertnes OA, Iversen HH, et al. Pasienterfaringer i
spesialisthelsetjenesten. Et generisk, kort spørreskjema. Oslo:
Nasjonalt kunnskapssenter for helsetjenesten, 2009.
17. Skudal KE, Bjertnes OA, Holmboe O, et al. The 2010
Commonwealth Fund survey: results from a comparative population
survey in 11 countries. 21. Oslo: The Norwegian Knowledge Centre
for the Health Services, 2010.
18. Lee KJ, Carlin JB. Multiple imputation for missing data: fully
conditional specification versus multivariate normal imputation.
Am J Epidemiol 2010;171:624–32.
19. van Buuren S. Multiple imputation of discrete and continuous data by
fully conditional specification. Stat Methods Med Res 2007;16:219–42.
20. Xiao H, Barber JP. The effect of perceived health status on patient
satisfaction. Value Health 2008;11:719–25.
Wåhlberg H, et al. BMJ Open 2016;6:e011651. doi:10.1136/bmjopen-2016-011651 7
Open Access
group.bmj.com on October 25, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
21. Fitzpatrick R. Surveys of patient satisfaction: II—designing a
questionnaire and conducting a survey. BMJ 1991;302:1129–32.
22. Da Costa D, Clarke AE, Dobkin PL, et alThe relationship between
health status, social support and satisfaction with medical care
among patients with systemic lupus erythematosus. Int J Qual
Health Care 1999;11:201–7.
23. Twisk J. Applied multilevel analysis. Cambridge: Cambridge
University Press, 2006.
24. White IR, Royston P, Wood AM. Multiple imputation using chained
equations: issues and guidance for practice. Stat Med
2011;30:377–99.
25. Eldridge S, Kerry S. A practical guide to cluster randomised trials in
health services research. 1st edn. Chichester: John Wiley & Sons,
Ltd, 2012.
26. Finch W. Imputation methods for missing categorical questionnaire
data: a comparison of approaches. J Data Sci 2010;8:361–78.
27. Leite W, Beretvas S. The performance of multiple imputation for
Likert-type items with missing data. J Mod Appl Stat Methods
2010;9:64–74.
28. Sitzia J, Wood N. Response rate in patient satisfaction research: an
analysis of 210 published studies. Int J Qual Health Care
1998;10:311–17.
29. Lasek RJ, Barkley W, Harper DL, et al. An Evaluation of the impact
of nonresponse bias on patient satisfaction surveys. Med Care
1997;35:646–52.
30. Perneger TV, Chamot E, Bovier PA. Nonresponse bias in a survey
of patient perceptions of hospital care. Med Care 2005;43:374–80.
31. Guldvog B, Hofoss D, Pettersen KI, et al. PS-RESKVA—
pasienttilfredshet i sykehus [PS-RESKVA—patient satisfaction in
hospitals]. Tidsskr Nor Laegeforen 1998;118:386–91.
32. Do non-respondents’ characteristics and experiences differ from
those of respondents? Poster at the 25th International Conference
by the Society for Quality in Health Care (ISQua). 25th International
Conference by the Society for Quality in Healthcare (ISQua); 08.
2008.
33. Using telephone interviews to explore potential non-response bias in
a national postal survey. Poster at the 26th International Conference
by the Society for Quality in Health Care (ISQua). 26th International
Conference by the Society for Quality in Health Care (ISQua); 09.
2009.
34. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health
survey (SF-36). I. Conceptual framework and item selection. Med
Care 1992;30:473–83.
35. Eaker S, Bergström R, Bergström A, et al. Response rate to mailed
epidemiologic questionnaires: a population-based randomized trial of
variations in design and mailing routines. Am J Epidemiol
1998;147:74–82.
36. Haugum M, Bjertnes OA, Iversen HH, et al. Commonwealth Fund’s
health policy survey in 11 countries: Norwegian results in 2013 and
development since 2010. 27 November 2014. Oslo: The Norwegian
Knowledge Centre for the Health Services, 2014.
37. Skudal KE, Holmboe O, Iversen HH, et al. Inpatients’ experience
with Norwegian hospitals: national results in 2011 and changes from
2006. March 2012. Oslo: Norwegian Knowledge Centre for the
Health Services, 2012.
38. Canadian Medical Association. National survey: experiences with
referrals from primary to specialty care. Canadian Medical
Association, 2013.
39. Bodek S, Ghori K, Edelstein M, et al. Contemporary referral of
patients from community care to cardiology lack diagnostic and
clinical detail. Int J Clin Pract 2006;60:595–601.
40. Hiidenhovi H, Nojonen K, Laippala P. Measurement of outpatients’
views of service quality in a Finnish university hospital. J Adv Nurs
2002;38:59–67.
41. Levinson W, Roter DL, Mullooly JP, et al. Physician–patient
communication. The relationship with malpractice claims among
primary care physicians and surgeons. JAMA 1997;277:553–9.
42. Beckman HB, Markakis KM, Suchman AL, et al. The doctor–patient
relationship and malpractice. Lessons from plaintiff depositions. Arch
Intern Med 1994;154:1365–70.
8 Wåhlberg H, et al. BMJ Open 2016;6:e011651. doi:10.1136/bmjopen-2016-011651
Open Access




Wåhlberg H, Valle PC, Malm S, Hovde Ø, Broderstad AR: The effect of referral templates on 
out-patient quality of care in a hospital setting: a cluster randomized controlled trial. BMC 
Health Services Research 2017, 17:177 
RESEARCH ARTICLE Open Access
The effect of referral templates on out-
patient quality of care in a hospital setting:
a cluster randomized controlled trial
Henrik Wåhlberg1*, Per Christian Valle2, Siri Malm2,3, Øistein Hovde4,5 and Ann Ragnhild Broderstad2,6
Abstract
Background: The assessment of quality of care is an integral part of modern medicine. The referral represents the
handing over of care from the general practitioner to the specialist. This study aimed to assess whether an
improved referral could lead to improved quality of care.
Methods: A cluster randomized trial with the general practitioner surgery as the clustering unit was performed.
Fourteen surgeries in the area surrounding the University Hospital of North Norway Harstad were randomized
stratified by town versus countryside location. The intervention consisted of implementing referral templates for
new referrals in four clinical areas: dyspepsia; suspected colorectal cancer; chest pain; and confirmed or suspected
chronic obstructive pulmonary disease. The control group followed standard referral practice. Quality of treatment
pathway as assessed by newly developed quality indicators was used as main outcome. Secondary outcomes
included subjective quality assessment, positive predictive value of referral and adequacy of prioritization.
Assessment of outcomes was done at the individual level. The patients, hospital doctors and outcome assessors
were blinded to the intervention status.
Results: A total of 500 patients were included, with 281 in the intervention and 219 in the control arm. From the
multilevel regression model the effect of the intervention on the quality indicator score was insignificant at 1.80%
(95% CI, −1.46 to 5.06, p = 0.280). No significant differences between the intervention and the control groups were
seen in the secondary outcomes. Active use of the referral intervention was low, estimated at approximately 50%.
There was also wide variation in outcome scoring between the different assessors.
Conclusions: In this study no measurable effect on quality of care or prioritization was revealed after
implementation of referral templates at the general practitioner/hospital interface. The results were hindered by a
limited uptake of the intervention at GP surgeries and inconsistencies in outcome assessment.
Trial registration: The study was registered under registration number NCT01470963 on September 5th, 2011.
Keywords: Quality of care, Referral, Care cooperation
Background
Quality of care is now an integral part of modern medicine,
exemplified most recently in Norway by the National Pa-
tient Safety Programme [1], a national strategy for quality
improvement in health and social services [2], and several
national registries [3, 4]. To define quality in health care,
though, is challenging because of its subjective nature [5].
The definition by Donabedian is “the application of medical
science and technology in a manner that maximises its
benefit to health without correspondingly increasing the
risk” [6]; in many ways this represents what many physi-
cians regard as high-quality care. Others have highlighted
the need to take patient expectations and financial con-
straints into account in the definition of quality of care [7].
Measurement of quality is important both to ensure
the quality of services and to aid hospital management.
Several authors have highlighted the usefulness of qual-
ity measurement in documenting the quality of care,
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making comparisons, prioritizing, quality improvement,
and accountability [8, 9]. However, as indicated in a re-
cent editorial, care must be taken to ensure that qual-
ity—not the measuring of quality—remains the aim [10].
Quality measures are usually classified as structural,
process, or outcome measures [11]. Structural measures
are often easy to evaluate, and examples include equip-
ment, facility, and staffing numbers. However, they tend
to be weakly associated with outcomes [12]. Process
measures are the components of the encounter between
the patient and health-care professional, such as ordered
tests [9, 13]. They aim to assess how often an interven-
tion known to correlate with a favourable outcome takes
place. Outcome measures use the health outcome, such
as survival, complications, and quality of life, as a quality
indicator [12]. The use of outcome measures is impeded
by several factors, such as the infrequent occurrence of
some events (e.g. mortality and morbidity), and the fact
that the interval between intervention and event may
extend for years [12, 14].
Many quality criteria have been developed [15–18],
often following the RAND Corporation/UCLA (University
of California) appropriateness method [19], but other
methods have also been described [20, 21]. A perfect qual-
ity measure would fully correlate with positive outcomes
for each individual patient. However, an error-free meas-
ure of quality of care is unlikely ever to be created [9].
Quality indicators are only “tools that can support quality
improvement”—not necessarily direct measures of quality
[22]. Some authors have expressed concern about quality
measures that focus on small aspects of care; they fear that
other aspects of equal, or greater, importance may receive
less attention [23, 24]. In a recent article, Bishop empha-
sized that quality measurement in outpatient care is in-
complete and that the focus is mainly on preventive care,
chronic disease management, and patient experience [25].
Similarly, a review of performance measures in the
specialist referral process identified multiple measures
[26]; most of these concentrated, though, on the
structural components of the referral process—as op-
posed to holistically depicting the quality of the entire
treatment process.
The referral constitutes the handing over of care from
one caregiver to another. For the purpose of this paper
referral is defined as the handing over of care from the
general practitioner (GP) to secondary care. To assure
high quality further down in the treatment process, the
referral letter from the GP should contain all the neces-
sary information in a context of shared understanding
among the GP, the patient, and hospital staff [27]. How-
ever, a number of publications have pointed to the vary-
ing quality and content of referrals in clinical practice
[28–30]. Over the years, many interventions have been
directed at the referral process. A Cochrane review on
this subject indicates the complexities of research in this
field and states that surprisingly few interventions on
the referral system have been rigorously evaluated [31].
In Norway, the health-care system is relatively uniform
throughout the country. Each GP has a list of patients
for whom he/she provides care. GPs act as gatekeepers
to secondary care [32]. Specialist health care is delivered
through governmentally owned regional health authori-
ties—mainly via public hospitals, but private health care is
available to some extent. Communication between GPs
and hospitals is almost exclusively electronic, with the
automatic retrieval of demographic information, such as
addresses, contact details, and GP details in each referral,
according to a national standard [33]. Apart from this
automatic retrieval referrals are, in normal practice,
mainly written in free text format containing the informa-
tion each referring GP deem necessary. Beyond basic de-
mographical information the referrals therefore contain
varying amount and type of clinical information.
According to several of the aspects indicated in the
Cochrane report mentioned above [31], the current study
is an attempt to evaluate a referral intervention in a set-
ting with a well-organized GP care system electronically
linked to the local hospital. Those aspects include referral
quality, secondary-care management of patients, and pa-
tient outcomes and satisfaction. We have previously
shown that the quality of the referrals in the intervention
group improved by 18% (95% CI 11, 25), p < 0.001 [34].
This increase however, is of limited value unless it trans-
lates into a measurable change in outcomes that matter to
patients and caregivers. The current article presents the
effect of this increase in referral quality as measured by
the assessment of individual patient pathways by quality
of care indicators and other secondary measurements.
The aim is to assess if an improvement that seem pertin-
ent, given the referral deficiencies discussed above, also




This study was designed as a cluster-randomized trial with
the GP surgery as the clustering unit. The 14 community
GP surgeries in the area served by the medical department
at the University Hospital of North Norway Harstad
(UNN Harstad) were randomized to an intervention or
control group. We chose the cluster-randomized design to
avoid potential “contamination” between GPs at the same
surgery—as could have occurred with individual GP
randomization. Randomisation was done by simple draw-
ing by a person not connected to the research team, strati-
fied by town vs countryside location of surgery.
Patients, hospital doctors, and outcome evaluators
were blinded to the intervention status of the patient;
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participating GPs could not be blinded since they ac-
tively used the intervention. Further details about the
randomization and study methods are described else-
where [35].
Intervention
The intervention consisted of the distribution of referral
templates—in electronic and paper form—to be used as
reference sheets when initiating a new referral to med-
ical outpatients at UNN Harstad. The GPs could choose
whether to use the electronic template directly or use
the paper template as a reference, when initiating a new
referral. The templates were to be used with the referral
of new patients in four separate clinical areas: dyspepsia;
suspected colorectal cancer; chest pain; and confirmed
or suspected chronic obstructive pulmonary disease
(COPD). We developed the referral templates based
upon national and international literature in collabor-
ation with local specialists in each medical field. To en-
sure the appropriateness of the templates, we also
obtained assessments from specialists at other Norwe-
gian hospitals. To promote adoption of the intervention,
we included only information perceived as imperative in
the referrals in the final templates. As an example, the
items in the referral template for patients with dyspepsia
appear in Table 1; other templates are available on re-
quest. The templates were distributed at educational or
lunch meetings, and follow-up visits were provided twice
a year during the inclusion phase. It was intended that
the intervention referrals within the project would be
sent to a specific electronic address at UNN Harstad to
enable assessment of intervention uptake. The interven-
tion was in use from September 2011 to November 2013
and stopped after the planned period of approximately
2 years [35]. The control group followed normal referral
practice.
Participants
We included all 14 GP surgeries in the geographical area
served by UNN Harstad in the randomization process.
In 2013, they had a total list size of 39,253 patients. Indi-
vidual consecutive patients referred from these GP sur-
geries received study information and a consent form
together with their appointment letter from the hospital.
They received an oral reminder regarding study partici-
pation at their first hospital appointment. Children
(<18 years of age) and patients with reduced capacity to
consent were excluded from the project. Patients were
recruited from September 2011 until February 2014.
Further details about the randomization and recruitment
processes are described elsewhere [35].
Sample size
In the actual study, the intraclass correlation coefficient
(ICC) turned out to be 0.02 (95% CI, 0.00–0.06). Esti-
mating the sample size based on the study effect esti-
mates and this ICC with the assumption of 80% power
to detect a 10% difference with a p value set at 0.05 leads
to a total sample size of 94 (84, 124). To detect a 5% dif-
ference, a total sample size of 576 (324, unattainable
with only 14 clusters) would seem appropriate.
Data
We retrieved data by manual review of the electronic
health records. Electronic retrieval was considered, but
seen as too complex and imprecise for clinical quality
indicators—a conclusion that has also been made by
others [36].
Outcomes
The present study aimed to assess the quality of the care
pathway by the following outcomes measures as outlined
in our previous paper [35] and further detailed below.
 Quality indicator score
 Specialist’s subjective quality assessment
 Positive predictive value of referral
 Adequacy of prioritization
Quality indicator score
Reviewing the literature few relevant quality indicators
assessing information from individual patient’s pathways
were found. The quality indicators used to assess quality
Table 1 Referral template for patients referred with dyspepsia












11 Previous peptic ulcer disease






17 If <50 years, Helicobacter pylori status
aNSAID non-steroidal anti-inflammatory drugs
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of care were therefore developed from previous quality-
assessment tools and treatment guidelines [13, 16, 18,
37–68]. The indicators were mainly process indicators.
Some adaptation was made to align the criteria with lo-
cally accepted practice, which has been demonstrated
elsewhere when transferring quality criteria to a new
context [69]. The indicators were assessed by specialists
in the appropriate field and reviewed based on the advice
received. However, no formal approach was employed in
developing the indicators. The full indicators are available
on request, and the set for dyspepsia is available in a trans-
lated version as Additional file 1.
Each patient care pathway was scored according to the
criteria. The indicator set for each clinical area consisted
of a general section and disease specific subsections de-
pending on the final diagnosis in the treatment pathway.
Scoring was undertaken by a panel of specialists from
different Norwegian hospitals—all blinded to the inter-
vention status of the patient. Eight gastroenterologists,
two cardiologists, and two pulmonologists participated.
All scorers were independent from the GP surgeries and
the hospital involved in the study. To allow assessment
of scoring agreement, a subsample of the cases was eval-
uated by two scorers independently.
The quality indicator score was calculated as an adher-
ence score (number of criteria met divided by number of
applicable criteria), as developed by Ashton et al. [70]. If
insufficient information was available to ascertain whether
or not an applicable criterion was met, it was classed as
“not met” [71], thereby producing a conservative quality
score. We considered weighting of the criteria based on
clinical importance, but this often adds complexity to the
analysis without providing insight into the clinical analysis
[72]. The total score was calibrated as a percentage to en-
able comparison and statistical analysis.
Subjective quality assessment
The panel of specialists also subjectively scored the treat-
ment pathway for each patient in two ways. Firstly, they
provided a quality rating of the treatment process on an or-
dinal scale of 1–10. Then, they assessed whether the treat-
ment pathway was appropriate with a yes/no response.
Positive predictive value of referral
Based on the method of Bennett et al. [73], we calcu-
lated the positive predictive value (PPV) of a referral.
This represents the chance of a referral leading to a rele-
vant diagnostic or management decision. Adapting this
concept from otolaryngology to a medical department,
we defined the PPV as the number of referrals that re-
sulted in a histological diagnosis, diagnostic clarification,
or change in medical management.
Adequacy of prioritization
Prior to including the patients, potential outcome diag-
noses within the four clinical areas were grouped into
four categories according to severity. As no prior classifi-
cation was found this was done by the main author
based on WHO International Statistical Classification of
Disease and Related Health problems 10th revision
(ICD-10) disease codes. The groupings were adjusted
after feedback from specialists within each clinical field.
Each patient was placed in a severity group based on the
final ICD-10 code from the hospital medical records. If
several codes were set for an individual patient the code
belonging to the most severe group was utilized. As an
example a final diagnosis of C18.2 (cancer in the ascend-
ing colon) would be placed in the most severe group
and a final pure symptomatic diagnosis of R19.4 (change
in bowel habit) would be placed in the least severe
group. When a diagnosis was encountered that could
not be categorized according to the pre-planned severity
grouping, consensus was achieved among the study or-
ganizers before putting it into the appropriate category.
This severity grouping was then used to compare the ad-
equacy of the waiting time between the intervention and
control groups. Waiting time was defined as the time
from the referral was received at the hospital until the
first out-patient appointment, measured in days.
Statistical methods
To assess scoring agreement for the main outcome, we
estimated repeatability coefficients [74]. We provide
plots of the mean for each pair of scores vs the differ-
ence in score between the two raters for the clinical
areas of chest pain and COPD (Bland-Altman plots). We
did not produce such plots for gastroenterological clin-
ical areas; as it was impossible to define primary and
secondary raters for the individual observational pairs
when eight raters overlapped, and Bland-Altman plots
depend on the sign of the difference between raters.
The cluster design of the present study demanded an
analysis that took into account the clustered nature of
the data [75]. In this study, we used multi-level regres-
sion modelling to evaluate the effect of the intervention
on the main outcome (quality indicator score). We
employed likelihood ratio tests to assess the appropriate-
ness of the model. To determine the effect of con-
founders to level one of the model, a change in the
regression coefficient for the intervention effect of >10%
was considered relevant. Based on prior assessment and
subject knowledge, we included patient gender, age, spe-
ciality status of hospital doctor, and severity of final
diagnosis in the model. We checked effect modification
for relevant variables using p < 0.05 as the significance
level. The CONSORT guideline for cluster randomised
trials was adhered to [75].
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For the subjective quality assessment, data are presented
as medians with interquartile ranges since the values were
not normally distributed. In addition, we employed multi-
level ordinal regression analysis to confirm the findings.
To assess PPV, we used a simple comparison of percenta-
ges—without correction for clustering.
We conducted the analyses throughout on an intention-
to-treat basis. With this analysis, patients referred from
intervention centres were regarded as belonging to the
intervention group—even if it was evident that the inter-
vention had not been used by the referring GP for that
particular patient. In all analyses the patient was the unit
of analysis and a two-level data structure was used.
Missing data
A small amount of data was missing from the outcome
scoring, representing 2/500 (0.4%) for the subjective
quality assessment score and 5/500 (1%) for the binary-
outcome of adequate treatment process. To allow for a
complete data-set analysis, these data were estimated.
For the subjective quality score, the two missing values
were set as the median value. For the binary outcome,
the response was set to yes (numerical value 1) for sub-
jective score values above six and no (numerical value 0)
for scores of five and under. Where both the subjective
and binary scores were missing, the median value was
used for the binary score (yes, numerical value 1).
Results
Baseline characteristics
In all, 500 patients were available for analysis in this study:
281 in the intervention arm and 219 in the control arm
after exclusion of nine in the intervention and eight in the
control arm [34]. No clusters were lost to follow up. There
were no significant baseline differences between the pa-
tients in the intervention and control arm, as seen in
Table 2. The majority of referrals were within the dyspep-
sia and suspected colorectal cancer clinical areas. More of
the GPs in the intervention than in the control group were
board certified GPs, but the years of experience were simi-
lar in both groups. Significantly more referrals in the inter-
vention arm were sent by female GPs, which probably
relates to the higher number of female GPs in the inter-
vention than in the control arm. Most referrals were elec-
tronic, but six paper referrals (2.7%) were received in the
control arm versus none in the intervention arm. Half
(49.5%) of the referrals in the intervention arm were sent
to the designated electronic address established for the
project; the rest were sent to the standard hospital elec-
tronic address.
Scorer agreement
A subsample of 86 care pathways was scored by two sep-
arate specialists to determine concordance between the
scorers. For the quality indicator score, the mean di-
fference between the two scoring measurements did not
significantly differ from 0, and estimation of the repeat-
ability coefficients, as suggested by Bland and Altman, is
presented in Table 3. These suggest a wide variation in
scoring between the different scorers. Bland-Altman
plots are presented in Fig. 1 for chest pain and COPD
since there were only two scorers. It is evident that for
chest pain, one of the scorers gave a much higher range
of scores than the other. In addition, there is quite
clearly a wide variation in scoring between the two
scorers for both clinical areas.
Using absolute values, the mean difference between the
scorers was 14% (95% confidence interval [CI], 11.6–16.4)
with a coefficient of variation of 80.6%.
For the subjective quality scoring, the repeatability co-
efficients were also high; Bland-Altman plots for the
chest pain and COPD clinical areas showed similar re-
sults, with wide variation in scoring (data not shown).
Quality indicator score
Average quality score, not adjusted for clustering, in the
intervention arm was 64.4% (95% CI, 62.4–66.3) and in
the control arm 60.0% (95% CI, 57.9–62.2); the averages
for each clinical area are presented in Table 4. Using a
baseline multi-level model with patients from all clinical
areas combined, the ICC was estimated at 0.02 (95%, CI
0.00–0.06). Adding a slope for the intervention status in-
creased the −2 log likelihood of the model and did not
make a large change in the residual variance. It was
therefore not retained in the model. Postulating a three
level data structure by allowing the results to vary ran-
domly at the level of the referring GP only marginally
reduced the −2 log likelihood and residual variance of
the model. The two level structure proposed in the
methods paper was therefore kept. No significant inter-
action was found. A significant effect of the intervention
was seen in the baseline model; however, after correction
for relevant confounders, the intervention effect was re-
duced to 1.80% (95% CI, −1.46 to 5.06, p = 0.280). Further
regression coefficients appear in Table 5. No clear viola-
tion of normality assumptions was noted. Additional mod-
elling for each individual rater revealed no significance of
the intervention for any rater (data not shown). Given the
significant difference (not corrected for clustering) shown
for the dyspepsia group in Table 4 modelling was also per-
formed for each of the four diagnostic groups. No signifi-
cant effect of the intervention was seen, after correction
for confounding factors (data not shown).
Subjective quality score
The subjective quality rating was done on an ordinal
scale of 1–10. As evident in Fig. 2, the variable was not
normally distributed. Overall, the median in the
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intervention arm and control arm was 8, with an inter-
quartile range of 2. Table 6 presents the median and
interquartile range by clinical area and intervention sta-
tus. No difference between the intervention and control
arms appeared in the graph or interquartile ranges. This
was confirmed with a multi-level ordinal regression
model, in which no difference was noted (data not shown).
No difference was observed between the intervention and
control arms in the binary(yes/no) assessment of patient
pathway appropriateness (data not shown).
PPV of referral
Table 7 shows the number of patients who had a hi-
stological diagnosis, diagnostic clarification, or change in
medical management as a result of their outpatient
Table 2 Selected baseline characteristics for patients and general practitioner surgeries by intervention statusa
Intervention group Control group p value
Patient demographics b
Female/male, n (%) 166 (59.1)/115 (40.9) 127 (58.0)/92 (42.0) 0.807
Age, years 59.2 ± 13.6 57.1 ± 15.3 0.101
Urban/rural, n (%) 169 (60.1)/112 (39.9) 121 (55.3)/98 (44.7) 0.272
Clinical group, n (%)
- Dyspepsia 144 (51.3) 120 (54.8)
- Suspected colonic malignancy 87 (31.0) 68 (31.1)
- Chest pain 46 (16.4) 27 (12.3)
- COPDc 4 (1.4) 4 (1.8)
Hospital appointment with senior
house officer/specialist, n (%)
130 (46.3)/151 (53.7) 96 (43.8)/123 (56.2) 0.588
Given right to health care after
assessment of referral, yes/no, n (%) d
222 (79.0)/59 (21.0) 168 (76.7)/51 (23.3) 0.587
GP surgery variablesb
List size 830.8 ± 208.8 865.5 ± 100.7 0.475
Female/male GP, n (%) 14 (58.3)/10 (41.7) 10 (43.5)/13 (56.5) 0.308
Board certified, yes/no, n (%) 18 (75.0)/6 (25.0) 11 (47.8)/12 (52.2) 0.055
Years experience 16.0 ± 10.4 15.2 ± 11.2 0.784
Number of GPs in surgery 4.3 ± 1.6 4.0 ± 1.6 0.536
- Median 5 5
- Mode 5 5
GP referral variables per referral in data setb
Female/male referring GP, n (%) 182 (64.8)/99 (35.2) 93 (42.5)/126 (57.5) <0.00001
Number of GPs in surgery 4.4 ± 1.5 4.0 ± 1.6 0.003
Specialist, yes/no n (%) 189 (67.3)/92 (32.7) 114 (52.1)/105 (47.9) 0.000556
Years experience 16.2 ± 12.0 15.4 ± 11.7 0.456
Other variables per referral in data setb
Electronic/paper referral, n (%) 281 (100)/0 (0) 213 (97.3)/6 (2.7) 0.005
aTwo GPs shared two lists at two separate surgeries, both in the intervention group. Weighted analysis that took this into account did not lead to significant
changes in the baseline characteristics
bData are presented as mean ± SD or number (%)
cCOPD chronic obstructive pulmonary disease
dAfter assessment of the referral Norwegian hospital doctors decided whether or not a patient had a legal “right to health care” within a given time





Dyspepsia (n = 44) +/− 40.71
Colorectal (n = 17) +/− 23.20
Chest pain (n = 17) +/− 20.25
COPD (n = 8) +/− 46.68
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appointment. There were some missing items: this was
because part of the scoring sheet with the PPV scoring
box appeared on a separate page and may therefore have
been overlooked. No clear difference was evident be-
tween the intervention and control arms.
Adequacy of prioritization
The average waiting time (time from referral to first out-
patient appointment) was 46 days (95% CI, 42–50) in
the intervention arm and 49 days (95% CI, 43–55) in the
control arm (p = 0.364, t test). The waiting times for the
four separate clinical areas appear in Table 8, with no
significant differences between the intervention and con-
trol arms. The large difference in the COPD area is due
to small numbers (N = 8) and random difference. The
average waiting time stratified by intervention or control
status and severity of final diagnosis is presented in
Table 9. No significant differences were observed be-
tween the intervention and control arms. In addition, no
definite trend was seen in the waiting time across sever-
ity groups—except that the waiting time was signifi-
cantly shorter for patients with a final diagnosis classed
as “very severe” than with the three other severity group-
ings (p = 0.01, t test). These average values are not cor-
rected for clustering; however, a simple multi-level
model with waiting time as the outcome variable and
intervention status as predictor suggested very little
effect of clustering, with an estimated ICC of
<0.00001. In addition, allowing for clustering in the
estimation of the mean led to narrower CIs, which is
counterintuitive.
Waiting time was not normally distributed. To assess
further the effect of the intervention on prioritization,
we divided waiting times into deciles and used ordinal
logistic regression, with waiting times in deciles as the
dependent variable and severity group as predictor. We
conducted a separate analysis for the intervention and
control arms. This suggested a significant trend in the
control arm only, as shown in Table 10. However, the
significant effect found in the control arm did not persist
if the variable waiting time was divided into ten groups
with set intervals (41, 82, 123 … 410) rather than deciles.
By way of sensitivity analysis, we also checked the ana-
lysis using a multi-level model; however, this did not
represent the data significantly better, and so for simpli-
city we retained the one-level model. Also, standard lin-
ear regression did not show any significant variation in
waiting time based on the severity score (data not
shown); this, though, should be interpreted with caution
since the variable was not normally distributed.
Discussion
In the present study, we aimed to assess whether imple-
menting a referral intervention would lead to improved
quality of care for medical outpatients. We have previ-
ously shown that the referral quality did increase [34],
however there was no clear effect on the quality indica-
tor score, subjective quality score, or PPV of referrals, as
detailed above. In addition, there was no evidence that
improving referrals enhanced prioritization at the hos-
pital; in one analysis, prioritization even seemed more
precise in the control arm. Hence, it would appear that
the use of referral templates did not generate a clear
clinical benefit for the individual patients.
In addition to the study limitations discussed below,
several factors may explain the lack of effect. First, it is
possible that care for patients has improved but that the
measurement instruments and outcomes have been un-
able to quantify it. Guidelines and clinical practice allow
Fig. 1 Bland-Altman plot for quality indicator score for area chest pain and chronic obstructive pulmonary disease (COPD)
Table 4 Average quality score per diagnostic group, not
corrected for clusteringa
Intervention Control p value
Dyspepsia 62.0 (59.2–64.8) 57.2 (54.1–60.3) 0.023
Suspected colorectal
malignancy
65.0 (61.5–68.3) 61.4 (58.3–64.5) 0.138
COPD 48.3 (11.9–84.7) 51.0 (29.0–73.0) 0.847
Chest pain 72.1 (68.5–75.7) 70.8 (65.2–76.4) 0.669
aPresented as mean and 95% confidence interval
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some flexibility for the treating clinician, whereas quality
criteria often are rigid [76]. Thus, an ideal patient
pathway—as was the goal in this study—will not neces-
sarily be represented by 100% adherence to any given set
of quality criteria; there will always be some level of sub-
jectivity in the assessment of quality for each individual
patient pathway. In future studies, therefore, even more
effort is necessary to develop precise, valid outcomes
measures to ensure that any potential effect is docu-
mented. The use of a mixed-methods approach may also
help identify improvements that are hard to quantify;
such an approach is regarded as especially useful in
health services research [77]. Second, it is possible that
the referrals in the control arm were of sufficiently high
quality to ensure adequate referral assessment and
prioritization at baseline. As such, the scope for im-
provement was small and therefore difficult to measure.
As such further studies in areas with more varied refer-
ral quality may allow the effects of referral interventions
to be quantified more precisely. Third, referrals are only
part of the complex care pathway, and it is possible that
improvement of only one part is insufficient to result in
quantifiable improvements of the entire process. Other
factors—medical, organizational, and individual—may
also govern the process.
We have been unable to locate many comparable stud-
ies that aimed to assess the effect of a referral interven-
tion on the further patient pathway in hospital—a
shortcoming also addressed in a Cochrane review on re-
ferral intervention [31]. There are, however, some excep-
tions, with limited findings that are in line with those of
the current project. In a UK study a referral intervention
led to improved referral content, but it did not increase
the amount of organic pathology revealed among those
referred for colonoscopy. The authors commented that
the value of the intervention may have been reduced by
limited uptake [78]. In the study by Bennett et al. noted
Table 5 Effect estimates for intervention on quality score
Regression
coefficient
95% CI p value
Crudea 4.33 1.39–7.27 0.004
Adjustedb 1.80 −1.46–5.06 0.280
- Patient gender (male) 1.43 −1.45–4.32 0.330
- Patient age (centred) 0.05 −0.05–0.15 0.314
- Doctor in trainingc vs.
specialist
−5.40 −8.21 to −2.60 <0.001
- Severity of final diagnosis 0.001*
- Not severed
- Less severe 3.20 0.11–6.29
- Severe 6.20 1.70–10.69
- Very severe 8.44 −0.17 to 17.05
- Quality of referral 0.09 0.03–0.15 0.004
aBaseline model with intervention effect and random intercept
bAdjusted for variables listed in table
cDoctor in training (resident) reference
dReference
*p value for trend
Fig. 2 Subjective quality score (1–10) for intervention and control groups
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above, more appropriate patients were referred, but no
information was presented regarding hospital manage-
ment [73]. In a urology study, the implementation of
education meetings and referral guidance led to a reduc-
tion in waiting time and an increase in the probability of
receiving a management decision at the first appoint-
ment, but no difference in patient outcomes was found
[79]. In Norwegian mental health services, a study is un-
derway attempting to explore the effect of the quality of
referrals on patient and organizational outcomes [80].
One way of promoting the use of referral interventions
would be to make them a mandatory part of the referral
process: they could appear as drop-down menus to-
gether with the relevant clinical information. This pro-
cedure would remove problems with uptake of the
intervention and enable a more precise determination of
the intervention effects. However, the present study
found no clear effect of the referral templates, and, as
seen in Tables 9 and 10, the prioritization was equally
good in the control arm. It therefore seems that there
are factors other than the pure informational quality in
the referrals that guide the hospital clinician in identify-
ing the most ill patients. It is possible that more subtle
clinical details would disappear if the ability to enter free
text were completely removed. Hence, the full imple-
mentation of obligatory referral guidance should occur
only after further assessment has shown it to be of clin-
ical importance.
This study found no significant effect of the interven-
tion. We included at total of 500 patients, with 281 in
the intervention and 219 in the control arm. Given the
sample size indicated above this means that the study
was well powered to detect the 10% change in the qual-
ity indicator score that was set as clinically interesting;
hence, the risk of a type II error is low. The power calcu-
lations do, however, underline the need to increase clus-
ter numbers, rather than cluster size, to increase the
power of cluster-randomized studies [81]. The current
study would have been underpowered if the ICC had
been at the upper end of the confidence interval of the
ICC, regardless of how many patients were recruited.
Strengths and limitations
Certain aspects regarding recruitment and use of the
intervention may have hampered the results. The aim of
the study was to investigate the use of referral templates
in actual clinical practice. In this real-world scenario, it
would be pertinent to determine how many of the po-
tential participants were actually recruited. Exact infor-
mation about this would have required manual searches
of outpatient lists and relevant electronic journals—this
Table 6 Median of subjective total scorea
Intervention Control
Dyspepsia 8 (2) 7.5 (3)
Suspected colorectal
malignancy
9 (2) 9 (2)
COPD 4 (7) 4.5 (5)
Chest pain 8 (2) 8 (2)
aPresented as median and interquartile range
Table 7 Tabulation of positive predictive value (PPV) of referral,
not corrected for clusteringa, b
Intervention Control
Histological diagnosisc
- Yes 86 (37.2) 67 (35.6)
- No 137 (59.3) 112 (59.6)
- Missing 8 (3.5) 9 (4.8)
Diagnostic clarification
- Yes 220 (78.3) 164 (74.9)
- No 51 (18.2) 46 (21.0)
- Missing 10 (3.5) 9 (4.1)
Change in medical
management
- Yes 154 (54.8) 105 (48.0)
- No 117 (41.6) 105 (48.0)
- Missing 10 (3.6) 9 (4.1)
PPV total
- Yes 243 (86.5) 183 (83.6)
- No 28 (10.0) 27 (12.3)
- Missing 10 (3.5) 9 (4.1)
aNumbers are presented as positive outcomes in absolute numbers
and percentages
bNo significant differences seen between intervention and control groups
cOnly for the clinical areas of dyspepsia and suspected CRC (not relevant for
COPD and chest pain), n = 419
Table 8 Average waiting time by clinical areaa
Clinical area Intervention group Control group
Dyspepsia 41 (28.6) 47 (46.3)
Suspicion of CRC 40 (31.4) 43 (37.5)
Chest pain 69 (42.5) 69 (39.1)
COPD 108 (59.6) 78 (44.3)
a Numbers are days (rounded to whole days) with SD in brackets; no
significant differences between intervention and control groups
Table 9 Average waiting time by severity of final diagnosis a
Severity of final diagnosis Intervention group Control group
Not severe (n = 190) 47 (35.4) 53 (40.6)
Less severe (n = 227) 45 (32.3) 49 (49.1)
Severe (n = 68) 55 (42.8) 41 (31.8)
Very severe (n = 15) 22 (14.0) 26 (17.7)
aNumbers are days (rounded to whole days) with SD brackets; no significant
differences between intervention and control groups
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was incompatible with the ethical approval for the pro-
ject and current legal regulations. However, indirect evi-
dence indicates that 60% of potential patient participants
were recruited. We have no indication that this figure
varied between the intervention and control arms. Al-
though we have no indication that the current sample
differs from those not recruited the study did not assess
this formally due to the constraints mentioned above. In
addition, it is not clear how often the referring GPs ac-
tively utilized the intervention when initiating new refer-
rals. The designated electronic project address was used
approximately 50% of the time, which suggests a fairly
modest uptake, although higher than in other studies [78].
This is likely to have attenuated the intervention effect
since intention-to-treat analysis was employed. In total,
these aspects are unlikely to have led to a significant selec-
tion bias, but may have attenuated the intervention effect.
The high variation in scoring among the scorers limits
the applicability of the statistical analysis. This study opted
to use numerous assessors, instead of just a few, to achieve
a manageable assessment workload. The result was that a
wide variety of scorers from different hospitals and clinical
cultures took part. To try and ensure the validity of the
conclusions, we performed subanalyses and ran the models
individually for each rater. This of course yielded higher
CIs, but the overall effects retained the same sign and mag-
nitude. This was not suprising as the raters were given a
mix of control and intervention patient pathways for scor-
ing. We therefore feel that although the variation may limit
the generalizability of the measurement instruments, it does
not necessarily invalidate the conclusions of this study.
Since health-care quality is not a defined physical entity
or even a clearly defined concept, it will always be difficult
to measure precisely. Many authors have tried to measure
quality of care and hospital quality and have used various
ways, even Facebook [82]. The development of quality cri-
teria is often challenging and should be based on accepted
standards of care using sound evidence [83]. What is being
measured should also represent an important aspect of care
for the particular condition. In addition, an indicator has to
be clearly defined, and the information must be available
[83]. Most criteria in use today are accountability measures,
designed to measure adherence to specific actions and
employed for accreditation or reimbursement [24, 84]. In
the present study, process indicators were developed for
the care of patient groups, who ended up with a plethora of
diagnoses instead of clearly defined diagnostic groups with
simple measurements. This approach is clearly in line with
the aim of this study, which was to investigate the use of re-
ferral guidance in normal clinical practice. Accordingly, it
may be seen as reflecting a strength of the study. However,
it added complexity to the development of the study out-
come criteria. The criteria employed in this study do not,
therefore, fulfil all requirements of ideal process criteria;
overall, however, they represent an attempt to quantify the
quality in everyday clinical practice at the level of the indi-
vidual patient. This limits comparability with other studies,
but we believe that this approach was more likely to iden-
tify the effects of referral intervention since such effects
were expected to be subtle rather than obvious.
Another potential limitation is the quality of the
source of clinical information. Hospital records were
used to obtain the relevant information. Implicitly,
this study did not therefore measure if a certain ac-
tion was performed, but whether the action was per-
formed and documented. Whereas the prospective
collection of information from electronic health re-
cords is the most thorough way of acquiring informa-
tion [85], the quality of medical records has been
debated for some time [86–88]. Electronic health re-
cords have facilitated documentation, but the quality and
completeness of the data is still under debate [89]. How-
ever, information gathering and assessment were per-
formed the same way for both the intervention and
control arms, and there was no indication that the manner
of documentation gathering led to information bias.
The main strength of the present study is closely re-
lated to its weaknesses. This study was performed in a
normal clinical setting without major intervention at any
level other than the referral. This real-life approach
should ensure that the results are applicable for many
other health-care settings where referral from the GP to
the hospital specialist is the norm.
Conclusions
This cluster-randomized trial was designed to assess the
impact of a referral intervention on the quality of care
and hospital management of patients. No measurable
effect on quality of care or prioritization of patients was
found. The results were hindered by a limited uptake of
the intervention at GP surgeries and inconsistencies in
outcome assessment. It seems reasonable to assume that
more information in the referral will improve further
management, but more stringent assessment may, in
future research, be necessary.
Table 10 Ordinal regression of waiting time (in deciles) versus








Less severe −0.77 (−0.53 to 0.38) −0.33 (−0.84 to 0.17)
Severe .41 (−0.24 to 1.06) −0.59 (−1.32 to 0.14)
Very severe −1.42 (−2.41 to −0.42) −1.90 (−4.06 to 0.27)
aReference category
*p = 0.333 for trend
**p = 0.032 for trend
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Practical health co-operation - the impact of a
referral template on quality of care and health
care co-operation: study protocol for a cluster
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Abstract
Background: The referral letter plays a key role both in the communication between primary and secondary care,
and in the quality of the health care process. Many studies have attempted to evaluate and improve the quality of
these referral letters, but few have assessed the impact of their quality on the health care delivered to each patient.
Methods: A cluster randomized trial, with the general practitioner office as the unit of randomization, has been
designed to evaluate the effect of a referral intervention on the quality of health care delivered. Referral templates
have been developed covering four diagnostic groups: dyspepsia, suspected colonic malignancy, chest pain, and
chronic obstructive pulmonary disease. Of the 14 general practitioner offices primarily served by University Hospital
of North Norway Harstad, seven were randomized to the intervention group. The primary outcome is a collated
quality indicator score developed for each diagnostic group. Secondary outcomes include: quality of the referral,
health process outcome such as waiting times, and adequacy of prioritization. In addition, information on patient
satisfaction will be collected using self-report questionnaires. Outcome data will be collected on the individual level
and analyzed by random effects linear regression.
Discussion: Poor communication between primary and secondary care can lead to inappropriate investigations
and erroneous prioritization. This study’s primary hypothesis is that the use of a referral template in this
communication will lead to a measurable increase in the quality of health care delivered.
Trial registration: This trial has been registered at ClinicalTrials.gov. The trial registration number is NCT01470963
Keywords: Cluster randomized trial, General practice, Quality of care, Referral
Background
Quality of healthcare is defined by the American Institute
of Medicine as ‘the degree to which health services for indi-
viduals and populations increase the likelihood of desired
health outcomes and are consistent with current profes-
sional knowledge’ [1]. The focus on prevention of medical
errors and improved quality of medical care continues to
increase [2,3]. This focus is evident in Norway by the publi-
cation of a national strategy for quality improvement in
health and social services [4], and the multitude of clinical
guidelines available from governmental and professional
sources.
The referral of a patient from a general practitioner
(GP) to a hospital environment represents a transition of
care, in which the major information exchange is
through the written referral letter [5]. This transition of
care represents an important step in the quality of the
care process, and it has been shown that key clinical in-
formation may not be communicated adequately at the
transition of care interface [6]. There has been consider-
able research into the quality of a referral and its impact
on the process of care. A Norwegian study from 2007
amongst elderly patients demonstrated that both referral
* Correspondence: henrik.wahlberg2@unn.no/henrik.wahlberg@uit.no
1Department of Community Medicine, Faculty of Health Sciences, University
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and discharge letters were missing vital information [7].
The consequences might represent a health hazard to
older patients [7]. A Finnish assessment of the quality of
referral letters for patients with asthma concludes that
45% of the referrals were of poor or unacceptable qual-
ity, based upon quality criteria developed by GPs and
hospital respiratory consultants [8]. Others have also
found varying quality and content of referrals [9-15].
Many studies have been designed for improving the re-
ferral process from GPs to the hospital [16,17]. A recent
Cochrane review on interventions to improve outpatient
referrals from primary to secondary care concludes that
surprisingly few interventions on the referral system have
been rigorously evaluated. Many of the studies evaluated
focused only on referral rates or referral quality. The re-
view highlights the complexities of research in this area,
especially as no single study managed to present findings
on all aspects of the referral process (referral behavior,
management of non-referred patients, secondary care
management of patients, the flow of patients through the
referral system, patient outcomes and satisfaction, and
resource use). However, structured referral sheets and
local education interventions have an impact on referral
rates [18].
The primary objective of the present study is to evalu-
ate whether the implementation of a referral template in
the referral from general practice to hospital care can
lead to a measurable increase in the quality of care deliv-
ered at the hospital. As secondary objectives, we will as-




This study is a cluster randomized trial, with the GP
clinics as the cluster. The local GP clinics are randomly
assigned either to use a referral template or to continue
standard referral practice.
Participants
The 14 community GP practices in the area primarily
served by University Hospital of North Norway Harstad
(UNN Harstad) were included in the randomization
process, with a total list size of 35,490 patients. In
Norway, each individual has a regular GP. These GPs act
as gatekeepers to secondary care. The health care system
is relatively uniform throughout the country. In the study
area, access to specialist care is practically impossible
without a GP referral, whereas some access is possible in
other areas of the country.
The study population will consist of patients referred
to the medical department at UNN Harstad. The refer-
rals received are, almost exclusively, electronic. Children
(<18 years of age) and patients with reduced capacity to
consent will be excluded from participation in the study.
Randomization
The GP clinics were randomized stratified by location, to
ensure adequate selection of cases and equal sociodemo-
graphic background data. Five of the centers are larger
town-based centers and nine are smaller, more rural
centers. The location of the center was not expected to in-
fluence the outcome variables. Initially, two centers
approached declined the invitation to participate in the
study, and therefore two additional GP clinics were ran-
domly selected, as illustrated by Figure 1.
Recruitment
New patients referred to the medical department within
one of the four diagnostic groups described below will
receive written information and a consent form together
with their appointment letter. These will be sent out by
a clinic nurse unaware of the status of the GP center
sending the referral (intervention or control). Patients
will be orally reminded at the appointment and may be
given a new consent form. This process is illustrated in
Figure 2.
Intervention
The referral templates have been developed based upon
international literature [19-27] and in collaboration with
local specialists in the appropriate medical field. The tem-
plates have also been through a process of clinical assess-
ment from subspecialists in other northern Norwegian
hospitals. In acknowledging the problems in earlier studies
with the uptake of referral interventions [17,18] we have
deliberately reduced the number of items in the referral
templates, to ensure ease of uptake. Only information that
the medical consultants thought imperative in the referral
have been included as items in the templates. The study
will implement referral guidelines for the following four
diagnostic groups:
 patients referred with dyspepsia;
 patients referred with suspected colonic malignancy;
 patients referred with chest pain;
 patients referred with chronic obstructive
pulmonary disease or suspected chronic obstructive
pulmonary disease.
These diagnostic groups were chosen as they represent
a substantial number of the referrals to a medical de-
partment (own data, 2008). They also represent a clear
diagnostic challenge in primary care and are adept for
simple referral guidelines.
The GPs at the intervention offices will use the referral
template when initiating a new referral process for a
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patient. To ensure adequate uptake of intervention, the
templates have been distributed as electronic templates
as well as hard copies. The templates function as guide-
lines, but are not implemented as compulsory electronic
checklists. The intervention referrals are sent to a separ-
ate electronic inbox at the hospital. The further evalu-
ation and process of care has not been altered in the
intervention group compared with the standard referral
practice in the control group (Figure 3).
In addition, questionnaires have been developed that
assess patient experiences within the care framework,
with one questionnaire designed for inpatients and one
for outpatients. These questionnaires have been pro-
duced by combining questions from previously validated
questionnaires regarding patient experiences in general
and with transitional care. They include questions from
a Norwegian patient experiences questionnaire [28]);
two questions about health interaction from the Com-
monwealth Fund Survey 2010 [29]; the Care Transitions
Measure 3 [30]; and demographic questions.
The questionnaires have been reviewed through an
interview process with patients. This was done to ensure
that the forms are acceptable to patients and to highlight
possible issues that patients felt were missing from the
questionnaires.
Objectives
We aim to examine the impact of a referral template on
the process of care, at the individual level. The primary
hypothesis is that the use of a referral template in the
communication between the GP and secondary care will
lead to a measurable increase in the quality of health
Figure 1 Flow chart of randomization process. ‡ From the four rural clinics initially randomized to the intervention group, two clinics refused.
Therefore two additional rural clinics, from the five rural clinics initially randomized to the control group were randomized, and consented to,
the intervention.
Figure 2 Recruitment process. Recruitment of patients in both the intervention and control groups follow the same procedure.
Wåhlberg et al. Trials 2013, 14:7 Page 3 of 8
http://www.trialsjournal.com/content/14/1/7
care delivered. Secondary hypotheses include that the
use of a referral template in the communication between
a GP and secondary care will lead to:
 a measurable improvement in referral quality;
 a change (up or down) in the number of patients
defined as being in need of prioritization (as defined
in national guidelines for prioritization in health
care [20,23,24]);
 more appropriate prioritization, as measured by final
diagnosis;
 an increase in the ‘appropriateness’ of the referrals
(positive predictive value (PPV) of referral [31];
 and better patient satisfaction, as measured by self-
report questionnaires.
Outcomes
The primary outcome will be a quality indicator score
compared between the intervention and the control group.
The quality indicators have been generated from previous
international quality assessment tools and national and
international treatment guidelines. Some adaptation to
locally accepted practice has been made, as demonstrated
by others when quality indicators are used in a new context
[32]. Each patient care process will be scored according to
the criteria. Scoring will be done by a panel of specialists
blinded to the intervention status of the patient. We will
calculate the quality score as adherence scores (number of
quality criteria met divided by number of applicable criteria
expressed as a percentage) as illustrated by Ashton et al.
[33]. If a criterion is applicable, but no information can be
found (applicable, but not answerable), it will be noted ‘not
met’ for statistical purposes [34]. Weighting of the criteria
based upon clinical importance will not be used, as this
adds complexity without adding much to the clinical find-
ings, a finding discussed by Lyons and Payne in 1975 [35].
The scores will be compared between the intervention and
control groups.
As secondary outcomes, the quality of the referrals will
be evaluated against the developed referral template, to de-
termine if the intervention has led to improved referral
quality. It is important to measure referral quality, as the
premise in the study is that more information will lead to
improved care. In addition, health process outcomes such
Figure 3 Referral pathway. Flow of referral and process of care in the intervention (blue arrows) and control group (red arrows).
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as waiting time from referral to appointment, number of
appointments before a diagnosis is reached, time before
treatment is initiated, the application or not of appoint-
ment prioritization, and the outcome of any given referral
(appointment, return information or referral rejected) will
be collected and compared between the groups. Bennett
et al. used the PPV of a referral as a measure of the appro-
priateness of the referral [31]. In adapting this concept
from glue ear in otolaryngology to a medical department
we have defined it as the proportion of the GP referrals
that result in a histological diagnosis, diagnostic clarifica-
tion or change in medical management. We will assess and
compare the PPV of referrals in the study groups. Patient
experiences will be compared between the intervention
and control group. Finally, the possible outcome diagnoses
have been grouped according to severity. We will correlate
the continuous outcome variable ‘waiting time’ with the
grouped severity, to see whether the prioritization in the
intervention group is more aligned with disease severity.
Sample size
Sample size was calculated based upon the primary out-
come, and the initial calculation was done without re-
gard for clustering. A change in the quality score of 10%
was determined to be clinically interesting. Setting the
significance level at 0.05 and using PASS 2008 (NCSS,
LLC, Kaysville, UT, USA) for the calculation provides
that the study would require 855 patients in the control
and 855 in the intervention group, for an 80% power to
detect a 10% difference between the groups.
To correct for clustering, the design effect (DE) may
be calculate as:
DE = 1 + ρ(m-1)
where ρ denoted the intracluster correlation coefficient
(ICC) and m is the size of each cluster [36]. No ICC for
equivalent designs was identified from literature searches.
Reviewing primary care-based interventions from the
literature [37-39], an expected ICC ranging from 0.001 to
0.08 does not seem improbable, giving a DE of 1.15 and
12.9, respectively, for a cluster size of 150 patients. Be-
cause only 14 GP clinics were available for randomization,
further inflation of the number of clusters to achieve
higher power was not possible, although this could have
been advisable [40].
Based upon a review of patient data at UNN Harstad
from 2008, the study is expected to achieve this rela-
tively high inclusion number by recruiting over a two-
year period (personal data).
Blinding
The referring GP cannot be blinded to the trial, as the
intervention is actively used by the GP. The patient will
not be aware of the intervention, but no active effort has
been made to keep the patients blinded. The patients
will be mixed with the general caseload to avoid bias in
the treatment process at the hospital. For the GPs that
use the electronic referral template, this usage will be
visible to the hospital doctor in the presentation of the
referral letter on the computer, but for the majority of
the cases the hospital doctor will be blinded to the inter-
vention status of the patient. The outcome assessors will
be blinded.
Data gathering
Data will be extracted by both automated computer
reports (for example, waiting times, number of appoint-
ments) and manual chart review (for example, PPV,
group of final diagnosis). Data will be collected after the
process of care that the referral initiated is completed.
Statistical methods
We will collect the following baseline characteristics:
 patient age (mean and confidence interval) and sex
(number and percentage)
 practice list size (median and interquartile range, or
mean and confidence interval if normally
distributed)
 referral type - electronic or paper (number and
percentage)
 referred by - GP or other doctor (number and
percentage).
For the primary outcome (quality score), we will calcu-
late adherence scores as described above and compare
between treatment arms. We expect substantial variation
in cluster size. Because of the small number of clusters,
analysis based upon the cluster level was considered
[41]. However, as there is no prior accurate estimate of
variation between clusters, weighting for cluster size
could not be achieved [41]. To offer increased precision
and take into account between-cluster variation, random
effects linear regression will be used [42] to generate esti-
mates of intervention effect. It has been suggested that this
can be used for studies with as few as 10 clusters [36]. The
estimated effect and confidence intervals will be reported.
A P-value <0.05 will be regarded as statistically significant.
Intention to treat analysis will be employed.
The referrals will be scored using a simple scoring sys-
tem related to the referral templates. Each unit of infor-
mation specified in the referral template (for example,
presence of weight loss specified) will provide one point
in the scoring system, with no weighting applied. Scores
will be compared between the groups as noted above.
For outcome severity, random effects linear regression
will be used, with the severity group score as a categorical
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variable, and the relationship compared between the inter-
vention and control group.
In the questionnaire, answers noted as ‘not applicable’
or no answer will be counted as missing data. The ques-
tionnaire will be scored according to a pre-set scoring
system. Scores will be analyzed using the regression
technique outlined above. The data will also be analyzed
to determine if factors such as self-perceived health, age,
gender, and education level have an impact on patient
experience.
The trial will be reported according to the CONSORT
standards for reporting cluster randomized trials [43].
Pilot study
No pilot study has been carried out. To ensure accept-
ability of the intervention, GPs were invited to, and par-
ticipated in, the development of the referral template.
To ensure feasibility, the authors have collected all data
specified in the protocol from the 20 patients included
first. To ensure an adequate uptake of the intervention,
regular reviews of all referrals received at UNN Harstad
will be undertaken.
Ethics
The study will follow the directions in the Helsinki
Declaration, and was presented to the Regional Ethical
Committee for Medical Research in northern Norway,
who determined it not to be within the scope of the
Health Research Act (REK NORD 2010/2259). The pro-
ject has been approved by the Data Protection Official for
Research. The study is registered at ClinicalTrials.gov. The
trial registration number is NCT01470963. All patients
must provide written informed consent.
Discussion
Transitions of care represent a point of frequent adverse
events [44,45]. The referral is the main form of commu-
nication in the transition from primary to secondary
care [13,46]. Although many referral interventions have
been evaluated, there appears to be limited knowledge
on how the referral letters affect specialist care. A recent
study protocol describes a similar project within mental
health care [47], although this study is still ongoing. The
primary objective of our study is to assess whether an
improved referral letter will lead to a measurable change
in the quality of care delivered in a medical department.
The aim is to go beyond an assessment of referral qual-
ity and waiting times per se, and evaluate quality of care
and the appropriateness of waiting times and treatment,
and, as such, help fill parts of the knowledge gap identi-
fied in a Cochrane review on the subject [18].
However, research at the interface between primary
and secondary care can be challenging [18,48]. The
choice of using an intervention with intuitive content
was made to make it acceptable in normal general prac-
tice. The assumption underlying this research project is
that a referral guideline will increase the amount of infor-
mation available to the hospital specialist, and that this
increase in information will translate into better care.
The cluster design was chosen because randomization
with this approach is well suited for interventions imple-
mented at the level of the health care organizational unit
[42]. In addition, randomizing at the individual patient
level would undermine findings, as the GPs could use
the information learned from the referral template in
their non-intervention referrals and as such contaminate
the data. For similar reasons, the GP clinic, as opposed
to the individual GP, was randomized, as contamination
between GPs in the same clinic was to be expected.
In choosing a cluster randomized design, we have a
design that is less statistically efficient than a standard
randomized design. A recent study involving a more
complex intervention [49] used randomization at the pa-
tient level to avoid this problem. We feel that the dan-
gers of contamination with individual randomization in
our design would be so large that results would be diffi-
cult to interpret.
In cluster randomized trials, post randomization bias
has been identified as a concern [40]. This entails the re-
cruitment of different cohorts in the intervention and
control groups, as the patients are recruited after
randomization of the clusters. We hope to reduce this
by actively recruiting the patients (obtaining signed con-
sent) in conjunction with the hospital appointment, both
for the intervention and control groups.
The intervention is intentionally simple to ensure that
an effect seen can be attributed to the intervention.
However, an intervention at an interface in a compli-
cated health care system can quickly affect the entire
process, in ways we have not yet envisaged.
There is also a risk of performance bias as systematic
differences in the care may not be due to the interven-
tion, but rather because the doctors will be aware of the
study protocol. By ensuring the mixing of cases in nor-
mal workloads and, as much as possible, blinding the
doctors involved, we hope to minimize this bias. The
fact that the care process is being studied may change
the behavior of the doctors in general, akin to a Haw-
thorn effect. This will potentially attenuate the effects of
the intervention, as the quality of care may improve for
both intervention and control patients.
The authors also recognize that many referrals from
primary to secondary care are not made only to identify
major pathology. Referrals are also made to reassure the
patient, reduce medico-legal risk, obtain a second opin-
ion or for handing over of care [50]. The authors fully
appreciate these as valid reasons for referral. We, there-
fore, do not aim to reduce the number of referrals, but
Wåhlberg et al. Trials 2013, 14:7 Page 6 of 8
http://www.trialsjournal.com/content/14/1/7
rather assess the effect on hospital care of improved
referrals.
This study aims to add to the knowledge regarding the
effect of the referral on the patient pathway and quality
of care. Simple diagnostic groups have been chosen. If
the study can identify benefits from improving referrals
in these areas, this may lead the way to further imple-
mentations of referral proforma, preferably electronically
integrated into the standard software packages. This
could improve the overall referral process to enable bet-
ter care and effective prioritization based upon the need
of the individual patients.
Trial status
The study began including patients in the fall of 2011
and inclusion is planned for approximately two years.
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 medikamenter (spes. NSAID, Albyl E, bisfosfonater) 
 




 tidligere ulcus 
 










 hvis <50 år – HP (Helicobacter pylori) status 
Mistanke om ca coli henvisningsmal 
 
I tillegg til standard informasjon i henvisning ønskes tilleggsinformasjon om følgende: 
 
 endring i avføringsmønster 
 




 familiær opphopning av ca. coli 
 
 tidligere påvist tarmsykdom eller funn ved tidligere tarmundersøkelser 
 




 funn ved us. av abdomen 
 
 resultat av Hemo-fec 
 





I tillegg til standard informasjon i henvisning ønskes tilleggsinformasjon om følgende: 
 
 familieanamnese (plutselig død eller prematur koronarsykdom hos 
førstegradsslektninger) 
 
 koronare risikofaktorer (røyking, fedme (BMI), diabetes, hypertensjon, 
hyperkolesterolemi) 
 
 komorbiditet (perifer karsykdom, cerebrovaskulær sykdom, nyresvikt) 
 
 brystsmerte (lokalisasjon, varighet, utstråling, effekt av aktivitet, effekt av nitro) 
 
 dyspné (utløsende årsak, progresjon, hviledyspné) 
 






 funksjonsnivå (se Canadian Cardiovascular Society angina grading scale) 
 
 allmennlegens kliniske vurdering/mistanke 
 









I tillegg til standard informasjon i henvisning ønskes tilleggsinformasjon om følgende: 
 
• hovedplager (inkl. varighet, grad, dynamikk) 
 






• residiverende behandlingstrengende infeksjoner 
 
• reaksjon på irritanter (kulde, værforandring ovs) 
 




• vekttap (mengde, over hvor lang tid) 
 




• behandling forsøkt, effekt? 
 
• komorbiditet og oppdater medikamentliste (inkl. inhalasjonsmedisiner) 
 
• spirometri verdier 
 
• RTG Thorax beskrivelse hvis tilgjengelig 
 
Hvilke erfaringer hadde du på medisinsk poliklinikk UNN Harstad?
Ettersom du nylig har vært til time ved poliklinikken medisinsk avdeling UNN Harstad (Harstad Sykehus) spør vi deg med dette om du 
vil besvare dette spørreskjemaet. Spørsmålene handler om dine opplevelser på poliklinikken, og din opplevelse av samhandlingen  
mellom din fastlege og sykehuset. Svarene vil bli brukt i et forskningsprosjekt om samarbeidet mellom fastlege og sykehuset. Det er  
helt frivillig og svare, og svarene vil bli behandlet anonymt.
Vennligst sett kryss i den boksen som tydeligst tilsvarer din mening:
Ikke i det 
hele tatt


















Snakket behandlerne til deg slik at du forsto  
dem?
Har du tillit til behandlernes faglige dyktighet?
Fikk du vite det du syntes var nødvendig om  
hvordan prøver, tester og undersøkelser  
skulle foregå?
Fikk du tilstrekkelig informasjon om din diag- 
nose/dine plager?
Opplevde du at behandlingen var tilpasset 
din situasjon?
Var du involvert i avgjørelser som angikk din  
behandling?
Opplevde du at institusjonens arbeid var godt 
organisert?




Var hjelpen og behandling du fikk på  
institusjonen, alt i alt, tilfredstillende?
Mener du at du på noen måte ble feilbehandlet  
(etter det du selv kan bedømme?)




Ja, altfor  
lenge














12 Hvilket utbytte har du hatt, alt i alt, av  
behandlingen ved institusjonen?
13 Opplevde du at sykehuset manglet viktig 
informasjon om deg fra fastlegen? (årsaken til at  





14 Etter at du hadde vært på sykehuset, opplevde 












15 Synes du at henvisning til poliklinikken var  

















Hvis Nei i spørsmål 16a; hvem henviste deg?
17 Hvis du ser behandlingen ved institusjonen 


















Hvem har fylt ut skjemaet?
Fylt ut skjemaet basert på egne 
vurdering (uten å snakke  
med pasienten)  
Jeg fylte ut skjemaet for pasienten,  
men svarene er stort sett basert på  
pasientens vurderinger  
Annet 
18b Hvis det er pårørende som har fylt ut skjemaet,  
hvordan er dette gjort?
  
Dårlig 
19 Stort sett, vil du si at din helse er

















   Videregående 
skole  
  
Høyskole eller  
universitet (1-4 år)
Høyskole eller  
universitet  
(4 år eller mer) 
21 Hvilket år er du født?
  
Årstall 






51-100 km   
  
11-50km







Er det noe du synes er viktig, og som du ikke er 
blitt spurt om i dette skjemaet?
Hvis Ja i 24a, vil vi gjerne vite hva du synes 
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Vennligst fyll ut følgende: 
 
- Del I 
o 1.1 – ”Utredning”: Fylles ut på hver pasient 
o 1.2 – ”Felles elementer” i behandling: Fylles ut på hver pasient 
o 1.3 – 1.8 – Fra ”Behandling av gastroøsofagal refluks” til og med ”Okkult 
blødning” fylles relevant subseksjon ut for pasienten ut i fra diagnose 
o 1.9 – ”Generelle indikatorer”: Fylles ut på hver pasient 
 











Del I – Kvalitetsindikatorsett 
 
Angi kriterium som ”ikke oppfylt” hvis det er relevant, men informasjon ikke kan lokaliseres. 
 




1.1 – Utredning 
 
1 Diagnose fastlagt i første kontakt, alternativt videre 
utredningsforløp planlagt 
 
   
2 Videre oppfølging planlagt eller ansvaret for dette 
tydelig overlatt til fastlege/annen instans 
 
   
3 Pasienter >50 år eller yngre med alarm symptomer* 
fått helsehjelp innen 6 uker fra henvisningsdato 
 
   
4 Burde denne pasienten, basert på henvisningen, fått 
’rett til helsehjelp’ i henhold til prioriteringsveileder 
(oppfylt = ja, ikke oppfylt = nei) 
 
   
5 Gastroskopi kun utført hvis: 
 > 50 år 
 < 50 år og H. pylori positiv eller anemi eller 
NSAID bruk i anamnesen  
 andre pasienter som ikke responderer på PPI 
eller har tilbakefall av symptomer etter 
adekvat medikamentelt forsøk 
 
   
6 Ved gastroskopi dokumentert informasjon til pasient 
om prosedyre og samtykke 
 
   
7 Dokumentert anamnese om alarmsymptomer* 
 
   
8 Dokumentert anamnese om NSAID bruk 
 
   
1.2 – Felles elementer i behandling 
 
9 Livsstilsråd, så som sunne matvaner, røykeslutt, 
vektnedgang dokumentert gitt 
 
   
10 Råd om å unngå utløsende faktorer, som stress, 
posisjon og lignende, dokumentert gitt 
 
   
11 For pasienter med langtidsbehandling råd om bruk av 
laveste effektive dose, intermitterende dosering (ved 
behov) og håndkjøpsprodukter gitt 
 
 
   
1.3 – Behandling av gastroøsofagal refluks 
 
12 Ved typisk anamnese eller gastroskopi funn, full dose 
PPI i 1-2 måneder tilbudt, med plan om revurdering 
effekt og videre behandling etter dette 
   
13 Ved symptom residiv laveste dose som kontrollerer 
symptomer tilbudt 
 
   
14 pH måling vurdert ved dårlig effekt av 
medikamentell behandling, inkludert dobbel dose PPI 
 
   
15 Henvisning til kirurgi vurdert kun ved uttalte plager 
på tross av maksimal medikamentell behandling 
 
   
1.4 – Behandling av peptiske sår 
 
16 Test for H. pylori utført 
 
   
17 Hvis H. pylori positiv tilbudt/anbefalt eradikasjon 
 
   
18 Hvis NSAID assosiert, tilby full dose PPI i to 
måneder, deretter eradikere H. pylori hvis til stede 
 
   
19 Hvis ulcus i ventrikkel (magesekk) og positiv H. 
pylori, planlagt retesting for H. pylori og 
regastroskopi 6-8 uker etter behandlingsstart 
 
   
20 Tilby full dose PPI i 1-2 måneder til H. pylori 
negative pasienter som ikke bruker NSAID 
 
   
21 For pasienter som bruker NSAID videre etter peptisk 
sykdom, dose reduksjon av NSAID eller substitusjon 
eller ved behovs behandling vurdert.  
 
   
22 Hos høy risiko pasienter (tidligere sår) som trenger 
videre NSAID, tilby beskyttende behandling (PPI 
eller H2) 
 
   
23 Hos pasienter med ulcus som ikke tilheler vurder 
non-compliance, malignitet, falsk negativ H. pylori 
test, utilsiktet NSAID bruk og uvanlige sykdommer 
som Chron og Zollinger-Ellison 
 
   
1.5 – Behandling av endoskopi verifisert non-ulcus dyspepsi 
 
24 Test for H. pylori utført 
 
   
25 Hvis H. pylori positiv, dokumentert at eradikasjon 
vurdert  
 
   
26 Ikke planlagt eller utført retesting etter 
eradikasjonsbehandling 
 
   
27 Forsøkt behandling med lav dose PPI eller H2 
blokker i 1 måned 
 
   
28 Ved vedvarende symptomer lavdose PPI/H2 blokker, 
alternativt behandling med dette ved behov tilbudt 
 
   
1.6 – Behandling av Barrets øsofagus/mistanke om Barrets øsofagus 
 
29 Funn klassifisert etter Prague klassifisering (CM) 
 
   
30 Anbefalinger om biopsering fulgt, eller dokumentert 
grunn til annen biopseringsstrategi 
- ingen kjent dysplasi: 4 kvadrant biopsier hver 
andre centimeter + biopsier fra suspekte 
områder 
- kjent dysplasi: 4 kvadrant biopsier hver 
centimeter + biopsier fra suspekte områder) 
 
   
31 Pasient satt opp til kontroll 
- om 3 år hvis ingen dysplasi 
- om 6-12 måneder ved lavgradig dysplasi 
- 3 måneder ved ubehandlet høygradig dysplasi 
 
   
32 Ved funn av høygradig dysplasi videre behandling 
planlagt 
 
   
33 Hvis symptomer eller refluks øsofagitt full dose PPI i 
1-2 måneder tilbudt 
 
   
34 Dokumentert diskusjon om indikasjon for langvarig 
PPI bruk 
 
   
1.7 – Cøliaki 
 
35 Diagnosen sikret med duodenalbiopsier eller 
dokumentasjon på hvorfor dette ikke er utført 
 
   
36 Dokumentert informasjon om blodprøvestatus med 
tanke på ernæring (ferritin, vitamin B12, folat osv) 
 
   
37 Gitt råd om glutenfritt kosthold og henvist til 
kostveiledning 
 
   
38 Informasjon gitt om pasientorganisasjon (NCF) 
 
   
39 Plan for videre oppfølging klarlagt 
 
   
1.8 – Okkult GI blødning 
 
40 Koloskopi vurdert ved positiv Hemo-fec eller jern-
mangel anemi og normale funn ved gastroskopi  
 
   
41 Ved okkult blødning og ingen forklarende funn ved 
gastro- og koloskopi fornyet endoskopisk 
undersøkelse eller henvisning til kapsel endoskopi 
vurdert 
 
   
42 Tynntarmsbiopsier med tanke på cøliaki tatt 
 
   
1.9 – Generelle indikatorer 
 
43 Totalt sett et adekvat behandlingsforløp (helt fra 
henvisning til avsluttet behandling) 
 




Sett en total score for behandlingsforløpet fra 1-10 
(1: dårlig forløp – 10: svært godt forløp) 
 
 




- progredierende dysfagi 
- odynofagi 
- gjentatte oppkast 
- tegn på GI blødning 
- familie anamnese på cancer 
- ikterus 
- palpabel tumor 
- tidligere ulcus 
- >50 år med nye symptomer 
- tidligere øsofagogastrisk kreft 
 
Del II - ”Positiv prediktiv verdi” av henvisning [12] 
 






  Nei 
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Del I – Kvalitetsindikatorsett 
 
Angi kriterium som ”ikke oppfylt” hvis det er relevant, men informasjon ikke kan lokaliseres. 
 





Generelle indikatorer i utredning 
 
1 Diagnose fastlagt i første kontakt på sykehus, 
alternativt videre utredningsforløp planlagt 
 
   
2 Videre oppfølging planlagt eller kontakt avsluttet, 
eller ansvaret for dette tydelig overlatt til 
fastlege/annen instans 
 
   
3 Pasient vurdert innen vurderingsfrister som angitt 
under: 
- uforklart endring i avføringsmønster 
o pas. >55 år: 4 uker 
o pas. 45-55 år: 6 uker 
o pas. <45 år: ikke rett til helsehjelp 
- GI blødning uten anemi 
o > 40 år: 4 uker 
o <40 år og lav klinisk risiko for 
malignitet: 6 uker 
- synlig GI blødning med jernmangelanemi 
o >40 år: 2 uker 
o <40 år og lav klinisk risiko for 
malignitet: 4 uker 
- klinisk signifikant ikke forklart vekttap 
o alder >40 år: 2 uker 
o alder< 40 og lav klinisk risiko for 
malignitet: 4 uker 
 
   
4 Burde denne pasienten, basert på henvisningen, fått 
’rett til helsehjelp’ i henhold til prioriteringsveileder 
(oppfylt = ja, ikke oppfylt = nei) 
 
   
Pre-prosedyre 
 
5 Koloskopi kun utført når det foreligger indikasjon (se 
vedlegg 1 ved usikkerhet) 
 
   
6 Informasjon til pasient om undersøkelse og informert 
samtykke dokumentert i journal 
 
   
7 Risikofaktorer for undersøkelsen vurdert (for 
eksempel antikoagulantia, platehemmere, 
sedasjonsbehov) 
   
8 Dokumentasjon i journal av tilstedeværelse, eller 
ikke, av symptomer tydende på cancer coli (3 av 5) 
- magesmerter 
- endring i avføringsvaner 
- hematochezia eller melena 
- asteni 
- vekttap 
   
9 Dokumentasjon i journal av familiær opphopning av 
ca. coli eller ikke 
 
   
10 Dokumentasjon i journal om tidligere 
tarmsykdommer 
 
   
11 Dokumentasjon av anemi (tatt, eller fått fra 
henvisende lege, Hb, MCV, MCH, ferritin) 
 
   
Prosedyre 
 
12 Kvalitet av tarmtømming vurdert og dokumentert 
 
   
13 Intubasjon av coecum dokumentert (fullstendig us.) 
 
   
14 Retraksjonstid dokumentert 
 
   
15 Ukomplisert prosedyre (ingen akutte komplikasjoner 
som krever intervensjon) 
 
   
Lesjon dokumentasjon 
 
16 Ved funn beskrivelse av funn, med mål, overflate, 
type lesjon 
 
   
Post-prosedyre 
 
17 Ved ikke komplett koloskopi, planlagt enten 
- ny koloskopi etter bedre tømming eller 
- røntgen undersøkelse av tarm 
 
   
18 Ved signifikante biopsifunn, resultatet fulgt opp av 
ansvarlig lege (tiltak satt i verk ved indikasjon, enten 
ved konsultasjon eller i etterkant) 
 
   
19 Ved funn av klinisk mistenkt malignitet pasient 
umiddelbart henvist til kirurgisk vurdering, eller 
dokumentert i journal konsultasjon med kirurg 
 
   
20 Ved histologisk funn av malignitet (uten oppfylt 
kriterium 21) videre tilleggsbehandling planlagt 
innen 2 dager 
 
   
21 Ved funn av polypp og ikke polyppfri tarm videre 
kontroller planlagt etter nasjonale retningslinjer 
angitt under eller annet avvikende kontroll opplegg 
planlagt med dokumentert begrunnelse for avvik[8] 
- infiltrerende cancer – umiddelbar 
tilleggsbehandling 
- høygradig intraepitelial neoplasi/carcinoma in 
situ – kontroll innen 3 måneder 
- lavgradig intrepitelial – individuell vurdering 
 
   
22 Ved funn av polypp og vurdert til å foreligge 
polyppfri tarm; videre kontroll planlagt etter 
nasjonale retningslinjer angitt under eller annet 
avvikende kontroll opplegg planlagt med 
dokumentert begrunnelse for avvik[8] 
- malign stilket slyngeresecert polypp fjernet 
med sikker fri margin endoskopisk og 
histologisk – kontroll hver 6 måned i 3 år 
- malign slyngeresecert bredbaset polypp 
fjernet med sikker fri margin 
o infiltrasjon øvre lag submucosa og 
fjernet in toto – kontroll ved 6 måned 
o dypere infiltrasjon eller fjernet i biter 
– henvise for colonreseksjon 
- 1-2 små, fjernede adenomer (<1 cm) uten 
grov dysplasi eller tubulovilløse elementer – 
ingen endoskopikontroll 
- >2 fjernede adenomer – kontroll om 5 år 
- 1-2 store, fjernede adenomer (>9 mm) eller 
tubulovilløse/villøse elementer – kan gis 
kontroll om 5 eller 10 år 
- kontroll fortsetter til 70-75 års alder, avhengig 
av allmenntilstand og komorbiditet 
 
   
Generelle indikatorer 
 
23 Totalt sett et adekvat behandlingsforløp (helt fra 
henvisning til avsluttet behandling) 
 




Sett en total score for behandlingsforløpet fra 1-10 
(1: dårlig forløp – 10: svært godt forløp) 
 
 








Del II - ”Positiv prediktiv verdi” av henvisning [9] 
 






  Nei 
 












































Vedlegg 1: Indikasjon for koloskopi kan faststilles basert på European Panel on the Appropriateness of 
Gastrointestinal Endoscopy (www.epgae.ch) eller i henhold til kriterier fra American Society for Gastrointestinal 
Endoscopy [10] redegjort under: 
 
Colonoscopy is generally indicated in the following circumstances 
 
A. Evaluation of an abnormality on barium enema or other imaging study that is likely to be clinically 
significant, such as a filling defect and stricture 
 
B. Evaluation of unexplained GI bleeding: 
 
1. Hematochezia 
2. Melena after an upper GI source has been excluded 
3. Presence of faecal occult blood 
 
C. Unexplained iron deficiency anaemia 
 
D. Screening and surveillance for colonic neoplasia 
1. Screening of asymptomatic, average-risk patients for colonic neoplasia 
2. Examination to evaluate the entire colon for synchronous cancer or neoplastic polyps in a 
patient with treatable cancer or neoplastic polyps 
3. Colonoscopy to remove synchronous neoplastic lesion at or around the time of curative 
resection of cancer followed by colonoscopy at 1 year and, if normal, then 3 years, and, if 
normal, then 5 years thereafter to detect metachronous cancer (i Norge kontroll etter 5 år – i 
henhold til Norsk Gastro Intestinal Cancer Gruppe) 
4. Surveillance of patients with neoplastic polyps 
5. Surveillance of patients with a significant family history of colorectal neoplasia 
 
E. For dysplasia and cancer surveillance in select patients with long-standing ulcerative or Crohn’s colitis. 
For evaluation of patients with chronic inflammatory bowel disease of the colon, if more precise 
diagnosis or determination of the extent of activity of disease will influence management 
 
F. Clinically significant diarrhoea of unexplained origin 
 
G. Intraoperative identification of a lesion not apparent at surgery (eg. polypectomy site, location of a 
bleeding site) 
 
H. Treatment of bleeding from such lesions as vascular malformation, ulceration, neoplasia and 
polypectomy site 
 
I. Intraoperative evaluation of anastomotic reconstructions typical of surgery to treat diseases of the colon 
and rectum (eg. evaluation of anastomotic leak and patency, bleeding, pouch formation) 
 
J. As an adjunct to minimally invasive surgery for the treatment of diseases of the colon and rectum 
 
K. Management or evaluation of operative complications (eg. dilation of anastomotic strictures) 
 
L. Foreign body removal 
 
M. Excision or ablation of lesions 
 
N. Decompression of acute megacolon or sigmoid volvulus 
 
O. Balloon dilation of stenotic lesions (eg. anastomotic strictures) 
 
P. Palliative treatment of stenosing or bleeding neoplasms (eg. laser, electrocoagulation, stenting) 
 
Q. Marking a neoplasm for localization 
 
 
Colonoscopy is generally not indicated in the following circumstances 
 
A. Chronic, stable, irritable bowel syndrome or chronic abdominal pain; there are unusual exceptions in 
which colonoscopy may be done once to rule out disease, especially if symptoms are unresponsive to 
therapy 
 
B. Acute diarrhoea 
 
C. Metastatic adenocarcinoma of unknown primary site in the absence of colonic signs or symptoms when 
it will not influence management 
 
D. Routine follow-up of inflammatory bowel disease (except for cancer surveillance in chronic ulcerative 
colitis and Crohn’s colitis) 
 
E. GI bleeding or melena with a demonstrated upper GI source 
 
Colonoscopy is generally contraindicated in: 
 
A. Fulminant colitis 
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Del I – Kvalitetsindikatorsett 
 
Angi kriterium som ”ikke oppfylt” hvis det er relevant, men informasjon ikke kan lokaliseres. 
 





Generelle indikatorer i utredning 
 
1 Røykestatus kartlagt og dokumentert 
 
   
2 Risk score – NORRISK /risikofaktorer dokumentert: 
røyking, diabetes, hypertensjon, hyperkolesterolemi, 
familie anamnese (kjent koronar arterie sykdom), 
overvekt, fysisk inaktivitet, kjønn, alder 
 
   
3 Dokumentert anamnese om brystsmerte 
- symptomer: frekvens, varighet, utstråling, 
styrke, kvalitet, lokalisasjon, 
forverrende/forbedrende faktorer 
- progresjon, hvilesmerter 
- fysisk kapasitet 
- assosierte symptomer 
- effekt av nitroglycerin hvis dette er forsøkt 
 
   
4 Dokumentert andre komorbiditeter eller angitt som 





5 Dokumentert klinisk undersøkelse inkludert BT, puls, 
cor, pulm og thorax 
 
   
6 EKG utført og tolkning dokumentert 
 
   
7 Dokumentert Hb status 
 
   
8 Dokumentert kolesterol nivå  
 
   
9 Ved indikasjon TSH/T4 dokumentert  
 
   
10 A-EKG utført hvis indikasjon  
 
   
11 A-EKG ikke utført hvis ikke indikasjon 
 
   
12 Hvis A-EKG indisert men gjennomført med 
suboptimal belastning, videre utredning utført eller 
planlagt 
 
   
13 Hvis a-EKG er indisert med ikke kan gjennomføres 
videre utredning utført eller planlagt 
 
   
14 Diagnose fastlagt i første kontakt, alternativt videre 
utredningsforløp planlagt 
 
   
15 Videre oppfølging planlagt eller avsluttet, eller 
ansvaret for dette tydelig overlatt til fastlege/annen 
instans 
 
   
16 Burde denne pasienten, basert på henvisningen, fått 
’rett til helsehjelp’ i henhold til prioriteringsveileder 
(oppfylt = ja, ikke oppfylt = nei) 
 
   
 
Felles elementer i behandling 
 
17 Hvis røyker gitt råd om røykeslutt 
 
   
18 Hvis overvektig råd om vektreduksjon 
 
   
19 Informasjon om øvrig risiko modifikasjon 
(hypertensjon, lipider, fysisk aktivitet, diet) 
 
   
20 Ekkokardiografi utført/henvist til ekkokardiografi 
hvis indikasjon (tidligere hjerteinfarkt, tegn 
til/mistanke om hjertesvikt, Q-bølger i EKG, bilyd, 
ventrikulære arytmier) 
 
   
21 Hos pasienter med diabetes mellitus utført vurdering 
av glycemisk kontroll (primært ved hjelp av HbA1c) 
 
   
 
Behandling ved mistanke om koronar iskemisk sykdom 
 
22 Pasient innlagt hvis mistanke om akutt koronart 
syndrom (AKS) 
 
   
23 Henvisning til koronar angiografi vurdert, eventuelt 
på bakgrunn av risikovurdering 
 
   
24 Hvis henvisning til koronar angiografi vurdert, er 
pasientens ønsker om egen behandling dokumentert 
 
   
25 Behandling med platehemmer igangsatt/kontinuert 
hvis ingen kontraindikasjon 
 
   
26 Behandling med kolesterolsenkende (statin) 
igangsatt/kontinuert hvis indikasjon og ingen 
kontraindikasjon 
 
   
27 Behandling med beta-blokker igangsatt/kontinuert 
hvis indikasjon og ingen kontraindikasjon 
   
28 Behandling med behovs nitroglycerin 
igangsatt/kontinuert hvis indikasjon og ingen 
kontraindikasjon 
 
   
29 Hvis klar indikasjon for betablokker behandling men 
også klar kontraindikasjon, behandling med kalsium 
blokker (verapamil eller diltiazem) vurdert 
 
   
30 Hvis behandling allerede igangsatt og vedvarende 
symptomer tillegg av langtidsvirkende nitrat vurdert 
 
   
31 Hvis hypertensjon under konsultasjon, behandling 
igangsatt eller videre utredning/kontroll planlagt 
 
   
32 Dokumentert informasjon til pasient om rekontakt 
med helsepersonell ved forverring av angina 
symptomer 
 
   
 
Behandling/vurdering ved tidligere kjent tilstedeværelse av koronar iskemisk sykdom 
 
33 Anamnese om endring i symptomer fra tidligere 
dokumentert 
 
   
34 Anamnese om effekt, bivirkninger og etterlevelse av 
behandling dokumentert 
 
   
35 Pasient innlagt hvis mistanke om AKS 
 
   
36 Behandling med platehemmer igangsatt/kontinuert 
hvis ingen kontraindikasjon 
 
   
37 Behandling med kolesterolsenkende (statin) 
igangsatt/kontinuert hvis indikasjon og ingen 
kontraindikasjon 
 
   
38 Hvis pasient allerede er under behandling med 
kolesterolsenkende (statin), behandlingseffekt 
vurdert ved hjelp av LDL og totalkolesterol 
 
   
39 Behandling med beta-blokker igangsatt/kontinuert 
hvis indikasjon og ingen kontraindikasjon 
 
   
40 Behandling med behovs nitroglycerin 
igangsatt/kontinuert hvis indikasjon og ingen 
kontraindikasjon 
 
   
41 Hvis klar indikasjon for betablokker behandling men 
også klar kontraindikasjon, behandling med kalsium 
blokker (verapamil eller diltiazem) vurdert 
   
42 Hvis behandling allerede igangsatt og vedvarende 
symptomer tillegg av langtidsvirkende nitrat vurdert 
 
   
43 Hvis hypertensjon under konsultasjon, behandling 
igangsatt eller videre utredning/kontroll planlagt 
 
   
44 Henvisning til koronar angiografi vurdert  
 
   
45 Hvis henvisning til koronar angiografi vurdert, er 
pasientens ønsker om egen behandling dokumentert 
 
   
 
Behandling/plan når ikke mistanke om koronar iskemisk sykdom 
 
46 Adekvat vurdering av årsak til smerter hvis ikke 
mistanke om koronar genese 
 
   
47 Ved thoraxmyalgier gitt informasjon om ufarlig 
tilstand og/eller ved vedvarende plager anbefalt 
smertelidring og/eller henvisning til fysioterapi 
 
   
48 Ved gastrointestinal årsak til symptomer vurdert 
indikasjon for gastroskopi/videre 
undersøkelse/behandling 
 
   
49 Ved mistanke om annen alvorlig årsak (respiratorisk, 
anemi, hyperthyroidisme osv) adekvat videre 
utredning/behandling dokumentert igangsatt 
 




50 Totalt sett et adekvat behandlingsforløp 
(eller en global score 1-10 for behandlingen?) 
 
   
51 Sett en total score for behandlingsforløpet fra 1-10 
(1: dårlig forløp – 10: svært godt forløp) 
 
 













Del II - ”Positiv prediktiv verdi” av henvisning[9] 
 






  Nei 
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Del I – Kvalitetsindikatorsett 
 
Angi kriterium som ”ikke oppfylt” hvis det er relevant, men informasjon ikke kan lokaliseres. 
 




Generelle indikatorer i utredning 
 
1 Burde denne pasienten, basert på henvisningen, fått 
’rett til helsehjelp’ i henhold til prioriteringsveileder 
(oppfylt = ja, ikke oppfylt = nei) 
 
   
2 Diagnose fastlagt i første kontakt, alternativt videre 
utredningsforløp planlagt 
 
   
3 Videre oppfølging planlagt, eller ansvaret for dette 
tydelig overlatt til fastlege/annen instans 
 
   
Diagnose 
 
4 Røykeanamnese dokumentert i journal 
 
   
5 Anamnese om eksponering for andre lunge irritanter 
(f.eks. gjennom yrkesanamnese) dokumentert 
 
   
6 Anamnestisk vurdering av forverringsfrekvens og 
alvorlighetsgrad av forverringer dokumentert 
 
   
7 Dokumentasjon av funksjonsnivå 
 
   
8 Klinisk us. av lunger dokumentert 
 
   
9 Spirometri utført 
 
   
10 Måling av Hb, hematocrit (EVF), hvite, og arteriell 
blogass eller pulsoksimetri utført 
 
   
11 ABG utført hvis 
- hematocrit (EVF) >55, eller 
- dokumentert cyanose eller cor pulmonale, 
eller 
- FEV1< 1 L, eller FEV1 <50%, eller 
- SaO2 <92% i stabil fase 
 
   
12 Kroppsmasseindeks (KMI) dokumentert 
 
   
13 RTG Thorax utført, hvis ikke utført nylig 
 
   
14 Dokumentasjon av komorbide faktorer (så som 
koronar sykdom, depresjon, osteoporose, lungekreft, 
   
underernæring og muskel svakhet) 
 
15 Pasient klassifisert etter GOLD inndeling (stadium I-
IV) 
   
 
 
16 Et verktøy for sammensatt vurdering av 
sykdomsalvorlighet brukt – for eksempel BODE 
 
   
Behandling i stabil fase 
 
17 Råd om røykeslutt eller henvisning for dette i løpet 
av 3 måneder etter diagnose/første kontakt 
 
   
18 Oppfølging av komorbiditet (koronar sykdom, 
osteoporose osv), eller henvisning for dette i løpet av 
3 måneder etter diagnose/første kontakt 
 
   
19 Langtidsvirkende bronkodilatering hos alle med 
behandlingstrengende KOLS grad II eller høyere 
 
   
20 Behandling med inhalerte glukokortikoider hos de 
med FEV1<60% og gjentatte forverringer 
 
   
21 Ved foreskriving av inhalasjonmedisin utdanning i 
bruk av inhalator eller spacer dokumentert 
 
   
22 Compliance og teknikk med inhalasjoner 
dokumentert diskutert/kontrollert ved hver kontroll 
 
   
23 Ved bruk av forstøverbehandling effekt vurdert 
symptomatisk og behandling kun videreført hvis 
effekt 
 
   
24 Tillegg av theophyllin vurdert hvis annen behandling 
ikke fører til oppnådd behandlingsmål 
 
   
25 Ved gjentatte forverringer og FEV1<50% vurdert 
oppstart med roflumilast (Daxas) 
 
   
26 Ved >2 prednisolonkurer pr år forebyggende 
behandling mot osteoporose igangsatt, hvis ingen 
kontraindikasjon 
 
   
27 Kontinuerlig oksygenbehandling (LTOT) vurdert 
hvis 
- SaO2 i hvile <88% eller pO2 <7,3 kPa, i 
stabil fase 
- pO2 7,3-8,0 kPa og dokumenterte tegn 
til/kjent pulmonal hypertensjon, tegn til/kjent 
kongestiv hjertesvikt eller polycytemi, 
   
vurdering utført med tanke på kontinuerlig 
oksygenbehandling (LTOT) 
 
28 Dokumentasjon av bruk av influensa vaksine 
 
   
29 Dokumentasjon av pneumokokkvaksine bruk/status 
hos de med KOLS og alder >65 år 
 
   
30 Ved KOLS grad ≥2 henvist til, eller vurdert henvist 
til, lungerehabilitering  
   
 
 
31 Ernæringsmessige tiltak startet ved KMI <21 kg/m
2
 
eller KMI 21-25 kg/m
2
 og vekttap 
 
   
32 Pasient fått skriftlig plan for tiltak ved forverring 
(behandlingsplan) 
 
   
Behandling ved akutt forverrelse 
 
32 Dokumentasjon ved vurdering/innleggelse av 
følgende: 
 
   
33 Dokumentasjon ved vurdering/innleggelse av faste 
KOLS medisiner  
 
   
34 Informasjon om tidligere innleggelser og 
forverrelser, f. eks. alvorlighetsgrad og antall/år 
 
   
35 Dokumentasjon ved vurdering/innleggelse av 
tilstedeværelse eller fravær av nytilkommet hoste 
 
   
36 Dokumentasjon ved vurdering/innleggelse av vitale 
parametre: BT, RR, temp, puls, SaO2 
 
   
37 Dokumentasjon ved vurdering/innleggelse av 
somatisk lungeundersøkelse 
 
   
38 RTG Thorax tatt ved vurdering/innleggelse 
 
   
39 Arteriell blodgass tatt ved vurdering/innleggelse 
 
   
40 Ved tidligere koronar sykdom EKG i løpet av 24 
timer etter innleggelse med akutt KOLS forverring 
 
   
41 Ved teofyllin behandling speil tatt ved innleggelse 
med forverring 
 
   
42 Tilbud om inhalasjonsbehandlig hvis RR >24 
 
   
43 Ved KOLS forverring tilførsel av O2 hvis SaO2    
<88% eller pO2 <7,3 kPa 
 
44 Hvis poliklinisk vurdering tilby innleggelse hvis 
- akutt iskemi, eller 
- pneumoni, 
- signifikant nytilkommet hypoxemi, SaO2 
<88% eller pO2 <7,3 kPa 
- alvorlig underliggende kols 
- arytmi 
- manglende effekt av initial behandling 
 
   
45 Monitorering (telemetri og pulse oximetri) ved 
innleggelse hvis  
- alvorlig dyspnoe (RR >35 og bruk av 
aksessorisk resp. muskler på tross av initial 
behandling) 
- forvirring eller ”lethargy” 
- persisterende eller forverring av hypoxemi på 
tross av tilførsel av oksygen 
- alvorlig acidose (pH<7,3) 
 
   
46 Ved akutt forverring behandling med økt 
bronkodilatasjon igangsatt/vurdert 
 
   
47 Ved akutt forverring behandling med steroider 
igangsatt/vurdert 
 
   
48 Ved akutt forverring behandling med antibiotika 
igangsatt/vurdert 
 
   
49 Ved forverring antibiotika igangsatt ved 
- øket dyspnoe, øket ekspektorat og øket 
purulens av ekspektorat eller 
- forverring med 2 av 3 tegn over, så fremt øket 
purulens er et av tegnene eller 
- behov for mekanisk ventilasjon 
 
   
50 KOLS pasienter innlagt med forverring 
utskrevet/vurdert utskrevet med hjemme oksygen 
hvis siste SaO2 før utreise < 88% 
 
   
Generelle indikatorer 
 
51 Totalt sett et adekvat behandlingsforløp 







Sett en total score for behandlingsforløpet fra 1-10 
(1: dårlig forløp – 10: svært godt forløp) 
 
 
1  2  3  4  5  6  7  8  9  10 
Del II - ”Positiv prediktiv verdi” av henvisning 
 






  Nei 
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Kommentar: Beholdt eldre GOLD kriterier da nye kom i løpet av prosjektperioden 
Dyspepsi diagnoser delt opp i grupper med tanke på prioritering 
 
Dyspepsi diagnosene i 2 grupper 
 
Gruppe 1 – Alvorlig 
C15 Ondartet svulst i spiserør 
C16 Ondartet svulst i magesekk 
D37 Svulst med usikkert eller ukjent malignitetspotensiale i munnhule og fordøyelsesorganer 
I85 Øsofagusvaricer 
K20 Øsofagitt  
K22.0 Akalasi 
K22.1 Sår i spiserør 
K22.2 Obstruksjon av spiserør 
K22.3 Perforasjon av spiserør 
K22.7 Barrets øsofagus 
K22.8 Andre spesifiserte sykdommer i spiserør (blødning i spiserør) 
K25 Sår i magesekk 
K26 Sår i tolvfingertarm 
K27 Magesår, uspesifisert lokalisasjon 
K28 Gastrojejunalt sår 
K29 Gastritt og duodenitt 
K31.0 Akutt ventrikkeldilatasjon 
K31.1 Hypertrofisk pylorusstenose hos voksne 
K31.5 Obstruksjon av tolvfingertarm 
K31.6 Fistel i magesekk og tolvfingertarm 
K90.0 Coeliaki  
Gruppe 2 – Mindre alvorlig 
B37.8 Candida infeksjon med annen spesifisert lokalisasjon 
D13.0-2 Godartet svulst i andre og ufullstendig angitte deler av fordøyelsessystemet 
K21 Gastroøsofageal reflukssykdom 
K22.4 Øsofagusdyskinesi 
K22.5 Ervervet øsofagusdivertikkel 
K22.6 Gastroøsofagealt sår og blødningssyndrom (Mallory Weiss) 
K22.9 Uspesifisert sykdom i spiserør 
K30 Dyspepsi 
K31.2 Timeglassformet striktur og stenose av magesekk 
K31.3 Pylorusspasme 
K31.4 Magedivertikkel 
K31.7 Polypp i magesekk og tolvfingertarm 
K31.8 Andre spesifiserte sykdommer i magesekk og tolvfingertarm 
K31.9 Uspesifisert sykdom i magesekk og tolvfingertarm 
K44 Mellomgulvsbrokk 
K92 Hematemese (og uspesifisert GI blødning) 
R10 Smerte i buk og bekken 
R11 Kvalme og oppkast 
R12 Halsbrann 
R13 Dysfagi 
K90 Intestinal malabsorpsjon  
 
 
Dyspepsi diagnosene i 3 grupper 
 
Gruppe 1 – Meget alvorlig 
C15 Ondartet svulst i spiserør 
C16 Ondartet svulst i magesekk 
I85.0 Øsofagusvaricer med blødning 
K22.1 Sår i spiserør 
K22.2 Obstruksjon av spiserør 
K22.3 Perforasjon av spiserør 
K25 Sår i magesekk 
K26 Sår i tolvfingertarm 
K27 Magesår, uspesifisert lokalisasjon 
K28 Gastrojejunalt sår 
Gruppe 2 – Alvorlig 
D37 Svulst med usikkert eller ukjent malignitetspotensiale i munnhule og fordøyelsesorganer 
I85.9 Øsofagusvaricer uten blødning 
K20 Øsofagitt 
K21 Gastroøsofageal reflukssykdom 
K22.0 Akalasi 
K22.7 Barrets øsofagus 
K22.8 Andre spesifiserte sykdommer i spiserør (blødning i spiserør) 
K29 Gastritt og duodenitt 
K31.0 Akutt ventrikkeldilatasjon 
K31.1 Hypertrofisk pylorusstenose hos voksne 
K31.2 Timeglassformet striktur og stenose av magesekk 
K31.3 Pylorusspasme 
K31.5 Obstruksjon av tolvfingertarm 
K31.6 Fistel i magesekk og tolvfingertarm 
K31.7 Polypp i magesekk og tolvfingertarm 
K90.0 Coeliaki 
K90 Intestinal malabsorpsjon  
K92.0 Hematemese 
K92.1 Melena 
K92.2 Uspesifisert GI blødning 
Gruppe 3 – Mindre alvorlig 
B37.8 Candida infeksjon med annen spesifisert lokalisasjon 
D13.0-2 Godartet svulst i andre og ufullstendig angitte deler av fordøyelsessystemet 
K22.4 Øsofagusdyskinesi 
K22.5 Ervervet øsofagusdivertikkel 
K22.6 Gastroøsofagealt sår og blødningssyndrom (Mallory Weiss) 
K22.9 Uspesifisert sykdom i spiserør 
K30 Dyspepsi 
K31.4 Magedivertikkel 
K31.8 Andre spesifiserte sykdommer i magesekk og tolvfingertarm 
K31.9 Uspesifisert sykdom i magesekk og tolvfingertarm 
K44 Mellomgulvsbrokk 
K92.8 Andre spesifiserte sykdommer i fordøyelsessystemet 
K92.9 Uspesifisert sykdom i fordøyelsessystemet 
R10 Smerte i buk og bekken 





Dyspepsi diagnosene i 4 grupper 
 
Gruppe 1 – Meget alvorlig 
C15 Ondartet svulst i spiserør 
C16 Ondartet svulst i magesekk 
I85.0 Øsofagusvaricer med blødning 
K25.0-2 og 4-6 Sår i magesekk (med perforasjon eller blødning) 
K26.0-2 og 4-6 Sår i tolvfingertarm (med perforasjon eller blødning) 
K27.0-2 og 4-6 Magesår, uspesifisert lokalisasjon (med perforasjon eller blødning) 
K28.0-2 og 4-6 Gastrojejunalt sår (med perforasjon eller blødning)(inkl. anastomose sår) 
Gruppe 2 – Alvorlig 
D37 Svulst med usikkert eller ukjent malignitetspotensiale i munnhule og fordøyelsesorganer 
I85.9 Øsofagusvaricer uten blødning 
K22.0 Akalasi 
K22.1 Sår i spiserør 
K22.2 Obstruksjon av spiserør 
K22.3 Perforasjon av spiserør 
K22.7 Barrets øsofagus 
K22.8 Andre spesifiserte sykdommer i spiserør (blødning i spiserør) 
K25.3, 7 og 9 Sår i magesekk (uten blødning eller perforasjon) 
K26.3, 7 og 9 Sår i tolvfingertarm (uten blødning eller perforasjon) 
K27.3, 7 og 9 Magesår, uspesifisert lokalisasjon (uten blødning eller perforasjon) 
K28.3, 7 og 9 Gastrojejunalt sår (uten blødning eller perforasjon) 
K31.0 Akutt ventrikkeldilatasjon 
K31.5 Obstruksjon av tolvfingertarm 




K92.2 Uspesifisert GI blødning 
Gruppe 3 – Mindre alvorlig 
K20 Øsofagitt 
K21 Gastroøsofageal reflukssykdom 
K29 Gastritt og duodenitt 
K31.1 Hypertrofisk pylorusstenose hos voksne 
K31.2 Timeglassformet striktur og stenose av magesekk 
K31.3 Pylorusspasme 
K31.7 Polypp i magesekk og tolvfingertarm 
K31.8 Andre spesifiserte sykdommer i magesekk og tolvfingertarm 
K90 Intestinal malabsorpsjon 
K92.8 Andre spesifiserte sykdommer i fordøyelsessystemet 
Gruppe 4 – Ikke alvorlig 
B37.8 Candida infeksjon med annen spesifisert lokalisasjon 
D13.0-2 Godartet svulst i andre og ufullstendig angitte deler av fordøyelsessystemet 
K22.4 Øsofagusdyskinesi 
K22.5 Ervervet øsofagusdivertikkel 
K22.6 Gastroøsofagealt sår og blødningssyndrom (Mallory Weiss) 
K22.9 Uspesifisert sykdom i spiserør 
K30 Dyspepsi 
K31.4 Magedivertikkel 
K31.9 Uspesifisert sykdom i magesekk og tolvfingertarm 
K44 Mellomgulvsbrokk 
K92.9 Uspesifisert sykdom i fordøyelsessystemet 
R10 Smerte i buk og bekken 




Mistanke cancer coli diagnoser delt opp i grupper med tanke på prioritering 
 
Mistanke cancer coli diagnoser i 2 grupper 
 
Gruppe 1 – Alvorlig 
C18 Ondartet svulst i tykktarm 
C19 Ondartet svulst i overgang mellom sigmoideum og endetarm 
C20 Ondartet svulst i endetarm 
C21 Ondartet svulst i endetarmsåpning og analkanal 
C26 Ondartet svulst i andre og ufullstendig angitte fordøyelsesorganer 
D37 Svulst med usikkert eller ukjent malignitetspotensiale i munnhule og fordøyelsesorganer 
K50 Crohns sykdom 
K51 Ulcerøs kolitt 
K55.0 Akutt vaskulær forstyrrelse i tarm 
K56 Paralytisk ileus og tarmobstruksjon uten brokk 
K57.0 Divertikkelsykdom i tynntarm med perforasjon og abscess 
K57.2 Divertikkelsykdom i tykktarm med perforasjon og abscess 
K57.4 Divertikkelsykdom i både tynn- og tykktarm med perforasjon og abscess 
K57.8 Divertikkelsykdom i tarm, uspesifisert del, med perforasjon eller abscess 
K59.3 Megacolon, ikke klassifisert annet sted 
K60 Fissur og fistel i anal- og rektalområdet 
K63.0 Tarmabscess 




K92.2 Uspesifisert GI blødning 
Gruppe 2 – Mindre alvorlig 
D12 Godartet svulst i tykktarm, endetarm, analkanal og endetarmsåpning 
D13 Godartet svulst i andre og ufullstendig angitte deler av fordøyelsessystemet 
D50 Jernmangelanemi (da denne står igjen etter utredning) 
I84 Hemoroider 
K52 Annen ikke infeksiøs gastroenteritt og kolitt 
K55.1 Kronisk vaskulær forstyrrelse i tarm  
K55.2 Angiodysplasi i tykktarm 
K55.8 Annen spesifisert vaskulær forstyrrelse i tarm 
K55.9 Uspesifisert vaskulær forstyrrelse i tarm 
K57.1 Divertikkelsykdom i tynntarm uten perforasjon og abscess 
K57.3 Divertikkelsykdom i tykktarm uten perforasjon og abscess 
K57.5 Divertikkelsykdom i både tynn- og tykktarm uten perforasjon og abscess 
K57.9 Divertikkelsykdom i tarm, uspesifisert del, uten perforasjon eller abscess 
K58 Irritable tarm-syndrom 
K59 Andre funksjonelle forstyrrelser i tarm (unntatt K59.3) 
K63.3 Sår i tarm 
K63.4 Tarmdescens (enteroptose)  
K63.5 Polypp i tykktarm 
K63.8 Andre spesifiserte sykdommer i tarm 
K63.9 Uspesifiserte sykdommer i tarm 
K92.8 Andre spesifiserte sykdommer i fordøyelsessystemet 
K92.9 Uspesifisert sykdom i fordøyelsessystemet 
R10 Smerte i buk og bekken 
R19.4 Endring i avføringsvane 
R53 Uvelhet og tretthet 
R63.0 Anorexi 
R63.4 Unormalt vekttap 
R70.0 Økt senkningsreaksjon 
Z03.1 Observasjon ved mistanke om ondartet svulst 
Z03.8 Observasjon ved mistank om annen spesifisert sykdom og tilstand 
Z12.1 Målrettet undersøkelse med henblikk på svulst i tarm 
 
Mistanke cancer coli diagnoser i 3 grupper 
 
Gruppe 1 – Meget alvorlig 
C18 Ondartet svulst i tykktarm 
C19 Ondartet svulst i overgang mellom sigmoideum og endetarm 
C20 Ondartet svulst i endetarm 
C21 Ondartet svulst i endetarmsåpning og analkanal 
C26 Ondartet svulst i andre og ufullstendig angitte fordøyelsesorganer 
K55.0 Akutt vaskulær forstyrrelse i tarm 
K56 Paralytisk ileus og tarmobstruksjon uten brokk 
K57.0 Divertikkelsykdom i tynntarm med perforasjon og abscess  
K57.2 Divertikkelsykdom i tykktarm med perforasjon og abscess  
K57.4 Divertikkelsykdom i både tynn- og tykktarm med perforasjon og abscess  
K57.8 Divertikkelsykdom i tarm, uspesifisert del, med perforasjon eller abscess  
Gruppe 2 – Alvorlig 
D37 Svulst med usikkert eller ukjent malignitetspotensiale i munnhule og fordøyelsesorganer 
K50 Crohns sykdom 
K51 Ulcerøs kolitt 
K55.1 Kronisk vaskulær forstyrrelse i tarm 
K59.3 Megacolon, ikke klassifisert annet sted 
K60 Fissur og fistel i anal- og rektalområdet 
K63.0 Tarmabscess 
K63.1 Perforasjon av tarm (ikke-traumatisk) 
K63.2 Tarmfistel 
K63.3 Sår i tarm 
K55.8 Annen spesifisert vaskulær forstyrrelse i tarm 
K55.9 Uspesifisert vaskulær forstyrrelse i tarm 
K92.0 Hematemese 
K92.1 Melena 
K92.2 Uspesifisert GI blødning 
R63.4 Unormalt vekttap 
Gruppe 3 – Mindre alvorlig 
D12 Godartet svulst i tykktarm, endetarm, analkanal og endetarmsåpning 
D13 Godartet svulst i andre og ufullstendig angitte deler av fordøyelsessystemet 
D50 Jernmangelanemi (da denne står igjen etter utredning) 
I84 Hemoroider 
K52 Annen ikke infeksiøs gastroenteritt og kolitt 
K55.2 Angiodysplasi i tykktarm 
K57.1 Divertikkelsykdom i tynntarm uten perforasjon og abscess 
K57.3 Divertikkelsykdom i tykktarm uten perforasjon og abscess 
K57.5 Divertikkelsykdom i både tynn- og tykktarm uten perforasjon og abscess 
K57.9 Divertikkelsykdom i tarm, uspesifisert del, uten perforasjon eller abscess 
K58 Irritable tarm-syndrom 
K59 Andre funksjonelle forstyrrelser i tarm (unntatt K59.3) 
K63.4 Tarmdescens (enteroptose) (hva er dette?) 
K63.5 Polypp i tykktarm 
K63.8 Andre spesifiserte sykdommer i tarm 
K63.9 Uspesifiserte sykdommer i tarm 
K92.8 Andre spesifiserte sykdommer i fordøyelsessystemet 
K92.9 Uspesifisert sykdom i fordøyelsessystemet 
R10 Smerte i buk og bekken 
R19.4 Endring i avføringsvane 
R53 Uvelhet og tretthet 
R63.0 Anorexi 
R70.0 Økt senkningsreaksjon 
Z03.1 Observasjon ved mistanke om ondartet svulst 
Z03.8 Observasjon ved mistank om annen spesifisert sykdom og tilstand 
Z12.1 Målrettet undersøkelse med henblikk på svulst i tarm 
 
Mistanke cancer coli diagnoser i 4 grupper 
 
Gruppe 1 – Meget alvorlig 
C18 Ondartet svulst i tykktarm 
C19 Ondartet svulst i overgang mellom sigmoideum og endetarm 
C20 Ondartet svulst i endetarm 
C21 Ondartet svulst i endetarmsåpning og analkanal 
C26 Ondartet svulst i andre og ufullstendig angitte fordøyelsesorganer 
K55.0 Akutt vaskulær forstyrrelse i tarm 
K56 Paralytisk ileus og tarmobstruksjon uten brokk 
K57.0 Divertikkelsykdom i tynntarm med perforasjon og abscess  
K57.2 Divertikkelsykdom i tykktarm med perforasjon og abscess  
K57.4 Divertikkelsykdom i både tynn- og tykktarm med perforasjon og abscess  
K57.8 Divertikkelsykdom i tarm, uspesifisert del, med perforasjon eller abscess  
Gruppe 2 – Alvorlig 
D37 Svulst med usikkert eller ukjent malignitetspotensiale i munnhule og fordøyelsesorganer 
K50 Crohns sykdom 
K51 Ulcerøs kolitt 
K59.3 Megacolon, ikke klassifisert annet sted 
K60 Fissur og fistel i anal- og rektalområdet 
K63.0 Tarmabscess 
K63.1 Perforasjon av tarm (ikke-traumatisk) 
K63.2 Tarmfistel 
K63.3 Sår i tarm 
K55.8 Annen spesifisert vaskulær forstyrrelse i tarm 
K92.0 Hematemese 
K92.1 Melena 
K92.2 Uspesifisert GI blødning 
Gruppe 3 – Mindre alvorlig 
D12 Godartet svulst i tykktarm, endetarm, analkanal og endetarmsåpning 
D13 Godartet svulst i andre og ufullstendig angitte deler av fordøyelsessystemet 
K52.0 Gastroenteritt og kolitt som skyldes stråling 
K52.1 Toksisk gastroenteritt og kolitt 
K52.2 Allergisk og diettbetinget gastroenteritt og kolitt 
K52.3 Ubestemt kolitt 
K52.8 Annen spesifisert ikke-infeksiøs gastroenteritt og kolitt 
K55.1 Kronisk vaskulær forstyrrelse i tarm 
K55.9 Uspesifisert vaskulær forstyrrelse i tarm 
D50 Jernmangelanemi (da denne står igjen etter utredning) 
K55.2 Angiodysplasi i tykktarm 
K57.1 Divertikkelsykdom i tynntarm uten perforasjon og abscess 
K57.3 Divertikkelsykdom i tykktarm uten perforasjon og abscess 
K57.5 Divertikkelsykdom i både tynn- og tykktarm uten perforasjon og abscess 
K57.9 Divertikkelsykdom i tarm, uspesifisert del, uten perforasjon eller abscess 
K63.4 Tarmdescens (enteroptose) (hva er dette?) 
K63.5 Polypp i tykktarm  
K63.8 Andre spesifiserte sykdommer i tarm 
K92.8 Andre spesifiserte sykdommer i fordøyelsessystemet 
R63.4 Unormalt vekttap 
Gruppe 4 – Ikke alvorlig 
I84 Hemoroider 
K52.9 Uspesifisert ikke-infeksiøs gastroenteritt og kolitt 
K58 Irritable tarm-syndrom 
K59 Andre funksjonelle forstyrrelser i tarm (unntatt K59.3) 
K63.9 Uspesifiserte sykdommer i tarm 
K92.9 Uspesifisert sykdom i fordøyelsessystemet 
R10 Smerte i buk og bekken 
R19.4 Endring i avføringsvane 
R53 Uvelhet og tretthet 
R63.0 Anorexi 
R70.0 Økt senkningsreaksjon 
Z03.1 Observasjon ved mistanke om ondartet svulst 
Z03.8 Observasjon ved mistank om annen spesifisert sykdom og tilstand 
Z12.1 Målrettet undersøkelse med henblikk på svulst i tarm 
 
Brystsmerte diagnoser delt opp i grupper med tanke på prioritering 
 
Brystsmerte diagnosene i 2 grupper 
 
Gruppe 1 - alvorlig 
I11.0 Hypertensiv hjertesykdom med stuvningssvikt 
I15 Sekundær hypertensjon 
I20 Angina pektoris 
I21 Akutt hjerteinfarkt 
I25 Kronisk iskemisk hjertesykdom 
I30 Akutt perikarditt 
I35 Ikke-reumatisk aortaklaffefeil 
I42 Kardiomyopati 
I44 Atrioventrikulært og venstresidig grenblokk 
I45.6 Preeksitasjonssyndromer 
I48 Atrieflimmer og atrieflutter 
I49.0 Ventrikkelflimmer og ventrikkelflutter 
I50 Hjertesvikt 
Gruppe 2 – mindre alvorlig 
B02 Herpes zoster 
F41 Angstlidelser (inkl. panikklidelse) 
I10 Hypertensjon 
I11.9 Hypertensiv hjertesykdom uten stuvningssvikt 
I45 Andre ledningsforstyrrelser (eksl. I45.6) 
I47 Paroxysmal takykardi 
I49.1-9 Annen hjertearytmi 
K21 Gastroøsofageal reflukssykdom 
K22.4 Øsofagusdyskinesi 
K30 Dyspepsi 
M 79.1 Thorax myalgi 
M94.0 Smerte på overgang mellom ribben og ribbensbrusk 
R00 Unormale hjerteslag 
R07.4 Brystsmerte 
R09.1 Pleuritt 
R55 Synkope og kollaps 















Brystsmerte diagnosene i 3 grupper 
 
Gruppe 1 – meget alvorlig 
I20.0 Ustabil angina 
I21 Akutt hjerteinfarkt 
I44.2 Atrioventrikulært blokk, totalt 
I49.0 Ventrikkelflimmer og ventrikkelflutter 
Gruppe 2 – alvorlig 
I11.0 Hypertensiv hjertesykdom med stuvningssvikt 
I15 Sekundær hypertensjon 
I20.1-9 Angina pektoris 
I25 Kronisk iskemisk hjertesykdom 
I30 Akutt perikarditt 
I35 Ikke-reumatisk aortaklaffefeil 
I42 Kardiomyopati 
I44.0-1 og 3-7 Atrioventrikulært og venstresidig grenblokk 
I45.6 Preeksitasjonssyndromer 
I47 Paroxysmal takykardi 
I48 Atrieflimmer og atrieflutter 
I49.5 Syk-sinus syndrom (SSS) 
I50 Hjertesvikt 
Gruppe 3 – mindre alvorlig 
B02 Herpes zoster 
F41 Angstlidelser (inkl. panikklidelse) 
I10 Hypertensjon 
I11.9 Hypertensiv hjertesykdom uten stuvningssvikt 
I45 Andre ledningsforstyrrelser (eksl. I45.6) 
I49.1-4 og 8-9 Annen hjertearytmi 
K21 Gastroøsofageal reflukssykdom 
K22.4 Øsofagusdyskinesi 
K30 Dyspepsi 
M 79.1 Thorax myalgi 
M94.0 Smerte på overgang mellom ribben og ribbensbrusk 
R00 Unormale hjerteslag 
R07.4 Brystsmerte 
R09.1 Pleuritt 
R55 Synkope og kollaps 













Brystsmerte diagnosene i 4 grupper 
 
Gruppe 1 – Meget alvorlig 
I20.0 Ustabil angina 
I21 Akutt hjerteinfarkt 
I44.2 Atrioventrikulært blokk, totalt 
I49.0 Ventrikkelflimmer og ventrikkelflutter 
Gruppe 2 – Alvorlig 
I11.0 Hypertensiv hjertesykdom med stuvningssvikt 
I15 Sekundær hypertensjon 
I20.1-9 Angina pektoris 
I30 Akutt perikarditt 
I35 Ikke-reumatisk aortaklaffefeil 
I42 Kardiomyopati 
I45.6 Preeksitasjonssyndromer 
I48 Atrieflimmer og atrieflutter 
I49.5 Syk-sinus-syndrom (SSS) 
I50.0-1 Hjertesvikt 
Gruppe 3 – Mindre alvorlig 
I10 Hypertensjon 
I11.9 Hypertensiv hjertesykdom uten stuvningssvikt 
I25 Kronisk iskemisk hjertesykdom 
I44.0-1 og 3-7 Atrioventrikulært og venstresidig grenblokk 
I45 Andre ledningsforstyrrelser (eksl. I45.6) 
I47 Paroxysmal takykardi 
I49.1-4 og 8-9 Annen hjertearytmi 
I50.9 Uspesifisert hjertesvikt 
K21 Gastroøsofageal reflukssykdom 
Gruppe 4 – Ikke alvorlig 
B02 Herpes zoster 
F41 Angstlidelser (inkl. panikklidelse) 
K22.4 Øsofagusdyskinesi 
K30 Dyspepsi 
M 79.1 Thorax myalgi 
M94.0 Smerte på overgang mellom ribben og ribbensbrusk 
R00 Unormale hjerteslag 
R07.4 Brystsmerte 
R09.1 Pleuritt 
R55 Synkope og kollaps 
Z03.5 Observasjon ved mistanke om andre hjerte-kar sykdommer 
 
KOLS diagnoser delt opp i grupper med tanke på prioritering 
 
KOLS diagnosene i 2 grupper 
 
Gruppe 1 - alvorlig 
C34 Ondartet svulst i bronkie eller lunge 
C45 Mesoteliom 
C78.0, 2 og 3 Lungemetastase, .2 i brysthinne og .3 andre åndedrettsorganer 
D02 Carcinoma in situ i mellomøre og åndedrettsorganer 
D14.2 Godartet svulst i trachea 
D14.3 Godartet svulst i bronkie eller lunge 
D14.4 Godartet svulst i åndedrettsorgan, uspesifisert 
D38.1 Svulst med usikkert eller ukjent malignitetspotensiale i luftrør, bronkie eller lunge 
D38.2 Svulst med usikkert eller ukjent malignitetspotensiale i brysthinne 
D38.6 Svulst med usikkert eller ukjent malignitetspotensiale i åndedrettsorgan, uspesifisert 
J46 Akutt alvorlig astma 
Gruppe 2 – mindre alvorlig 
D19.0 Godartet svulst i pleura 
E84 Cystisk fibrose 
J40 Bronkitt, ikke spesifisert som akutt eller kronisk 
J41 Ukomplisert og mukopurulent kronisk bronkitt 





J60-67 Pneumokoniose og luftveissykdom pga. organisk støv 
J84 Interstitielle lungesykdommer 






















KOLS diagnosene i 3 grupper 
 
Gruppe 1 – meget alvorlig 
C34 Ondartet svulst i bronkie eller lunge 
C45 Mesoteliom 
C78.0, 2 og 3 Lungemetastase, .2 i brysthinne og .3 andre åndedrettsorganer 
D02 Carcinoma in situ i mellomøre og åndedrettsorganer 
D14.2 Godartet svulst i trachea 
D14.3 Godartet svulst i bronkie eller lunge 
D14.4 Godartet svulst i åndedrettsorgan, uspesifisert 
D38.1 Svulst med usikkert eller ukjent malignitetspotensiale i luftrør, bronkie eller lunge 
D38.2 Svulst med usikkert eller ukjent malignitetspotensiale i brysthinne 
D38.6 Svulst med usikkert eller ukjent malignitetspotensiale i åndedrettsorgan, uspesifisert 
J46 Akutt alvorlig astma 
Gruppe 2 – alvorlig 
J44 KOLS stadium IV 
J84 Interstitielle lungesykdommer 
Gruppe 3 – mindre alvorlig 
D14.2 Godartet svulst i trachea 
D14.3 Godartet svulst i bronkie eller lunge 
D14.4 Godartet svulst i åndedrettsorgan, uspesifisert 
D19.0 Godartet svulst i pleura 
E84 Cystisk fibrose 
J40 Bronkitt, ikke spesifisert som akutt eller kronisk 
J41 Ukomplisert og mukopurulent kronisk bronkitt 
J42 Uspesifisert kronisk bronkitt 
J43 Emfysem 
J44 KOLS – stadium I-III 
J45 Astma 
J47 Bronkiektasier 
J60-67 Pneumokoniose og luftveissykdom pga. organisk støv 



















KOLS diagnosene i 4 grupper 
 
Gruppe 1 – Meget alvorlig 
D14.2 Godartet svulst i trachea 
D14.3 Godartet svulst i bronkie eller lunge 
D14.4 Godartet svulst i åndedrettsorgan, uspesifisert 
C34 Ondartet svulst i bronkie eller lunge 
D38.1 Svulst med usikkert eller ukjent malignitetspotensiale i luftrør, bronkie eller lunge 
D38.2 Svulst med usikkert eller ukjent malignitetspotensiale i brysthinne 
D38.6 Svulst med usikkert eller ukjent malignitetspotensiale i åndedrettsorgan, uspesifisert 
C45 Mesoteliom 
C78.0, 2 og 3 Lungemetastase, .2 i brysthinne og .3 andre åndedrettsorganer 
D02 Carcinoma in situ i mellomøre og åndedrettsorganer 
J46 Akutt alvorlig astma 
Gruppe 2 – Alvorlig 
J44 KOLS stadium IV 
Gruppe 3 – Mindre alvorlig 
E84 Cystisk fibrose 
J43 Emfysem 
J44 KOLS I-II 
J44 KOLS – stadium III 
J45 Astma 
J47 Bronkiektasier 
J84 Interstitielle lungesykdommer 
Gruppe 4 – Ikke alvorlig 
D19.0 Godartet svulst i pleura 
J40 Bronkitt, ikke spesifisert som akutt eller kronisk 
J41 Ukomplisert og mukopurulent kronisk bronkitt 
J42 Uspesifisert kronisk bronkitt 
J60-67 Pneumokoniose og luftveissykdom pga. organisk støv 
Z03.9 Observasjon ved mistanke om uspesifisert sykdom eller tilstand 
 
 
            Samhandling i praksis.          
 
Forespørsel om deltakelse i forskningsprosjektet 
 ”Samhandling i praksis – en randomisert kontrollert 
intervensjonsstudie ” 
 
Bakgrunn og hensikt: Dette informasjonsskrivet er et spørsmål til deg om å delta i en 
forskningsstudie som skal utvikle samarbeidet mellom fastlegen og sykehuset. Medisinsk avdeling 
UNN Harstad er ansvarlige for prosjektet.  
 
Hva innebærer studien? Studien innebærer at en gruppe fastleger benytter et forhåndsbestemt skjema 
ved henvisning til sykehuset, mens noen bruker vanlige henvisninger. Videre utredning og behandling 
vil være helt lik i de to gruppene. Vi kommer deretter til å undersøke om bruken av dette skjemaet har 
ført til endringer i behandlingsløpet for den enkelte pasient. Vi kommer også til å sende et 
spørreskjema til pasientene, for å se hvor fornøyde de er med behandlingen. 
 
Mulige fordeler og ulemper: Vi tror at denne studien kan hjelpe oss å finne bedre måter å samarbeide 
mellom fastleger og sykehuset, og dermed kunne gi bedre behandling til hver enkelt pasient. For deg 
vil ikke studien medføre spesielle fordeler eller ulemper, men vi kommer til å be deg fylle ut et kort 
spørreskjema i forbindelse med sykehusbesøket. En doktor på sykehuset vil også gå gjennom din 
journal for å kartlegge ditt behandlingsforløp i etterkant. Denne informasjonen vil bli anonymisert. 
 
Hva skjer med informasjonen om deg? Informasjonen som registreres om deg skal kun brukes slik 
som beskrevet i hensikten med studien. Alle opplysningene og prøvene vil bli behandlet uten navn og 
fødselsnummer eller andre direkte gjenkjennende opplysninger. En kode knytter deg til dine 
opplysninger gjennom en konfidensiell navneliste.  
 
Det er kun autorisert personell knyttet til prosjektet som har adgang til navnelisten og som kan finne 
tilbake til deg. Det vil ikke være mulig å identifisere deg i resultatene av studien når disse publiseres.  
 
Frivillig deltakelse: Det er frivillig å delta i studien. Du kan når som helst og uten å oppgi noen grunn 
trekke ditt samtykke til å delta i studien. Dette vil ikke få konsekvenser for din videre behandling. 
Dersom du ønsker å delta, undertegner du samtykkeerklæringen på siste side. Om du nå sier ja til å 
delta, kan du senere trekke tilbake ditt samtykke uten at det påvirker din øvrige behandling. Dersom du 
senere ønsker å trekke deg eller har spørsmål til studien, kan du kontakte: 
 
Prosjektmedarbeider assistent lege Henrik Wåhlberg – 770 15 000 eller henrik.wahlberg2@unn.no 
Prosjektleder overlege dr. med. Ann Ragnhild Broderstad – 770 15 000 
 
 




Ytterligere informasjon om personvern og studien finnes i kapittel A 
 
 
            Samhandling i praksis.          
 
 
Kapittel A - Personvern 
 
Personvern: Opplysninger som registreres om deg vil bli hentet fra din elektroniske journal ved 
medisinsk avdeling UNN Harstad. Det som vil bli registrert er demografiske variabler (som kjønn og 
alder), og detaljer om behandlingsforløpet (ventetid før time, antall legetimer før diagnose osv) og vi 
vil ut fra forhåndsoppsatte kriterier gi en totalt kvalitetsskår på ditt behandlingsforløp. Dataene vil bli 
lagt anonymt inn i en database, og i alle publikasjoner vil være fullt ut anonyme. 
 
Universitetssykehuset Nord-Norge ved administrerende direktør Tor Ingebrigtsen er 
databehandlingsansvarlig. 
 
Rett til innsyn og sletting av opplysninger om deg og sletting av prøver: Hvis du sier ja til å delta i 
studien, har du rett til å få innsyn i hvilke opplysninger som er registrert om deg. Du har videre rett til 
å få korrigert eventuelle feil i de opplysningene vi har registrert. Dersom du trekker deg fra studien, 
kan du kreve å få slettet innsamlede prøver og opplysninger, med mindre opplysningene allerede er 
inngått i analyser eller brukt i vitenskapelige publikasjoner.  
 
Økonomi og rolle: Studien er finansiert gjennom forskningsmidler fra Helse Nord.  
 
Informasjon om utfallet av studien: Hvis du ønsker å få vite om utfallet av studien, kan du kontakte 
prosjektmedarbeider Henrik Wåhlberg på henrik.wahlberg2@unn.no (prosjektet forventes ferdig i 
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Samtykke til deltakelse i studien 
 
 


















(Signert, rolle i studien, dato) 
 
 
 
